id	sid	tid	token	lemma	pos
cord-003926-ycdaw2vh	1	1	key	key	NN
cord-003926-ycdaw2vh	1	2	:	:	:
cord-003926-ycdaw2vh	2	1	cord-003926-ycdaw2vh	cord-003926-ycdaw2vh	NNP
cord-003926-ycdaw2vh	3	1	authors	author	NNS
cord-003926-ycdaw2vh	3	2	:	:	:
cord-003926-ycdaw2vh	3	3	Maslow	Maslow	NNP
cord-003926-ycdaw2vh	3	4	,	,	,
cord-003926-ycdaw2vh	3	5	Joel	Joel	NNP
cord-003926-ycdaw2vh	3	6	N.	N.	NNP
cord-003926-ycdaw2vh	3	7	title	title	NN
cord-003926-ycdaw2vh	3	8	:	:	:
cord-003926-ycdaw2vh	3	9	Zika	Zika	NNP
cord-003926-ycdaw2vh	3	10	Vaccine	Vaccine	NNP
cord-003926-ycdaw2vh	3	11	Development	Development	NNP
cord-003926-ycdaw2vh	3	12	—	—	:
cord-003926-ycdaw2vh	3	13	Current	Current	NNP
cord-003926-ycdaw2vh	3	14	Progress	Progress	NNP
cord-003926-ycdaw2vh	3	15	and	and	CC
cord-003926-ycdaw2vh	3	16	Challenges	challenge	NNS
cord-003926-ycdaw2vh	3	17	for	for	IN
cord-003926-ycdaw2vh	3	18	the	the	DT
cord-003926-ycdaw2vh	3	19	Future	future	JJ
cord-003926-ycdaw2vh	3	20	date	date	NN
cord-003926-ycdaw2vh	3	21	:	:	:
cord-003926-ycdaw2vh	3	22	2019	2019	CD
cord-003926-ycdaw2vh	3	23	-	-	HYPH
cord-003926-ycdaw2vh	3	24	07	07	CD
cord-003926-ycdaw2vh	3	25	-	-	SYM
cord-003926-ycdaw2vh	3	26	14	14	CD
cord-003926-ycdaw2vh	3	27	journal	journal	NN
cord-003926-ycdaw2vh	3	28	:	:	:
cord-003926-ycdaw2vh	4	1	Trop	Trop	NNP
cord-003926-ycdaw2vh	4	2	Med	Med	NNP
cord-003926-ycdaw2vh	4	3	Infect	infect	VB
cord-003926-ycdaw2vh	4	4	Dis	dis	NN
cord-003926-ycdaw2vh	4	5	DOI	doi	NN
cord-003926-ycdaw2vh	5	1	:	:	:
cord-003926-ycdaw2vh	5	2	10.3390	10.3390	CD
cord-003926-ycdaw2vh	5	3	/	/	SYM
cord-003926-ycdaw2vh	5	4	tropicalmed4030104	tropicalmed4030104	NNP
cord-003926-ycdaw2vh	5	5	sha	sha	NNP
cord-003926-ycdaw2vh	5	6	:	:	:
cord-003926-ycdaw2vh	6	1	7a8f035845b43c4e3b01a3034bff85a7ae9b8dfc	7a8f035845b43c4e3b01a3034bff85a7ae9b8dfc	NNP
cord-003926-ycdaw2vh	6	2	doc_id	doc_id	CD
cord-003926-ycdaw2vh	6	3	:	:	:
cord-003926-ycdaw2vh	6	4	3926	3926	CD
cord-003926-ycdaw2vh	6	5	cord_uid	cord_uid	NN
cord-003926-ycdaw2vh	6	6	:	:	:
cord-003926-ycdaw2vh	7	1	ycdaw2vh	ycdaw2vh	NNP
cord-003926-ycdaw2vh	7	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	7	3	virus	virus	NN
cord-003926-ycdaw2vh	7	4	is	be	VBZ
cord-003926-ycdaw2vh	7	5	an	an	DT
cord-003926-ycdaw2vh	7	6	emergent	emergent	JJ
cord-003926-ycdaw2vh	7	7	pathogen	pathogen	NN
cord-003926-ycdaw2vh	7	8	that	that	WDT
cord-003926-ycdaw2vh	7	9	gained	gain	VBD
cord-003926-ycdaw2vh	7	10	significant	significant	JJ
cord-003926-ycdaw2vh	7	11	importance	importance	NN
cord-003926-ycdaw2vh	7	12	during	during	IN
cord-003926-ycdaw2vh	7	13	the	the	DT
cord-003926-ycdaw2vh	7	14	epidemic	epidemic	NN
cord-003926-ycdaw2vh	7	15	in	in	IN
cord-003926-ycdaw2vh	7	16	South	South	NNP
cord-003926-ycdaw2vh	7	17	and	and	CC
cord-003926-ycdaw2vh	7	18	Central	Central	NNP
cord-003926-ycdaw2vh	7	19	America	America	NNP
cord-003926-ycdaw2vh	7	20	as	as	IN
cord-003926-ycdaw2vh	7	21	unusual	unusual	JJ
cord-003926-ycdaw2vh	7	22	and	and	CC
cord-003926-ycdaw2vh	7	23	alarming	alarming	JJ
cord-003926-ycdaw2vh	7	24	complications	complication	NNS
cord-003926-ycdaw2vh	7	25	of	of	IN
cord-003926-ycdaw2vh	7	26	infection	infection	NN
cord-003926-ycdaw2vh	7	27	were	be	VBD
cord-003926-ycdaw2vh	7	28	recognized	recognize	VBN
cord-003926-ycdaw2vh	7	29	.	.	.
cord-003926-ycdaw2vh	8	1	Although	although	IN
cord-003926-ycdaw2vh	8	2	initially	initially	RB
cord-003926-ycdaw2vh	8	3	considered	consider	VBD
cord-003926-ycdaw2vh	8	4	a	a	DT
cord-003926-ycdaw2vh	8	5	self	self	NN
cord-003926-ycdaw2vh	8	6	-	-	HYPH
cord-003926-ycdaw2vh	8	7	limited	limit	VBN
cord-003926-ycdaw2vh	8	8	benign	benign	JJ
cord-003926-ycdaw2vh	8	9	infection	infection	NN
cord-003926-ycdaw2vh	8	10	,	,	,
cord-003926-ycdaw2vh	8	11	a	a	DT
cord-003926-ycdaw2vh	8	12	panoply	panoply	NN
cord-003926-ycdaw2vh	8	13	of	of	IN
cord-003926-ycdaw2vh	8	14	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	8	15	complications	complication	NNS
cord-003926-ycdaw2vh	8	16	were	be	VBD
cord-003926-ycdaw2vh	8	17	recognized	recognize	VBN
cord-003926-ycdaw2vh	8	18	including	include	VBG
cord-003926-ycdaw2vh	8	19	a	a	DT
cord-003926-ycdaw2vh	8	20	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	8	21	–	–	:
cord-003926-ycdaw2vh	8	22	Barré	Barré	NNP
cord-003926-ycdaw2vh	8	23	-	-	HYPH
cord-003926-ycdaw2vh	8	24	like	like	JJ
cord-003926-ycdaw2vh	8	25	syndrome	syndrome	NN
cord-003926-ycdaw2vh	8	26	and	and	CC
cord-003926-ycdaw2vh	8	27	in	in	IN
cord-003926-ycdaw2vh	8	28	-	-	HYPH
cord-003926-ycdaw2vh	8	29	utero	utero	NN
cord-003926-ycdaw2vh	8	30	fetal	fetal	JJ
cord-003926-ycdaw2vh	8	31	infection	infection	NN
cord-003926-ycdaw2vh	8	32	causing	cause	VBG
cord-003926-ycdaw2vh	8	33	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	8	34	,	,	,
cord-003926-ycdaw2vh	8	35	blindness	blindness	NN
cord-003926-ycdaw2vh	8	36	,	,	,
cord-003926-ycdaw2vh	8	37	and	and	CC
cord-003926-ycdaw2vh	8	38	other	other	JJ
cord-003926-ycdaw2vh	8	39	congenital	congenital	JJ
cord-003926-ycdaw2vh	8	40	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	8	41	complications	complication	NNS
cord-003926-ycdaw2vh	8	42	.	.	.
cord-003926-ycdaw2vh	9	1	Numerous	numerous	JJ
cord-003926-ycdaw2vh	9	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	9	3	virus	virus	NN
cord-003926-ycdaw2vh	9	4	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	9	5	were	be	VBD
cord-003926-ycdaw2vh	9	6	developed	develop	VBN
cord-003926-ycdaw2vh	9	7	,	,	,
cord-003926-ycdaw2vh	9	8	with	with	IN
cord-003926-ycdaw2vh	9	9	nine	nine	CD
cord-003926-ycdaw2vh	9	10	different	different	JJ
cord-003926-ycdaw2vh	9	11	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	9	12	representing	represent	VBG
cord-003926-ycdaw2vh	9	13	five	five	CD
cord-003926-ycdaw2vh	9	14	different	different	JJ
cord-003926-ycdaw2vh	9	15	platforms	platform	NNS
cord-003926-ycdaw2vh	9	16	entered	enter	VBN
cord-003926-ycdaw2vh	9	17	into	into	IN
cord-003926-ycdaw2vh	9	18	clinical	clinical	JJ
cord-003926-ycdaw2vh	9	19	trials	trial	NNS
cord-003926-ycdaw2vh	9	20	,	,	,
cord-003926-ycdaw2vh	9	21	one	one	CD
cord-003926-ycdaw2vh	9	22	progressing	progress	VBG
cord-003926-ycdaw2vh	9	23	to	to	IN
cord-003926-ycdaw2vh	9	24	Phase	Phase	NNP
cord-003926-ycdaw2vh	9	25	II	II	NNP
cord-003926-ycdaw2vh	9	26	.	.	.
cord-003926-ycdaw2vh	10	1	Here	here	RB
cord-003926-ycdaw2vh	10	2	we	-PRON-	PRP
cord-003926-ycdaw2vh	10	3	review	review	VBP
cord-003926-ycdaw2vh	10	4	the	the	DT
cord-003926-ycdaw2vh	10	5	current	current	JJ
cord-003926-ycdaw2vh	10	6	landscape	landscape	NN
cord-003926-ycdaw2vh	10	7	and	and	CC
cord-003926-ycdaw2vh	10	8	challenges	challenge	NNS
cord-003926-ycdaw2vh	10	9	confronting	confront	VBG
cord-003926-ycdaw2vh	10	10	Zika	Zika	NNP
cord-003926-ycdaw2vh	10	11	virus	virus	NN
cord-003926-ycdaw2vh	10	12	vaccine	vaccine	NN
cord-003926-ycdaw2vh	10	13	development	development	NN
cord-003926-ycdaw2vh	10	14	.	.	.
cord-003926-ycdaw2vh	11	1	The	the	DT
cord-003926-ycdaw2vh	11	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	11	3	virus	virus	NN
cord-003926-ycdaw2vh	11	4	,	,	,
cord-003926-ycdaw2vh	11	5	discovered	discover	VBN
cord-003926-ycdaw2vh	11	6	in	in	IN
cord-003926-ycdaw2vh	11	7	Uganda	Uganda	NNP
cord-003926-ycdaw2vh	11	8	in	in	IN
cord-003926-ycdaw2vh	11	9	1947	1947	CD
cord-003926-ycdaw2vh	11	10	[	[	-LRB-
cord-003926-ycdaw2vh	11	11	1	1	CD
cord-003926-ycdaw2vh	11	12	]	]	-RRB-
cord-003926-ycdaw2vh	11	13	,	,	,
cord-003926-ycdaw2vh	11	14	was	be	VBD
cord-003926-ycdaw2vh	11	15	shown	show	VBN
cord-003926-ycdaw2vh	11	16	to	to	TO
cord-003926-ycdaw2vh	11	17	be	be	VB
cord-003926-ycdaw2vh	11	18	endemic	endemic	JJ
cord-003926-ycdaw2vh	11	19	through	through	IN
cord-003926-ycdaw2vh	11	20	Sub	Sub	NNP
cord-003926-ycdaw2vh	11	21	-	-	HYPH
cord-003926-ycdaw2vh	11	22	Saharan	Saharan	NNP
cord-003926-ycdaw2vh	11	23	Africa	Africa	NNP
cord-003926-ycdaw2vh	11	24	and	and	CC
cord-003926-ycdaw2vh	11	25	tropical	tropical	JJ
cord-003926-ycdaw2vh	11	26	areas	area	NNS
cord-003926-ycdaw2vh	11	27	of	of	IN
cord-003926-ycdaw2vh	11	28	Southeastern	Southeastern	NNP
cord-003926-ycdaw2vh	11	29	Asia	Asia	NNP
cord-003926-ycdaw2vh	11	30	in	in	IN
cord-003926-ycdaw2vh	11	31	studies	study	NNS
cord-003926-ycdaw2vh	11	32	through	through	IN
cord-003926-ycdaw2vh	11	33	the	the	DT
cord-003926-ycdaw2vh	11	34	second	second	JJ
cord-003926-ycdaw2vh	11	35	half	half	NN
cord-003926-ycdaw2vh	11	36	of	of	IN
cord-003926-ycdaw2vh	11	37	the	the	DT
cord-003926-ycdaw2vh	11	38	20th	20th	JJ
cord-003926-ycdaw2vh	11	39	century	century	NN
cord-003926-ycdaw2vh	11	40	[	[	-LRB-
cord-003926-ycdaw2vh	11	41	2	2	CD
cord-003926-ycdaw2vh	11	42	]	]	-RRB-
cord-003926-ycdaw2vh	11	43	.	.	.
cord-003926-ycdaw2vh	12	1	Isolated	isolated	JJ
cord-003926-ycdaw2vh	12	2	outbreaks	outbreak	NNS
cord-003926-ycdaw2vh	12	3	occurred	occur	VBD
cord-003926-ycdaw2vh	12	4	in	in	IN
cord-003926-ycdaw2vh	12	5	Yap	Yap	NNP
cord-003926-ycdaw2vh	12	6	Island	Island	NNP
cord-003926-ycdaw2vh	12	7	in	in	IN
cord-003926-ycdaw2vh	12	8	2007	2007	CD
cord-003926-ycdaw2vh	12	9	[	[	-LRB-
cord-003926-ycdaw2vh	12	10	3	3	CD
cord-003926-ycdaw2vh	12	11	]	]	-RRB-
cord-003926-ycdaw2vh	12	12	and	and	CC
cord-003926-ycdaw2vh	12	13	on	on	IN
cord-003926-ycdaw2vh	12	14	French	French	NNP
cord-003926-ycdaw2vh	12	15	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	12	16	in	in	IN
cord-003926-ycdaw2vh	12	17	2014	2014	CD
cord-003926-ycdaw2vh	12	18	[	[	-LRB-
cord-003926-ycdaw2vh	12	19	4	4	CD
cord-003926-ycdaw2vh	12	20	]	]	-RRB-
cord-003926-ycdaw2vh	12	21	.	.	.
cord-003926-ycdaw2vh	13	1	Starting	start	VBG
cord-003926-ycdaw2vh	13	2	in	in	IN
cord-003926-ycdaw2vh	13	3	mid-2015	mid-2015	NN
cord-003926-ycdaw2vh	13	4	,	,	,
cord-003926-ycdaw2vh	13	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	13	6	virus	virus	NN
cord-003926-ycdaw2vh	13	7	infection	infection	NN
cord-003926-ycdaw2vh	13	8	achieved	achieve	VBD
cord-003926-ycdaw2vh	13	9	epidemic	epidemic	NN
cord-003926-ycdaw2vh	13	10	status	status	NN
cord-003926-ycdaw2vh	13	11	,	,	,
cord-003926-ycdaw2vh	13	12	spreading	spread	VBG
cord-003926-ycdaw2vh	13	13	rapidly	rapidly	RB
cord-003926-ycdaw2vh	13	14	through	through	IN
cord-003926-ycdaw2vh	13	15	South	South	NNP
cord-003926-ycdaw2vh	13	16	America	America	NNP
cord-003926-ycdaw2vh	13	17	,	,	,
cord-003926-ycdaw2vh	13	18	Central	Central	NNP
cord-003926-ycdaw2vh	13	19	America	America	NNP
cord-003926-ycdaw2vh	13	20	,	,	,
cord-003926-ycdaw2vh	13	21	and	and	CC
cord-003926-ycdaw2vh	13	22	the	the	DT
cord-003926-ycdaw2vh	13	23	Caribbean	Caribbean	NNP
cord-003926-ycdaw2vh	13	24	Islands	Islands	NNPS
cord-003926-ycdaw2vh	13	25	[	[	-LRB-
cord-003926-ycdaw2vh	13	26	5	5	CD
cord-003926-ycdaw2vh	13	27	]	]	-RRB-
cord-003926-ycdaw2vh	13	28	.	.	.
cord-003926-ycdaw2vh	14	1	It	-PRON-	PRP
cord-003926-ycdaw2vh	14	2	was	be	VBD
cord-003926-ycdaw2vh	14	3	soon	soon	RB
cord-003926-ycdaw2vh	14	4	recognized	recognize	VBN
cord-003926-ycdaw2vh	14	5	that	that	IN
cord-003926-ycdaw2vh	14	6	Zika	Zika	NNP
cord-003926-ycdaw2vh	14	7	virus	virus	NN
cord-003926-ycdaw2vh	14	8	infection	infection	NN
cord-003926-ycdaw2vh	14	9	occurring	occur	VBG
cord-003926-ycdaw2vh	14	10	during	during	IN
cord-003926-ycdaw2vh	14	11	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	14	12	caused	cause	VBD
cord-003926-ycdaw2vh	14	13	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	14	14	and	and	CC
cord-003926-ycdaw2vh	14	15	other	other	JJ
cord-003926-ycdaw2vh	14	16	congenital	congenital	JJ
cord-003926-ycdaw2vh	14	17	disorders	disorder	NNS
cord-003926-ycdaw2vh	14	18	in	in	IN
cord-003926-ycdaw2vh	14	19	the	the	DT
cord-003926-ycdaw2vh	14	20	developing	develop	VBG
cord-003926-ycdaw2vh	14	21	fetus	fetus	NN
cord-003926-ycdaw2vh	14	22	,	,	,
cord-003926-ycdaw2vh	14	23	the	the	DT
cord-003926-ycdaw2vh	14	24	latter	latter	JJ
cord-003926-ycdaw2vh	14	25	being	be	VBG
cord-003926-ycdaw2vh	14	26	the	the	DT
cord-003926-ycdaw2vh	14	27	primary	primary	JJ
cord-003926-ycdaw2vh	14	28	reason	reason	NN
cord-003926-ycdaw2vh	14	29	for	for	IN
cord-003926-ycdaw2vh	14	30	the	the	DT
cord-003926-ycdaw2vh	14	31	World	World	NNP
cord-003926-ycdaw2vh	14	32	Health	Health	NNP
cord-003926-ycdaw2vh	14	33	Organization	Organization	NNP
cord-003926-ycdaw2vh	14	34	(	(	-LRB-
cord-003926-ycdaw2vh	14	35	WHO	who	WP
cord-003926-ycdaw2vh	14	36	)	)	-RRB-
cord-003926-ycdaw2vh	14	37	labelling	label	VBG
cord-003926-ycdaw2vh	14	38	Zika	Zika	NNP
cord-003926-ycdaw2vh	14	39	as	as	IN
cord-003926-ycdaw2vh	14	40	an	an	DT
cord-003926-ycdaw2vh	14	41	international	international	JJ
cord-003926-ycdaw2vh	14	42	threat	threat	NN
cord-003926-ycdaw2vh	14	43	in	in	IN
cord-003926-ycdaw2vh	14	44	early	early	JJ
cord-003926-ycdaw2vh	14	45	2016	2016	CD
cord-003926-ycdaw2vh	14	46	.	.	.
cord-003926-ycdaw2vh	15	1	Beginning	begin	VBG
cord-003926-ycdaw2vh	15	2	in	in	IN
cord-003926-ycdaw2vh	15	3	late	late	JJ
cord-003926-ycdaw2vh	15	4	2015	2015	CD
cord-003926-ycdaw2vh	15	5	,	,	,
cord-003926-ycdaw2vh	15	6	numerous	numerous	JJ
cord-003926-ycdaw2vh	15	7	academic	academic	JJ
cord-003926-ycdaw2vh	15	8	labs	lab	NNS
cord-003926-ycdaw2vh	15	9	and	and	CC
cord-003926-ycdaw2vh	15	10	pharmaceutical	pharmaceutical	NN
cord-003926-ycdaw2vh	15	11	companies	company	NNS
cord-003926-ycdaw2vh	15	12	initiated	initiate	VBD
cord-003926-ycdaw2vh	15	13	work	work	NN
cord-003926-ycdaw2vh	15	14	to	to	TO
cord-003926-ycdaw2vh	15	15	develop	develop	VB
cord-003926-ycdaw2vh	15	16	a	a	DT
cord-003926-ycdaw2vh	15	17	vaccine	vaccine	NN
cord-003926-ycdaw2vh	15	18	against	against	IN
cord-003926-ycdaw2vh	15	19	Zika	Zika	NNP
cord-003926-ycdaw2vh	15	20	,	,	,
cord-003926-ycdaw2vh	15	21	however	however	RB
cord-003926-ycdaw2vh	15	22	,	,	,
cord-003926-ycdaw2vh	15	23	by	by	IN
cord-003926-ycdaw2vh	15	24	the	the	DT
cord-003926-ycdaw2vh	15	25	time	time	NN
cord-003926-ycdaw2vh	15	26	the	the	DT
cord-003926-ycdaw2vh	15	27	first	first	JJ
cord-003926-ycdaw2vh	15	28	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	15	29	entered	enter	VBD
cord-003926-ycdaw2vh	15	30	clinical	clinical	JJ
cord-003926-ycdaw2vh	15	31	trials	trial	NNS
cord-003926-ycdaw2vh	15	32	,	,	,
cord-003926-ycdaw2vh	15	33	the	the	DT
cord-003926-ycdaw2vh	15	34	Zika	Zika	NNP
cord-003926-ycdaw2vh	15	35	epidemic	epidemic	NN
cord-003926-ycdaw2vh	15	36	had	have	VBD
cord-003926-ycdaw2vh	15	37	started	start	VBN
cord-003926-ycdaw2vh	15	38	to	to	TO
cord-003926-ycdaw2vh	15	39	wane	wane	VB
cord-003926-ycdaw2vh	15	40	creating	create	VBG
cord-003926-ycdaw2vh	15	41	significant	significant	JJ
cord-003926-ycdaw2vh	15	42	challenges	challenge	NNS
cord-003926-ycdaw2vh	15	43	to	to	IN
cord-003926-ycdaw2vh	15	44	vaccine	vaccine	NN
cord-003926-ycdaw2vh	15	45	assessment	assessment	NN
cord-003926-ycdaw2vh	15	46	[	[	-LRB-
cord-003926-ycdaw2vh	15	47	6	6	CD
cord-003926-ycdaw2vh	15	48	]	]	-RRB-
cord-003926-ycdaw2vh	15	49	that	that	WDT
cord-003926-ycdaw2vh	15	50	has	have	VBZ
cord-003926-ycdaw2vh	15	51	engendered	engender	VBN
cord-003926-ycdaw2vh	15	52	discussion	discussion	NN
cord-003926-ycdaw2vh	15	53	of	of	IN
cord-003926-ycdaw2vh	15	54	other	other	JJ
cord-003926-ycdaw2vh	15	55	regulatory	regulatory	JJ
cord-003926-ycdaw2vh	15	56	pathways	pathway	NNS
cord-003926-ycdaw2vh	15	57	to	to	TO
cord-003926-ycdaw2vh	15	58	licensure	licensure	VB
cord-003926-ycdaw2vh	15	59	[	[	-LRB-
cord-003926-ycdaw2vh	15	60	7	7	CD
cord-003926-ycdaw2vh	15	61	]	]	-RRB-
cord-003926-ycdaw2vh	15	62	.	.	.
cord-003926-ycdaw2vh	16	1	In	in	IN
cord-003926-ycdaw2vh	16	2	this	this	DT
cord-003926-ycdaw2vh	16	3	paper	paper	NN
cord-003926-ycdaw2vh	16	4	,	,	,
cord-003926-ycdaw2vh	16	5	we	-PRON-	PRP
cord-003926-ycdaw2vh	16	6	provide	provide	VBP
cord-003926-ycdaw2vh	16	7	a	a	DT
cord-003926-ycdaw2vh	16	8	brief	brief	JJ
cord-003926-ycdaw2vh	16	9	update	update	NN
cord-003926-ycdaw2vh	16	10	of	of	IN
cord-003926-ycdaw2vh	16	11	current	current	JJ
cord-003926-ycdaw2vh	16	12	progress	progress	NN
cord-003926-ycdaw2vh	16	13	in	in	IN
cord-003926-ycdaw2vh	16	14	Zika	Zika	NNP
cord-003926-ycdaw2vh	16	15	virus	virus	NN
cord-003926-ycdaw2vh	16	16	vaccine	vaccine	NN
cord-003926-ycdaw2vh	16	17	development	development	NN
cord-003926-ycdaw2vh	16	18	and	and	CC
cord-003926-ycdaw2vh	16	19	explore	explore	VB
cord-003926-ycdaw2vh	16	20	the	the	DT
cord-003926-ycdaw2vh	16	21	challenges	challenge	NNS
cord-003926-ycdaw2vh	16	22	to	to	IN
cord-003926-ycdaw2vh	16	23	vaccine	vaccine	NN
cord-003926-ycdaw2vh	16	24	assessment	assessment	NN
cord-003926-ycdaw2vh	16	25	and	and	CC
cord-003926-ycdaw2vh	16	26	eventual	eventual	JJ
cord-003926-ycdaw2vh	16	27	licensure	licensure	NN
cord-003926-ycdaw2vh	16	28	.	.	.
cord-003926-ycdaw2vh	17	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	17	2	virus	virus	NN
cord-003926-ycdaw2vh	17	3	infection	infection	NN
cord-003926-ycdaw2vh	17	4	presents	present	VBZ
cord-003926-ycdaw2vh	17	5	with	with	IN
cord-003926-ycdaw2vh	17	6	a	a	DT
cord-003926-ycdaw2vh	17	7	symptom	symptom	NN
cord-003926-ycdaw2vh	17	8	complex	complex	NN
cord-003926-ycdaw2vh	17	9	consisting	consist	VBG
cord-003926-ycdaw2vh	17	10	of	of	IN
cord-003926-ycdaw2vh	17	11	a	a	DT
cord-003926-ycdaw2vh	17	12	diffuse	diffuse	JJ
cord-003926-ycdaw2vh	17	13	maculo	maculo	NN
cord-003926-ycdaw2vh	17	14	-	-	HYPH
cord-003926-ycdaw2vh	17	15	papular	papular	JJ
cord-003926-ycdaw2vh	17	16	rash	rash	NN
cord-003926-ycdaw2vh	17	17	,	,	,
cord-003926-ycdaw2vh	17	18	fever	fever	NN
cord-003926-ycdaw2vh	17	19	,	,	,
cord-003926-ycdaw2vh	17	20	asthenia	asthenia	NN
cord-003926-ycdaw2vh	17	21	,	,	,
cord-003926-ycdaw2vh	17	22	myalgias	myalgias	NNP
cord-003926-ycdaw2vh	17	23	,	,	,
cord-003926-ycdaw2vh	17	24	arthralgias	arthralgias	NNP
cord-003926-ycdaw2vh	17	25	,	,	,
cord-003926-ycdaw2vh	17	26	headache	headache	NN
cord-003926-ycdaw2vh	17	27	,	,	,
cord-003926-ycdaw2vh	17	28	and	and	CC
cord-003926-ycdaw2vh	17	29	retroorbital	retroorbital	NNP
cord-003926-ycdaw2vh	17	30	pain	pain	NN
cord-003926-ycdaw2vh	17	31	.	.	.
cord-003926-ycdaw2vh	18	1	The	the	DT
cord-003926-ycdaw2vh	18	2	frequency	frequency	NN
cord-003926-ycdaw2vh	18	3	and	and	CC
cord-003926-ycdaw2vh	18	4	degree	degree	NN
cord-003926-ycdaw2vh	18	5	of	of	IN
cord-003926-ycdaw2vh	18	6	symptomatology	symptomatology	NN
cord-003926-ycdaw2vh	18	7	has	have	VBZ
cord-003926-ycdaw2vh	18	8	,	,	,
cord-003926-ycdaw2vh	18	9	however	however	RB
cord-003926-ycdaw2vh	18	10	,	,	,
cord-003926-ycdaw2vh	18	11	varied	varied	JJ
cord-003926-ycdaw2vh	18	12	between	between	IN
cord-003926-ycdaw2vh	18	13	studies	study	NNS
cord-003926-ycdaw2vh	18	14	.	.	.
cord-003926-ycdaw2vh	19	1	A	a	DT
cord-003926-ycdaw2vh	19	2	retrospective	retrospective	JJ
cord-003926-ycdaw2vh	19	3	study	study	NN
cord-003926-ycdaw2vh	19	4	immediately	immediately	RB
cord-003926-ycdaw2vh	19	5	following	follow	VBG
cord-003926-ycdaw2vh	19	6	the	the	DT
cord-003926-ycdaw2vh	19	7	outbreak	outbreak	NN
cord-003926-ycdaw2vh	19	8	on	on	IN
cord-003926-ycdaw2vh	19	9	Yap	Yap	NNP
cord-003926-ycdaw2vh	19	10	Island	Island	NNP
cord-003926-ycdaw2vh	19	11	found	find	VBD
cord-003926-ycdaw2vh	19	12	that	that	IN
cord-003926-ycdaw2vh	19	13	only	only	RB
cord-003926-ycdaw2vh	19	14	19	19	CD
cord-003926-ycdaw2vh	19	15	%	%	NN
cord-003926-ycdaw2vh	19	16	of	of	IN
cord-003926-ycdaw2vh	19	17	survey	survey	NN
cord-003926-ycdaw2vh	19	18	participants	participant	NNS
cord-003926-ycdaw2vh	19	19	reported	report	VBD
cord-003926-ycdaw2vh	19	20	symptoms	symptom	NNS
cord-003926-ycdaw2vh	19	21	consistent	consistent	JJ
cord-003926-ycdaw2vh	19	22	with	with	IN
cord-003926-ycdaw2vh	19	23	Zika	Zika	NNP
cord-003926-ycdaw2vh	19	24	virus	virus	NN
cord-003926-ycdaw2vh	19	25	infection	infection	NN
cord-003926-ycdaw2vh	19	26	[	[	-LRB-
cord-003926-ycdaw2vh	19	27	3	3	CD
cord-003926-ycdaw2vh	19	28	]	]	-RRB-
cord-003926-ycdaw2vh	19	29	,	,	,
cord-003926-ycdaw2vh	19	30	a	a	DT
cord-003926-ycdaw2vh	19	31	figure	figure	NN
cord-003926-ycdaw2vh	19	32	that	that	WDT
cord-003926-ycdaw2vh	19	33	has	have	VBZ
cord-003926-ycdaw2vh	19	34	been	be	VBN
cord-003926-ycdaw2vh	19	35	cited	cite	VBN
cord-003926-ycdaw2vh	19	36	to	to	TO
cord-003926-ycdaw2vh	19	37	suggest	suggest	VB
cord-003926-ycdaw2vh	19	38	that	that	IN
cord-003926-ycdaw2vh	19	39	Zika	Zika	NNP
cord-003926-ycdaw2vh	19	40	virus	virus	NN
cord-003926-ycdaw2vh	19	41	infection	infection	NN
cord-003926-ycdaw2vh	19	42	is	be	VBZ
cord-003926-ycdaw2vh	19	43	asymptomatic	asymptomatic	JJ
cord-003926-ycdaw2vh	19	44	in	in	IN
cord-003926-ycdaw2vh	19	45	as	as	RB
cord-003926-ycdaw2vh	19	46	many	many	JJ
cord-003926-ycdaw2vh	19	47	as	as	IN
cord-003926-ycdaw2vh	19	48	80	80	CD
cord-003926-ycdaw2vh	19	49	%	%	NN
cord-003926-ycdaw2vh	19	50	of	of	IN
cord-003926-ycdaw2vh	19	51	individuals	individual	NNS
cord-003926-ycdaw2vh	19	52	.	.	.
cord-003926-ycdaw2vh	20	1	However	however	RB
cord-003926-ycdaw2vh	20	2	,	,	,
cord-003926-ycdaw2vh	20	3	of	of	IN
cord-003926-ycdaw2vh	20	4	557	557	CD
cord-003926-ycdaw2vh	20	5	individuals	individual	NNS
cord-003926-ycdaw2vh	20	6	who	who	WP
cord-003926-ycdaw2vh	20	7	provided	provide	VBD
cord-003926-ycdaw2vh	20	8	blood	blood	NN
cord-003926-ycdaw2vh	20	9	samples	sample	NNS
cord-003926-ycdaw2vh	20	10	,	,	,
cord-003926-ycdaw2vh	20	11	representing	represent	VBG
cord-003926-ycdaw2vh	20	12	16	16	CD
cord-003926-ycdaw2vh	20	13	%	%	NN
cord-003926-ycdaw2vh	20	14	of	of	IN
cord-003926-ycdaw2vh	20	15	households	household	NNS
cord-003926-ycdaw2vh	20	16	,	,	,
cord-003926-ycdaw2vh	20	17	38	38	CD
cord-003926-ycdaw2vh	20	18	%	%	NN
cord-003926-ycdaw2vh	20	19	were	be	VBD
cord-003926-ycdaw2vh	20	20	symptomatic	symptomatic	JJ
cord-003926-ycdaw2vh	20	21	[	[	-LRB-
cord-003926-ycdaw2vh	20	22	3	3	CD
cord-003926-ycdaw2vh	20	23	]	]	-RRB-
cord-003926-ycdaw2vh	20	24	.	.	.
cord-003926-ycdaw2vh	21	1	A	a	DT
cord-003926-ycdaw2vh	21	2	second	second	JJ
cord-003926-ycdaw2vh	21	3	retrospective	retrospective	JJ
cord-003926-ycdaw2vh	21	4	study	study	NN
cord-003926-ycdaw2vh	21	5	of	of	IN
cord-003926-ycdaw2vh	21	6	the	the	DT
cord-003926-ycdaw2vh	21	7	larger	large	JJR
cord-003926-ycdaw2vh	21	8	outbreak	outbreak	NN
cord-003926-ycdaw2vh	21	9	in	in	IN
cord-003926-ycdaw2vh	21	10	French	French	NNP
cord-003926-ycdaw2vh	21	11	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	21	12	[	[	-LRB-
cord-003926-ycdaw2vh	21	13	8	8	CD
cord-003926-ycdaw2vh	21	14	,	,	,
cord-003926-ycdaw2vh	21	15	9	9	CD
cord-003926-ycdaw2vh	21	16	]	]	-RRB-
cord-003926-ycdaw2vh	21	17	,	,	,
cord-003926-ycdaw2vh	21	18	similarly	similarly	RB
cord-003926-ycdaw2vh	21	19	appeared	appear	VBD
cord-003926-ycdaw2vh	21	20	to	to	TO
cord-003926-ycdaw2vh	21	21	have	have	VB
cord-003926-ycdaw2vh	21	22	a	a	DT
cord-003926-ycdaw2vh	21	23	low	low	JJ
cord-003926-ycdaw2vh	21	24	rate	rate	NN
cord-003926-ycdaw2vh	21	25	of	of	IN
cord-003926-ycdaw2vh	21	26	symptomatology	symptomatology	NN
cord-003926-ycdaw2vh	21	27	based	base	VBN
cord-003926-ycdaw2vh	21	28	on	on	IN
cord-003926-ycdaw2vh	21	29	a	a	DT
cord-003926-ycdaw2vh	21	30	sample	sample	NN
cord-003926-ycdaw2vh	21	31	of	of	IN
cord-003926-ycdaw2vh	21	32	blood	blood	NN
cord-003926-ycdaw2vh	21	33	donors	donor	NNS
cord-003926-ycdaw2vh	21	34	[	[	-LRB-
cord-003926-ycdaw2vh	21	35	10	10	CD
cord-003926-ycdaw2vh	21	36	]	]	-RRB-
cord-003926-ycdaw2vh	21	37	.	.	.
cord-003926-ycdaw2vh	22	1	However	however	RB
cord-003926-ycdaw2vh	22	2	,	,	,
cord-003926-ycdaw2vh	22	3	a	a	DT
cord-003926-ycdaw2vh	22	4	subsequent	subsequent	JJ
cord-003926-ycdaw2vh	22	5	seroprevalence	seroprevalence	NN
cord-003926-ycdaw2vh	22	6	study	study	NN
cord-003926-ycdaw2vh	22	7	found	find	VBD
cord-003926-ycdaw2vh	22	8	that	that	IN
cord-003926-ycdaw2vh	22	9	43	43	CD
cord-003926-ycdaw2vh	22	10	%	%	NN
cord-003926-ycdaw2vh	22	11	of	of	IN
cord-003926-ycdaw2vh	22	12	those	those	DT
cord-003926-ycdaw2vh	22	13	with	with	IN
cord-003926-ycdaw2vh	22	14	evidence	evidence	NN
cord-003926-ycdaw2vh	22	15	of	of	IN
cord-003926-ycdaw2vh	22	16	prior	prior	JJ
cord-003926-ycdaw2vh	22	17	infection	infection	NN
cord-003926-ycdaw2vh	22	18	had	have	VBD
cord-003926-ycdaw2vh	22	19	symptoms	symptom	NNS
cord-003926-ycdaw2vh	22	20	consistent	consistent	JJ
cord-003926-ycdaw2vh	22	21	with	with	IN
cord-003926-ycdaw2vh	22	22	Zika	Zika	NNP
cord-003926-ycdaw2vh	22	23	virus	virus	NN
cord-003926-ycdaw2vh	22	24	infection	infection	NN
cord-003926-ycdaw2vh	22	25	[	[	-LRB-
cord-003926-ycdaw2vh	22	26	11	11	CD
cord-003926-ycdaw2vh	22	27	]	]	-RRB-
cord-003926-ycdaw2vh	22	28	.	.	.
cord-003926-ycdaw2vh	23	1	A	a	DT
cord-003926-ycdaw2vh	23	2	more	more	RBR
cord-003926-ycdaw2vh	23	3	recent	recent	JJ
cord-003926-ycdaw2vh	23	4	meta	meta	JJ
cord-003926-ycdaw2vh	23	5	-	-	HYPH
cord-003926-ycdaw2vh	23	6	analysis	analysis	NN
cord-003926-ycdaw2vh	23	7	of	of	IN
cord-003926-ycdaw2vh	23	8	23	23	CD
cord-003926-ycdaw2vh	23	9	studies	study	NNS
cord-003926-ycdaw2vh	23	10	noted	note	VBD
cord-003926-ycdaw2vh	23	11	that	that	IN
cord-003926-ycdaw2vh	23	12	between	between	IN
cord-003926-ycdaw2vh	23	13	0	0	CD
cord-003926-ycdaw2vh	23	14	and	and	CC
cord-003926-ycdaw2vh	23	15	83	83	CD
cord-003926-ycdaw2vh	23	16	%	%	NN
cord-003926-ycdaw2vh	23	17	of	of	IN
cord-003926-ycdaw2vh	23	18	cases	case	NNS
cord-003926-ycdaw2vh	23	19	were	be	VBD
cord-003926-ycdaw2vh	23	20	reported	report	VBN
cord-003926-ycdaw2vh	23	21	as	as	IN
cord-003926-ycdaw2vh	23	22	asymptomatic	asymptomatic	JJ
cord-003926-ycdaw2vh	23	23	,	,	,
cord-003926-ycdaw2vh	23	24	although	although	IN
cord-003926-ycdaw2vh	23	25	as	as	IN
cord-003926-ycdaw2vh	23	26	the	the	DT
cord-003926-ycdaw2vh	23	27	authors	author	NNS
cord-003926-ycdaw2vh	23	28	note	note	VBP
cord-003926-ycdaw2vh	23	29	,	,	,
cord-003926-ycdaw2vh	23	30	assessment	assessment	NN
cord-003926-ycdaw2vh	23	31	of	of	IN
cord-003926-ycdaw2vh	23	32	the	the	DT
cord-003926-ycdaw2vh	23	33	prevalence	prevalence	NN
cord-003926-ycdaw2vh	23	34	of	of	IN
cord-003926-ycdaw2vh	23	35	symptoms	symptom	NNS
cord-003926-ycdaw2vh	23	36	was	be	VBD
cord-003926-ycdaw2vh	23	37	not	not	RB
cord-003926-ycdaw2vh	23	38	the	the	DT
cord-003926-ycdaw2vh	23	39	goal	goal	NN
cord-003926-ycdaw2vh	23	40	of	of	IN
cord-003926-ycdaw2vh	23	41	many	many	JJ
cord-003926-ycdaw2vh	23	42	studies	study	NNS
cord-003926-ycdaw2vh	23	43	[	[	-LRB-
cord-003926-ycdaw2vh	23	44	12	12	CD
cord-003926-ycdaw2vh	23	45	]	]	-RRB-
cord-003926-ycdaw2vh	23	46	.	.	.
cord-003926-ycdaw2vh	24	1	In	in	IN
cord-003926-ycdaw2vh	24	2	adults	adult	NNS
cord-003926-ycdaw2vh	24	3	,	,	,
cord-003926-ycdaw2vh	24	4	the	the	DT
cord-003926-ycdaw2vh	24	5	most	most	RBS
cord-003926-ycdaw2vh	24	6	common	common	JJ
cord-003926-ycdaw2vh	24	7	reported	report	VBN
cord-003926-ycdaw2vh	24	8	complication	complication	NN
cord-003926-ycdaw2vh	24	9	of	of	IN
cord-003926-ycdaw2vh	24	10	Zika	Zika	NNP
cord-003926-ycdaw2vh	24	11	virus	virus	NN
cord-003926-ycdaw2vh	24	12	infection	infection	NN
cord-003926-ycdaw2vh	24	13	is	be	VBZ
cord-003926-ycdaw2vh	24	14	a	a	DT
cord-003926-ycdaw2vh	24	15	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	24	16	-	-	HYPH
cord-003926-ycdaw2vh	24	17	Barré	Barré	NNP
cord-003926-ycdaw2vh	24	18	-	-	HYPH
cord-003926-ycdaw2vh	24	19	like	like	JJ
cord-003926-ycdaw2vh	24	20	illness	illness	NN
cord-003926-ycdaw2vh	24	21	that	that	WDT
cord-003926-ycdaw2vh	24	22	had	have	VBD
cord-003926-ycdaw2vh	24	23	a	a	DT
cord-003926-ycdaw2vh	24	24	prevalence	prevalence	NN
cord-003926-ycdaw2vh	24	25	of	of	IN
cord-003926-ycdaw2vh	24	26	0.24	0.24	CD
cord-003926-ycdaw2vh	24	27	cases	case	NNS
cord-003926-ycdaw2vh	24	28	per	per	IN
cord-003926-ycdaw2vh	24	29	1000	1000	CD
cord-003926-ycdaw2vh	24	30	cases	case	NNS
cord-003926-ycdaw2vh	24	31	of	of	IN
cord-003926-ycdaw2vh	24	32	infection	infection	NN
cord-003926-ycdaw2vh	24	33	in	in	IN
cord-003926-ycdaw2vh	24	34	the	the	DT
cord-003926-ycdaw2vh	24	35	French	french	JJ
cord-003926-ycdaw2vh	24	36	Polynesian	polynesian	JJ
cord-003926-ycdaw2vh	24	37	epidemic	epidemic	NN
cord-003926-ycdaw2vh	24	38	[	[	-LRB-
cord-003926-ycdaw2vh	24	39	13	13	CD
cord-003926-ycdaw2vh	24	40	]	]	-RRB-
cord-003926-ycdaw2vh	24	41	.	.	.
cord-003926-ycdaw2vh	25	1	Of	of	IN
cord-003926-ycdaw2vh	25	2	interest	interest	NN
cord-003926-ycdaw2vh	25	3	,	,	,
cord-003926-ycdaw2vh	25	4	a	a	DT
cord-003926-ycdaw2vh	25	5	recent	recent	JJ
cord-003926-ycdaw2vh	25	6	meta	meta	JJ
cord-003926-ycdaw2vh	25	7	-	-	HYPH
cord-003926-ycdaw2vh	25	8	analysis	analysis	NN
cord-003926-ycdaw2vh	25	9	has	have	VBZ
cord-003926-ycdaw2vh	25	10	questioned	question	VBN
cord-003926-ycdaw2vh	25	11	this	this	DT
cord-003926-ycdaw2vh	25	12	causal	causal	NN
cord-003926-ycdaw2vh	25	13	association	association	NN
cord-003926-ycdaw2vh	25	14	[	[	-LRB-
cord-003926-ycdaw2vh	25	15	14	14	CD
cord-003926-ycdaw2vh	25	16	]	]	-RRB-
cord-003926-ycdaw2vh	25	17	.	.	.
cord-003926-ycdaw2vh	26	1	Other	other	JJ
cord-003926-ycdaw2vh	26	2	less	less	RBR
cord-003926-ycdaw2vh	26	3	common	common	JJ
cord-003926-ycdaw2vh	26	4	reported	report	VBN
cord-003926-ycdaw2vh	26	5	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	26	6	complications	complication	NNS
cord-003926-ycdaw2vh	26	7	in	in	IN
cord-003926-ycdaw2vh	26	8	adults	adult	NNS
cord-003926-ycdaw2vh	26	9	include	include	VBP
cord-003926-ycdaw2vh	26	10	meningoencephalitis	meningoencephalitis	NNP
cord-003926-ycdaw2vh	26	11	[	[	-LRB-
cord-003926-ycdaw2vh	26	12	15	15	CD
cord-003926-ycdaw2vh	26	13	]	]	-RRB-
cord-003926-ycdaw2vh	26	14	and	and	CC
cord-003926-ycdaw2vh	26	15	an	an	DT
cord-003926-ycdaw2vh	26	16	ADEM	ADEM	NNP
cord-003926-ycdaw2vh	26	17	illness	illness	NN
cord-003926-ycdaw2vh	26	18	.	.	.
cord-003926-ycdaw2vh	27	1	In	in	IN
cord-003926-ycdaw2vh	27	2	contrast	contrast	NN
cord-003926-ycdaw2vh	27	3	,	,	,
cord-003926-ycdaw2vh	27	4	infection	infection	NN
cord-003926-ycdaw2vh	27	5	during	during	IN
cord-003926-ycdaw2vh	27	6	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	27	7	has	have	VBZ
cord-003926-ycdaw2vh	27	8	been	be	VBN
cord-003926-ycdaw2vh	27	9	associated	associate	VBN
cord-003926-ycdaw2vh	27	10	with	with	IN
cord-003926-ycdaw2vh	27	11	fetal	fetal	JJ
cord-003926-ycdaw2vh	27	12	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	27	13	and	and	CC
cord-003926-ycdaw2vh	27	14	a	a	DT
cord-003926-ycdaw2vh	27	15	number	number	NN
cord-003926-ycdaw2vh	27	16	of	of	IN
cord-003926-ycdaw2vh	27	17	other	other	JJ
cord-003926-ycdaw2vh	27	18	congenital	congenital	JJ
cord-003926-ycdaw2vh	27	19	illnesses	illness	NNS
cord-003926-ycdaw2vh	27	20	including	include	VBG
cord-003926-ycdaw2vh	27	21	visual	visual	JJ
cord-003926-ycdaw2vh	27	22	deficits	deficit	NNS
cord-003926-ycdaw2vh	27	23	,	,	,
cord-003926-ycdaw2vh	27	24	hearing	hear	VBG
cord-003926-ycdaw2vh	27	25	disorders	disorder	NNS
cord-003926-ycdaw2vh	27	26	,	,	,
cord-003926-ycdaw2vh	27	27	neural	neural	JJ
cord-003926-ycdaw2vh	27	28	calcifications	calcification	NNS
cord-003926-ycdaw2vh	27	29	,	,	,
cord-003926-ycdaw2vh	27	30	learning	learn	VBG
cord-003926-ycdaw2vh	27	31	disabilities	disability	NNS
cord-003926-ycdaw2vh	27	32	,	,	,
cord-003926-ycdaw2vh	27	33	and	and	CC
cord-003926-ycdaw2vh	27	34	arthrogryposis	arthrogryposis	NN
cord-003926-ycdaw2vh	27	35	that	that	WDT
cord-003926-ycdaw2vh	27	36	may	may	MD
cord-003926-ycdaw2vh	27	37	affect	affect	VB
cord-003926-ycdaw2vh	27	38	as	as	RB
cord-003926-ycdaw2vh	27	39	many	many	JJ
cord-003926-ycdaw2vh	27	40	as	as	IN
cord-003926-ycdaw2vh	27	41	30	30	CD
cord-003926-ycdaw2vh	27	42	%	%	NN
cord-003926-ycdaw2vh	27	43	children	child	NNS
cord-003926-ycdaw2vh	27	44	born	bear	VBN
cord-003926-ycdaw2vh	27	45	to	to	IN
cord-003926-ycdaw2vh	27	46	mothers	mother	NNS
cord-003926-ycdaw2vh	27	47	infected	infect	VBN
cord-003926-ycdaw2vh	27	48	during	during	IN
cord-003926-ycdaw2vh	27	49	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	27	50	[	[	-LRB-
cord-003926-ycdaw2vh	27	51	16	16	CD
cord-003926-ycdaw2vh	27	52	]	]	-RRB-
cord-003926-ycdaw2vh	27	53	[	[	-LRB-
cord-003926-ycdaw2vh	27	54	17	17	CD
cord-003926-ycdaw2vh	27	55	]	]	-RRB-
cord-003926-ycdaw2vh	27	56	[	[	-LRB-
cord-003926-ycdaw2vh	27	57	18	18	CD
cord-003926-ycdaw2vh	27	58	]	]	-RRB-
cord-003926-ycdaw2vh	27	59	[	[	-LRB-
cord-003926-ycdaw2vh	27	60	19	19	CD
cord-003926-ycdaw2vh	27	61	]	]	-RRB-
cord-003926-ycdaw2vh	27	62	[	[	-LRB-
cord-003926-ycdaw2vh	27	63	20	20	CD
cord-003926-ycdaw2vh	27	64	]	]	-RRB-
cord-003926-ycdaw2vh	27	65	[	[	-LRB-
cord-003926-ycdaw2vh	27	66	21	21	CD
cord-003926-ycdaw2vh	27	67	]	]	-RRB-
cord-003926-ycdaw2vh	27	68	.	.	.
cord-003926-ycdaw2vh	28	1	Additionally	additionally	RB
cord-003926-ycdaw2vh	28	2	,	,	,
cord-003926-ycdaw2vh	28	3	Zika	Zika	NNP
cord-003926-ycdaw2vh	28	4	can	can	MD
cord-003926-ycdaw2vh	28	5	directly	directly	RB
cord-003926-ycdaw2vh	28	6	invade	invade	VB
cord-003926-ycdaw2vh	28	7	the	the	DT
cord-003926-ycdaw2vh	28	8	placenta	placenta	NN
cord-003926-ycdaw2vh	28	9	and	and	CC
cord-003926-ycdaw2vh	28	10	has	have	VBZ
cord-003926-ycdaw2vh	28	11	been	be	VBN
cord-003926-ycdaw2vh	28	12	associated	associate	VBN
cord-003926-ycdaw2vh	28	13	with	with	IN
cord-003926-ycdaw2vh	28	14	prolonged	prolong	VBN
cord-003926-ycdaw2vh	28	15	maternal	maternal	JJ
cord-003926-ycdaw2vh	28	16	viremia	viremia	NN
cord-003926-ycdaw2vh	28	17	[	[	-LRB-
cord-003926-ycdaw2vh	28	18	22	22	CD
cord-003926-ycdaw2vh	28	19	]	]	-RRB-
cord-003926-ycdaw2vh	28	20	[	[	-LRB-
cord-003926-ycdaw2vh	28	21	23	23	CD
cord-003926-ycdaw2vh	28	22	]	]	-RRB-
cord-003926-ycdaw2vh	28	23	[	[	-LRB-
cord-003926-ycdaw2vh	28	24	24	24	CD
cord-003926-ycdaw2vh	28	25	]	]	-RRB-
cord-003926-ycdaw2vh	28	26	.	.	.
cord-003926-ycdaw2vh	29	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	29	2	virus	virus	NN
cord-003926-ycdaw2vh	29	3	can	can	MD
cord-003926-ycdaw2vh	29	4	also	also	RB
cord-003926-ycdaw2vh	29	5	be	be	VB
cord-003926-ycdaw2vh	29	6	transmitted	transmit	VBN
cord-003926-ycdaw2vh	29	7	through	through	IN
cord-003926-ycdaw2vh	29	8	sexual	sexual	JJ
cord-003926-ycdaw2vh	29	9	contact	contact	NN
cord-003926-ycdaw2vh	29	10	,	,	,
cord-003926-ycdaw2vh	29	11	first	first	RB
cord-003926-ycdaw2vh	29	12	reported	report	VBN
cord-003926-ycdaw2vh	29	13	for	for	IN
cord-003926-ycdaw2vh	29	14	a	a	DT
cord-003926-ycdaw2vh	29	15	researcher	researcher	NN
cord-003926-ycdaw2vh	29	16	returning	return	VBG
cord-003926-ycdaw2vh	29	17	from	from	IN
cord-003926-ycdaw2vh	29	18	Senegal	Senegal	NNP
cord-003926-ycdaw2vh	29	19	in	in	IN
cord-003926-ycdaw2vh	29	20	2008	2008	CD
cord-003926-ycdaw2vh	29	21	[	[	-LRB-
cord-003926-ycdaw2vh	29	22	25	25	CD
cord-003926-ycdaw2vh	29	23	]	]	-RRB-
cord-003926-ycdaw2vh	29	24	.	.	.
cord-003926-ycdaw2vh	30	1	Numerous	numerous	JJ
cord-003926-ycdaw2vh	30	2	subsequent	subsequent	JJ
cord-003926-ycdaw2vh	30	3	case	case	NN
cord-003926-ycdaw2vh	30	4	reports	report	NNS
cord-003926-ycdaw2vh	30	5	were	be	VBD
cord-003926-ycdaw2vh	30	6	published	publish	VBN
cord-003926-ycdaw2vh	30	7	among	among	IN
cord-003926-ycdaw2vh	30	8	travelers	traveler	NNS
cord-003926-ycdaw2vh	30	9	as	as	IN
cord-003926-ycdaw2vh	30	10	part	part	NN
cord-003926-ycdaw2vh	30	11	of	of	IN
cord-003926-ycdaw2vh	30	12	the	the	DT
cord-003926-ycdaw2vh	30	13	epidemic	epidemic	NN
cord-003926-ycdaw2vh	30	14	affecting	affect	VBG
cord-003926-ycdaw2vh	30	15	the	the	DT
cord-003926-ycdaw2vh	30	16	Americas	Americas	NNPS
cord-003926-ycdaw2vh	30	17	[	[	-LRB-
cord-003926-ycdaw2vh	30	18	26	26	CD
cord-003926-ycdaw2vh	30	19	]	]	-RRB-
cord-003926-ycdaw2vh	30	20	.	.	.
cord-003926-ycdaw2vh	31	1	The	the	DT
cord-003926-ycdaw2vh	31	2	frequency	frequency	NN
cord-003926-ycdaw2vh	31	3	of	of	IN
cord-003926-ycdaw2vh	31	4	sexual	sexual	JJ
cord-003926-ycdaw2vh	31	5	transmission	transmission	NN
cord-003926-ycdaw2vh	31	6	in	in	IN
cord-003926-ycdaw2vh	31	7	endemic	endemic	JJ
cord-003926-ycdaw2vh	31	8	regions	region	NNS
cord-003926-ycdaw2vh	31	9	is	be	VBZ
cord-003926-ycdaw2vh	31	10	unknown	unknown	JJ
cord-003926-ycdaw2vh	31	11	and	and	CC
cord-003926-ycdaw2vh	31	12	could	could	MD
cord-003926-ycdaw2vh	31	13	not	not	RB
cord-003926-ycdaw2vh	31	14	be	be	VB
cord-003926-ycdaw2vh	31	15	differentiated	differentiate	VBN
cord-003926-ycdaw2vh	31	16	from	from	IN
cord-003926-ycdaw2vh	31	17	mosquito	mosquito	NN
cord-003926-ycdaw2vh	31	18	-	-	HYPH
cord-003926-ycdaw2vh	31	19	borne	bear	VBN
cord-003926-ycdaw2vh	31	20	transmission	transmission	NN
cord-003926-ycdaw2vh	31	21	.	.	.
cord-003926-ycdaw2vh	32	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	32	2	virus	virus	NN
cord-003926-ycdaw2vh	32	3	carriage	carriage	NN
cord-003926-ycdaw2vh	32	4	in	in	IN
cord-003926-ycdaw2vh	32	5	the	the	DT
cord-003926-ycdaw2vh	32	6	male	male	JJ
cord-003926-ycdaw2vh	32	7	urogenital	urogenital	JJ
cord-003926-ycdaw2vh	32	8	tract	tract	NN
cord-003926-ycdaw2vh	32	9	is	be	VBZ
cord-003926-ycdaw2vh	32	10	common	common	JJ
cord-003926-ycdaw2vh	32	11	through	through	IN
cord-003926-ycdaw2vh	32	12	90	90	CD
cord-003926-ycdaw2vh	32	13	days	day	NNS
cord-003926-ycdaw2vh	32	14	post	post	NN
cord-003926-ycdaw2vh	32	15	infection	infection	NN
cord-003926-ycdaw2vh	32	16	and	and	CC
cord-003926-ycdaw2vh	32	17	may	may	MD
cord-003926-ycdaw2vh	32	18	persist	persist	VB
cord-003926-ycdaw2vh	32	19	in	in	IN
cord-003926-ycdaw2vh	32	20	some	some	DT
cord-003926-ycdaw2vh	32	21	to	to	IN
cord-003926-ycdaw2vh	32	22	9	9	CD
cord-003926-ycdaw2vh	32	23	months	month	NNS
cord-003926-ycdaw2vh	32	24	[	[	-LRB-
cord-003926-ycdaw2vh	32	25	27	27	CD
cord-003926-ycdaw2vh	32	26	]	]	-RRB-
cord-003926-ycdaw2vh	32	27	.	.	.
cord-003926-ycdaw2vh	33	1	In	in	IN
cord-003926-ycdaw2vh	33	2	mice	mouse	NNS
cord-003926-ycdaw2vh	33	3	,	,	,
cord-003926-ycdaw2vh	33	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	33	5	virus	virus	NN
cord-003926-ycdaw2vh	33	6	infection	infection	NN
cord-003926-ycdaw2vh	33	7	causes	cause	VBZ
cord-003926-ycdaw2vh	33	8	testicular	testicular	JJ
cord-003926-ycdaw2vh	33	9	atrophy	atrophy	NN
cord-003926-ycdaw2vh	33	10	and	and	CC
cord-003926-ycdaw2vh	33	11	significantly	significantly	RB
cord-003926-ycdaw2vh	33	12	decreases	decrease	VBZ
cord-003926-ycdaw2vh	33	13	spermatic	spermatic	JJ
cord-003926-ycdaw2vh	33	14	function	function	NN
cord-003926-ycdaw2vh	33	15	and	and	CC
cord-003926-ycdaw2vh	33	16	fertility	fertility	NN
cord-003926-ycdaw2vh	33	17	rates	rate	NNS
cord-003926-ycdaw2vh	33	18	[	[	-LRB-
cord-003926-ycdaw2vh	33	19	28	28	CD
cord-003926-ycdaw2vh	33	20	]	]	-RRB-
cord-003926-ycdaw2vh	34	1	[	[	-LRB-
cord-003926-ycdaw2vh	34	2	29	29	CD
cord-003926-ycdaw2vh	34	3	]	]	-RRB-
cord-003926-ycdaw2vh	34	4	[	[	-LRB-
cord-003926-ycdaw2vh	34	5	30	30	CD
cord-003926-ycdaw2vh	34	6	]	]	-RRB-
cord-003926-ycdaw2vh	34	7	.	.	.
cord-003926-ycdaw2vh	35	1	In	in	IN
cord-003926-ycdaw2vh	35	2	one	one	CD
cord-003926-ycdaw2vh	35	3	study	study	NN
cord-003926-ycdaw2vh	35	4	of	of	IN
cord-003926-ycdaw2vh	35	5	a	a	DT
cord-003926-ycdaw2vh	35	6	Zika	Zika	NNP
cord-003926-ycdaw2vh	35	7	virus	virus	NN
cord-003926-ycdaw2vh	35	8	DNA	dna	NN
cord-003926-ycdaw2vh	35	9	vaccine	vaccine	NN
cord-003926-ycdaw2vh	35	10	,	,	,
cord-003926-ycdaw2vh	35	11	the	the	DT
cord-003926-ycdaw2vh	35	12	adverse	adverse	JJ
cord-003926-ycdaw2vh	35	13	effects	effect	NNS
cord-003926-ycdaw2vh	35	14	in	in	IN
cord-003926-ycdaw2vh	35	15	the	the	DT
cord-003926-ycdaw2vh	35	16	male	male	JJ
cord-003926-ycdaw2vh	35	17	reproductive	reproductive	JJ
cord-003926-ycdaw2vh	35	18	system	system	NN
cord-003926-ycdaw2vh	35	19	were	be	VBD
cord-003926-ycdaw2vh	35	20	prevented	prevent	VBN
cord-003926-ycdaw2vh	35	21	by	by	IN
cord-003926-ycdaw2vh	35	22	vaccination	vaccination	NN
cord-003926-ycdaw2vh	35	23	[	[	-LRB-
cord-003926-ycdaw2vh	35	24	30	30	CD
cord-003926-ycdaw2vh	35	25	]	]	-RRB-
cord-003926-ycdaw2vh	35	26	.	.	.
cord-003926-ycdaw2vh	36	1	The	the	DT
cord-003926-ycdaw2vh	36	2	question	question	NN
cord-003926-ycdaw2vh	36	3	of	of	IN
cord-003926-ycdaw2vh	36	4	whether	whether	IN
cord-003926-ycdaw2vh	36	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	36	6	virus	virus	NN
cord-003926-ycdaw2vh	36	7	can	can	MD
cord-003926-ycdaw2vh	36	8	adversely	adversely	RB
cord-003926-ycdaw2vh	36	9	affect	affect	VB
cord-003926-ycdaw2vh	36	10	human	human	JJ
cord-003926-ycdaw2vh	36	11	reproductive	reproductive	JJ
cord-003926-ycdaw2vh	36	12	potential	potential	NN
cord-003926-ycdaw2vh	36	13	and	and	CC
cord-003926-ycdaw2vh	36	14	,	,	,
cord-003926-ycdaw2vh	36	15	if	if	IN
cord-003926-ycdaw2vh	36	16	so	so	RB
cord-003926-ycdaw2vh	36	17	,	,	,
cord-003926-ycdaw2vh	36	18	whether	whether	IN
cord-003926-ycdaw2vh	36	19	such	such	JJ
cord-003926-ycdaw2vh	36	20	effects	effect	NNS
cord-003926-ycdaw2vh	36	21	would	would	MD
cord-003926-ycdaw2vh	36	22	be	be	VB
cord-003926-ycdaw2vh	36	23	age	age	NN
cord-003926-ycdaw2vh	36	24	-	-	HYPH
cord-003926-ycdaw2vh	36	25	related	relate	VBN
cord-003926-ycdaw2vh	36	26	is	be	VBZ
cord-003926-ycdaw2vh	36	27	unknown	unknown	JJ
cord-003926-ycdaw2vh	36	28	.	.	.
cord-003926-ycdaw2vh	37	1	Females	female	NNS
cord-003926-ycdaw2vh	37	2	may	may	MD
cord-003926-ycdaw2vh	37	3	also	also	RB
cord-003926-ycdaw2vh	37	4	excrete	excrete	VB
cord-003926-ycdaw2vh	37	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	37	6	virus	virus	NN
cord-003926-ycdaw2vh	37	7	RNA	rna	NN
cord-003926-ycdaw2vh	37	8	for	for	IN
cord-003926-ycdaw2vh	37	9	extended	extended	JJ
cord-003926-ycdaw2vh	37	10	times	time	NNS
cord-003926-ycdaw2vh	37	11	.	.	.
cord-003926-ycdaw2vh	38	1	A	a	DT
cord-003926-ycdaw2vh	38	2	prospective	prospective	JJ
cord-003926-ycdaw2vh	38	3	study	study	NN
cord-003926-ycdaw2vh	38	4	of	of	IN
cord-003926-ycdaw2vh	38	5	five	five	CD
cord-003926-ycdaw2vh	38	6	women	woman	NNS
cord-003926-ycdaw2vh	38	7	showed	show	VBD
cord-003926-ycdaw2vh	38	8	that	that	IN
cord-003926-ycdaw2vh	38	9	Zika	Zika	NNP
cord-003926-ycdaw2vh	38	10	RNA	RNA	NNP
cord-003926-ycdaw2vh	38	11	was	be	VBD
cord-003926-ycdaw2vh	38	12	detected	detect	VBN
cord-003926-ycdaw2vh	38	13	in	in	IN
cord-003926-ycdaw2vh	38	14	vaginal	vaginal	JJ
cord-003926-ycdaw2vh	38	15	fluid	fluid	NN
cord-003926-ycdaw2vh	38	16	for	for	IN
cord-003926-ycdaw2vh	38	17	as	as	RB
cord-003926-ycdaw2vh	38	18	long	long	JJ
cord-003926-ycdaw2vh	38	19	as	as	IN
cord-003926-ycdaw2vh	38	20	6	6	CD
cord-003926-ycdaw2vh	38	21	months	month	NNS
cord-003926-ycdaw2vh	38	22	and	and	CC
cord-003926-ycdaw2vh	38	23	a	a	DT
cord-003926-ycdaw2vh	38	24	month	month	NN
cord-003926-ycdaw2vh	38	25	or	or	CC
cord-003926-ycdaw2vh	38	26	more	more	JJR
cord-003926-ycdaw2vh	38	27	in	in	IN
cord-003926-ycdaw2vh	38	28	three	three	CD
cord-003926-ycdaw2vh	38	29	of	of	IN
cord-003926-ycdaw2vh	38	30	the	the	DT
cord-003926-ycdaw2vh	38	31	five	five	CD
cord-003926-ycdaw2vh	38	32	[	[	-LRB-
cord-003926-ycdaw2vh	38	33	31	31	CD
cord-003926-ycdaw2vh	38	34	]	]	-RRB-
cord-003926-ycdaw2vh	38	35	.	.	.
cord-003926-ycdaw2vh	39	1	Murine	murine	JJ
cord-003926-ycdaw2vh	39	2	studies	study	NNS
cord-003926-ycdaw2vh	39	3	showed	show	VBD
cord-003926-ycdaw2vh	39	4	that	that	IN
cord-003926-ycdaw2vh	39	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	39	6	virus	virus	NN
cord-003926-ycdaw2vh	39	7	caused	cause	VBD
cord-003926-ycdaw2vh	39	8	infection	infection	NN
cord-003926-ycdaw2vh	39	9	of	of	IN
cord-003926-ycdaw2vh	39	10	the	the	DT
cord-003926-ycdaw2vh	39	11	ovaries	ovary	NNS
cord-003926-ycdaw2vh	39	12	of	of	IN
cord-003926-ycdaw2vh	39	13	non	non	JJ
cord-003926-ycdaw2vh	39	14	-	-	JJ
cord-003926-ycdaw2vh	39	15	immunosuppressed	immunosuppressed	JJ
cord-003926-ycdaw2vh	39	16	C57Bl/6	C57Bl/6	NNPS
cord-003926-ycdaw2vh	39	17	mice	mouse	NNS
cord-003926-ycdaw2vh	39	18	and	and	CC
cord-003926-ycdaw2vh	39	19	induced	induce	VBD
cord-003926-ycdaw2vh	39	20	a	a	DT
cord-003926-ycdaw2vh	39	21	T	t	NN
cord-003926-ycdaw2vh	39	22	-	-	HYPH
cord-003926-ycdaw2vh	39	23	cell	cell	NN
cord-003926-ycdaw2vh	39	24	inflammatory	inflammatory	JJ
cord-003926-ycdaw2vh	39	25	reaction	reaction	NN
cord-003926-ycdaw2vh	39	26	,	,	,
cord-003926-ycdaw2vh	39	27	but	but	CC
cord-003926-ycdaw2vh	39	28	without	without	IN
cord-003926-ycdaw2vh	39	29	affecting	affect	VBG
cord-003926-ycdaw2vh	39	30	reproductive	reproductive	JJ
cord-003926-ycdaw2vh	39	31	potential	potential	NN
cord-003926-ycdaw2vh	39	32	[	[	-LRB-
cord-003926-ycdaw2vh	39	33	32	32	CD
cord-003926-ycdaw2vh	39	34	]	]	-RRB-
cord-003926-ycdaw2vh	39	35	.	.	.
cord-003926-ycdaw2vh	40	1	In	in	IN
cord-003926-ycdaw2vh	40	2	contrast	contrast	NN
cord-003926-ycdaw2vh	40	3	to	to	IN
cord-003926-ycdaw2vh	40	4	the	the	DT
cord-003926-ycdaw2vh	40	5	above	above	JJ
cord-003926-ycdaw2vh	40	6	human	human	JJ
cord-003926-ycdaw2vh	40	7	study	study	NN
cord-003926-ycdaw2vh	40	8	,	,	,
cord-003926-ycdaw2vh	40	9	female	female	JJ
cord-003926-ycdaw2vh	40	10	macaques	macaque	NNS
cord-003926-ycdaw2vh	40	11	rapidly	rapidly	RB
cord-003926-ycdaw2vh	40	12	cleared	clear	VBD
cord-003926-ycdaw2vh	40	13	virus	virus	NN
cord-003926-ycdaw2vh	40	14	from	from	IN
cord-003926-ycdaw2vh	40	15	the	the	DT
cord-003926-ycdaw2vh	40	16	genital	genital	JJ
cord-003926-ycdaw2vh	40	17	tract	tract	NN
cord-003926-ycdaw2vh	40	18	[	[	-LRB-
cord-003926-ycdaw2vh	40	19	33	33	CD
cord-003926-ycdaw2vh	40	20	]	]	-RRB-
cord-003926-ycdaw2vh	40	21	.	.	.
cord-003926-ycdaw2vh	41	1	Thus	thus	RB
cord-003926-ycdaw2vh	41	2	,	,	,
cord-003926-ycdaw2vh	41	3	while	while	IN
cord-003926-ycdaw2vh	41	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	41	5	virus	virus	NN
cord-003926-ycdaw2vh	41	6	infection	infection	NN
cord-003926-ycdaw2vh	41	7	is	be	VBZ
cord-003926-ycdaw2vh	41	8	mildly	mildly	RB
cord-003926-ycdaw2vh	41	9	symptomatic	symptomatic	JJ
cord-003926-ycdaw2vh	41	10	and	and	CC
cord-003926-ycdaw2vh	41	11	self	self	NN
cord-003926-ycdaw2vh	41	12	-	-	HYPH
cord-003926-ycdaw2vh	41	13	limited	limit	VBN
cord-003926-ycdaw2vh	41	14	for	for	IN
cord-003926-ycdaw2vh	41	15	the	the	DT
cord-003926-ycdaw2vh	41	16	vast	vast	JJ
cord-003926-ycdaw2vh	41	17	majority	majority	NN
cord-003926-ycdaw2vh	41	18	of	of	IN
cord-003926-ycdaw2vh	41	19	individuals	individual	NNS
cord-003926-ycdaw2vh	41	20	,	,	,
cord-003926-ycdaw2vh	41	21	with	with	IN
cord-003926-ycdaw2vh	41	22	infrequent	infrequent	JJ
cord-003926-ycdaw2vh	41	23	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	41	24	complications	complication	NNS
cord-003926-ycdaw2vh	41	25	in	in	IN
cord-003926-ycdaw2vh	41	26	adults	adult	NNS
cord-003926-ycdaw2vh	41	27	,	,	,
cord-003926-ycdaw2vh	41	28	vaccination	vaccination	NN
cord-003926-ycdaw2vh	41	29	of	of	IN
cord-003926-ycdaw2vh	41	30	the	the	DT
cord-003926-ycdaw2vh	41	31	general	general	JJ
cord-003926-ycdaw2vh	41	32	population	population	NN
cord-003926-ycdaw2vh	41	33	may	may	MD
cord-003926-ycdaw2vh	41	34	not	not	RB
cord-003926-ycdaw2vh	41	35	be	be	VB
cord-003926-ycdaw2vh	41	36	warranted	warrant	VBN
cord-003926-ycdaw2vh	41	37	.	.	.
cord-003926-ycdaw2vh	42	1	However	however	RB
cord-003926-ycdaw2vh	42	2	,	,	,
cord-003926-ycdaw2vh	42	3	vaccination	vaccination	NN
cord-003926-ycdaw2vh	42	4	of	of	IN
cord-003926-ycdaw2vh	42	5	females	female	NNS
cord-003926-ycdaw2vh	42	6	at	at	IN
cord-003926-ycdaw2vh	42	7	or	or	CC
cord-003926-ycdaw2vh	42	8	entering	enter	VBG
cord-003926-ycdaw2vh	42	9	reproductive	reproductive	JJ
cord-003926-ycdaw2vh	42	10	age	age	NN
cord-003926-ycdaw2vh	42	11	and	and	CC
cord-003926-ycdaw2vh	42	12	their	-PRON-	PRP$
cord-003926-ycdaw2vh	42	13	male	male	JJ
cord-003926-ycdaw2vh	42	14	partners	partner	NNS
cord-003926-ycdaw2vh	42	15	is	be	VBZ
cord-003926-ycdaw2vh	42	16	prudent	prudent	JJ
cord-003926-ycdaw2vh	42	17	.	.	.
cord-003926-ycdaw2vh	43	1	As	as	IN
cord-003926-ycdaw2vh	43	2	discussed	discuss	VBN
cord-003926-ycdaw2vh	43	3	previously	previously	RB
cord-003926-ycdaw2vh	43	4	,	,	,
cord-003926-ycdaw2vh	43	5	vaccination	vaccination	NN
cord-003926-ycdaw2vh	43	6	during	during	IN
cord-003926-ycdaw2vh	43	7	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	43	8	is	be	VBZ
cord-003926-ycdaw2vh	43	9	non	non	JJ
cord-003926-ycdaw2vh	43	10	-	-	JJ
cord-003926-ycdaw2vh	43	11	ideal	ideal	JJ
cord-003926-ycdaw2vh	43	12	due	due	IN
cord-003926-ycdaw2vh	43	13	to	to	IN
cord-003926-ycdaw2vh	43	14	the	the	DT
cord-003926-ycdaw2vh	43	15	time	time	NN
cord-003926-ycdaw2vh	43	16	to	to	TO
cord-003926-ycdaw2vh	43	17	generate	generate	VB
cord-003926-ycdaw2vh	43	18	protective	protective	JJ
cord-003926-ycdaw2vh	43	19	immunity	immunity	NN
cord-003926-ycdaw2vh	43	20	and	and	CC
cord-003926-ycdaw2vh	43	21	unknown	unknown	JJ
cord-003926-ycdaw2vh	43	22	vaccine	vaccine	NN
cord-003926-ycdaw2vh	43	23	safety	safety	NN
cord-003926-ycdaw2vh	43	24	[	[	-LRB-
cord-003926-ycdaw2vh	43	25	34	34	CD
cord-003926-ycdaw2vh	43	26	]	]	-RRB-
cord-003926-ycdaw2vh	43	27	.	.	.
cord-003926-ycdaw2vh	44	1	The	the	DT
cord-003926-ycdaw2vh	44	2	one	one	CD
cord-003926-ycdaw2vh	44	3	unknown	unknown	JJ
cord-003926-ycdaw2vh	44	4	aspect	aspect	NN
cord-003926-ycdaw2vh	44	5	is	be	VBZ
cord-003926-ycdaw2vh	44	6	whether	whether	IN
cord-003926-ycdaw2vh	44	7	vaccination	vaccination	NN
cord-003926-ycdaw2vh	44	8	of	of	IN
cord-003926-ycdaw2vh	44	9	males	male	NNS
cord-003926-ycdaw2vh	44	10	of	of	IN
cord-003926-ycdaw2vh	44	11	any	any	DT
cord-003926-ycdaw2vh	44	12	age	age	NN
cord-003926-ycdaw2vh	44	13	may	may	MD
cord-003926-ycdaw2vh	44	14	be	be	VB
cord-003926-ycdaw2vh	44	15	beneficial	beneficial	JJ
cord-003926-ycdaw2vh	44	16	to	to	TO
cord-003926-ycdaw2vh	44	17	protect	protect	VB
cord-003926-ycdaw2vh	44	18	against	against	IN
cord-003926-ycdaw2vh	44	19	testicular	testicular	JJ
cord-003926-ycdaw2vh	44	20	complications	complication	NNS
cord-003926-ycdaw2vh	44	21	.	.	.
cord-003926-ycdaw2vh	45	1	Calls	call	NNS
cord-003926-ycdaw2vh	45	2	for	for	IN
cord-003926-ycdaw2vh	45	3	generalized	generalized	JJ
cord-003926-ycdaw2vh	45	4	vaccination	vaccination	NN
cord-003926-ycdaw2vh	45	5	programs	program	NNS
cord-003926-ycdaw2vh	45	6	have	have	VBP
cord-003926-ycdaw2vh	45	7	,	,	,
cord-003926-ycdaw2vh	45	8	however	however	RB
cord-003926-ycdaw2vh	45	9	,	,	,
cord-003926-ycdaw2vh	45	10	been	be	VBN
cord-003926-ycdaw2vh	45	11	put	put	VBN
cord-003926-ycdaw2vh	45	12	on	on	IN
cord-003926-ycdaw2vh	45	13	hold	hold	NN
cord-003926-ycdaw2vh	45	14	due	due	IN
cord-003926-ycdaw2vh	45	15	to	to	IN
cord-003926-ycdaw2vh	45	16	the	the	DT
cord-003926-ycdaw2vh	45	17	decreasing	decrease	VBG
cord-003926-ycdaw2vh	45	18	incidence	incidence	NN
cord-003926-ycdaw2vh	45	19	of	of	IN
cord-003926-ycdaw2vh	45	20	Zika	Zika	NNP
cord-003926-ycdaw2vh	45	21	infection	infection	NN
cord-003926-ycdaw2vh	45	22	rates	rate	NNS
cord-003926-ycdaw2vh	45	23	,	,	,
cord-003926-ycdaw2vh	45	24	as	as	IN
cord-003926-ycdaw2vh	45	25	discussed	discuss	VBN
cord-003926-ycdaw2vh	45	26	in	in	IN
cord-003926-ycdaw2vh	45	27	the	the	DT
cord-003926-ycdaw2vh	45	28	next	next	JJ
cord-003926-ycdaw2vh	45	29	section	section	NN
cord-003926-ycdaw2vh	45	30	.	.	.
cord-003926-ycdaw2vh	46	1	In	in	IN
cord-003926-ycdaw2vh	46	2	late	late	JJ
cord-003926-ycdaw2vh	46	3	2015	2015	CD
cord-003926-ycdaw2vh	46	4	and	and	CC
cord-003926-ycdaw2vh	46	5	through	through	IN
cord-003926-ycdaw2vh	46	6	mid-2016	mid-2016	NN
cord-003926-ycdaw2vh	46	7	,	,	,
cord-003926-ycdaw2vh	46	8	global	global	JJ
cord-003926-ycdaw2vh	46	9	concern	concern	NN
cord-003926-ycdaw2vh	46	10	for	for	IN
cord-003926-ycdaw2vh	46	11	this	this	DT
cord-003926-ycdaw2vh	46	12	spreading	spread	VBG
cord-003926-ycdaw2vh	46	13	epidemic	epidemic	NN
cord-003926-ycdaw2vh	46	14	was	be	VBD
cord-003926-ycdaw2vh	46	15	increasing	increase	VBG
cord-003926-ycdaw2vh	46	16	,	,	,
cord-003926-ycdaw2vh	46	17	however	however	RB
cord-003926-ycdaw2vh	46	18	,	,	,
cord-003926-ycdaw2vh	46	19	the	the	DT
cord-003926-ycdaw2vh	46	20	experience	experience	NN
cord-003926-ycdaw2vh	46	21	in	in	IN
cord-003926-ycdaw2vh	46	22	the	the	DT
cord-003926-ycdaw2vh	46	23	two	two	CD
cord-003926-ycdaw2vh	46	24	prior	prior	JJ
cord-003926-ycdaw2vh	46	25	epidemics	epidemic	NNS
cord-003926-ycdaw2vh	46	26	was	be	VBD
cord-003926-ycdaw2vh	46	27	predictive	predictive	JJ
cord-003926-ycdaw2vh	46	28	of	of	IN
cord-003926-ycdaw2vh	46	29	the	the	DT
cord-003926-ycdaw2vh	46	30	subsequent	subsequent	JJ
cord-003926-ycdaw2vh	46	31	epidemiology	epidemiology	NN
cord-003926-ycdaw2vh	46	32	in	in	IN
cord-003926-ycdaw2vh	46	33	the	the	DT
cord-003926-ycdaw2vh	46	34	Americas	Americas	NNPS
cord-003926-ycdaw2vh	46	35	.	.	.
cord-003926-ycdaw2vh	47	1	The	the	DT
cord-003926-ycdaw2vh	47	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	47	3	virus	virus	NN
cord-003926-ycdaw2vh	47	4	outbreaks	outbreak	NNS
cord-003926-ycdaw2vh	47	5	in	in	IN
cord-003926-ycdaw2vh	47	6	Yap	Yap	NNP
cord-003926-ycdaw2vh	47	7	Island	Island	NNP
cord-003926-ycdaw2vh	47	8	and	and	CC
cord-003926-ycdaw2vh	47	9	French	French	NNP
cord-003926-ycdaw2vh	47	10	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	47	11	were	be	VBD
cord-003926-ycdaw2vh	47	12	characterized	characterize	VBN
cord-003926-ycdaw2vh	47	13	by	by	IN
cord-003926-ycdaw2vh	47	14	rapid	rapid	JJ
cord-003926-ycdaw2vh	47	15	onset	onset	NN
cord-003926-ycdaw2vh	47	16	and	and	CC
cord-003926-ycdaw2vh	47	17	rapid	rapid	JJ
cord-003926-ycdaw2vh	47	18	resolution	resolution	NN
cord-003926-ycdaw2vh	47	19	over	over	IN
cord-003926-ycdaw2vh	47	20	a	a	DT
cord-003926-ycdaw2vh	47	21	span	span	NN
cord-003926-ycdaw2vh	47	22	of	of	IN
cord-003926-ycdaw2vh	47	23	3	3	CD
cord-003926-ycdaw2vh	47	24	-	-	SYM
cord-003926-ycdaw2vh	47	25	4	4	CD
cord-003926-ycdaw2vh	47	26	months	month	NNS
cord-003926-ycdaw2vh	47	27	[	[	-LRB-
cord-003926-ycdaw2vh	47	28	3	3	CD
cord-003926-ycdaw2vh	47	29	,	,	,
cord-003926-ycdaw2vh	47	30	9	9	CD
cord-003926-ycdaw2vh	47	31	]	]	-RRB-
cord-003926-ycdaw2vh	47	32	.	.	.
cord-003926-ycdaw2vh	48	1	The	the	DT
cord-003926-ycdaw2vh	48	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	48	3	epidemic	epidemic	NN
cord-003926-ycdaw2vh	48	4	in	in	IN
cord-003926-ycdaw2vh	48	5	the	the	DT
cord-003926-ycdaw2vh	48	6	Americas	Americas	NNPS
cord-003926-ycdaw2vh	48	7	was	be	VBD
cord-003926-ycdaw2vh	48	8	characterized	characterize	VBN
cord-003926-ycdaw2vh	48	9	by	by	IN
cord-003926-ycdaw2vh	48	10	a	a	DT
cord-003926-ycdaw2vh	48	11	longer	long	JJR
cord-003926-ycdaw2vh	48	12	time	time	NN
cord-003926-ycdaw2vh	48	13	to	to	TO
cord-003926-ycdaw2vh	48	14	reach	reach	VB
cord-003926-ycdaw2vh	48	15	peak	peak	NN
cord-003926-ycdaw2vh	48	16	incidence	incidence	NN
cord-003926-ycdaw2vh	48	17	,	,	,
cord-003926-ycdaw2vh	48	18	taking	take	VBG
cord-003926-ycdaw2vh	48	19	approximately	approximately	RB
cord-003926-ycdaw2vh	48	20	one	one	CD
cord-003926-ycdaw2vh	48	21	year	year	NN
cord-003926-ycdaw2vh	48	22	for	for	IN
cord-003926-ycdaw2vh	48	23	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	48	24	[	[	-LRB-
cord-003926-ycdaw2vh	48	25	35	35	CD
cord-003926-ycdaw2vh	48	26	]	]	-RRB-
cord-003926-ycdaw2vh	48	27	presumably	presumably	RB
cord-003926-ycdaw2vh	48	28	related	relate	VBN
cord-003926-ycdaw2vh	48	29	to	to	IN
cord-003926-ycdaw2vh	48	30	the	the	DT
cord-003926-ycdaw2vh	48	31	larger	large	JJR
cord-003926-ycdaw2vh	48	32	and	and	CC
cord-003926-ycdaw2vh	48	33	more	more	RBR
cord-003926-ycdaw2vh	48	34	varied	varied	JJ
cord-003926-ycdaw2vh	48	35	geography	geography	NN
cord-003926-ycdaw2vh	48	36	,	,	,
cord-003926-ycdaw2vh	48	37	with	with	IN
cord-003926-ycdaw2vh	48	38	attack	attack	NN
cord-003926-ycdaw2vh	48	39	rates	rate	NNS
cord-003926-ycdaw2vh	48	40	decreasing	decrease	VBG
cord-003926-ycdaw2vh	48	41	greater	great	JJR
cord-003926-ycdaw2vh	48	42	than	than	IN
cord-003926-ycdaw2vh	48	43	100-fold	100-fold	CD
cord-003926-ycdaw2vh	48	44	the	the	DT
cord-003926-ycdaw2vh	48	45	next	next	JJ
cord-003926-ycdaw2vh	48	46	year	year	NN
cord-003926-ycdaw2vh	48	47	[	[	-LRB-
cord-003926-ycdaw2vh	48	48	35	35	CD
cord-003926-ycdaw2vh	48	49	]	]	-RRB-
cord-003926-ycdaw2vh	48	50	.	.	.
cord-003926-ycdaw2vh	49	1	Data	datum	NNS
cord-003926-ycdaw2vh	49	2	published	publish	VBN
cord-003926-ycdaw2vh	49	3	by	by	IN
cord-003926-ycdaw2vh	49	4	the	the	DT
cord-003926-ycdaw2vh	49	5	Pan	Pan	NNP
cord-003926-ycdaw2vh	49	6	American	American	NNP
cord-003926-ycdaw2vh	49	7	Health	Health	NNP
cord-003926-ycdaw2vh	49	8	Organization	Organization	NNP
cord-003926-ycdaw2vh	49	9	(	(	-LRB-
cord-003926-ycdaw2vh	49	10	PAHO	PAHO	NNP
cord-003926-ycdaw2vh	49	11	)	)	-RRB-
cord-003926-ycdaw2vh	49	12	found	find	VBD
cord-003926-ycdaw2vh	49	13	similar	similar	JJ
cord-003926-ycdaw2vh	49	14	patterns	pattern	NNS
cord-003926-ycdaw2vh	49	15	through	through	IN
cord-003926-ycdaw2vh	49	16	South	South	NNP
cord-003926-ycdaw2vh	49	17	and	and	CC
cord-003926-ycdaw2vh	49	18	Central	Central	NNP
cord-003926-ycdaw2vh	49	19	America	America	NNP
cord-003926-ycdaw2vh	49	20	(	(	-LRB-
cord-003926-ycdaw2vh	49	21	https://www.paho.org/	https://www.paho.org/	ADD
cord-003926-ycdaw2vh	49	22	)	)	-RRB-
cord-003926-ycdaw2vh	49	23	.	.	.
cord-003926-ycdaw2vh	50	1	The	the	DT
cord-003926-ycdaw2vh	50	2	almost	almost	RB
cord-003926-ycdaw2vh	50	3	complete	complete	JJ
cord-003926-ycdaw2vh	50	4	disappearance	disappearance	NN
cord-003926-ycdaw2vh	50	5	of	of	IN
cord-003926-ycdaw2vh	50	6	Zika	Zika	NNP
cord-003926-ycdaw2vh	50	7	has	have	VBZ
cord-003926-ycdaw2vh	50	8	created	create	VBN
cord-003926-ycdaw2vh	50	9	significant	significant	JJ
cord-003926-ycdaw2vh	50	10	barriers	barrier	NNS
cord-003926-ycdaw2vh	50	11	to	to	IN
cord-003926-ycdaw2vh	50	12	ongoing	ongoing	JJ
cord-003926-ycdaw2vh	50	13	vaccine	vaccine	NN
cord-003926-ycdaw2vh	50	14	studies	study	NNS
cord-003926-ycdaw2vh	50	15	as	as	IN
cord-003926-ycdaw2vh	50	16	attack	attack	NN
cord-003926-ycdaw2vh	50	17	rates	rate	NNS
cord-003926-ycdaw2vh	50	18	have	have	VBP
cord-003926-ycdaw2vh	50	19	fallen	fall	VBN
cord-003926-ycdaw2vh	50	20	below	below	IN
cord-003926-ycdaw2vh	50	21	those	those	DT
cord-003926-ycdaw2vh	50	22	need	need	VBP
cord-003926-ycdaw2vh	50	23	to	to	TO
cord-003926-ycdaw2vh	50	24	meet	meet	VB
cord-003926-ycdaw2vh	50	25	reasonable	reasonable	JJ
cord-003926-ycdaw2vh	50	26	sample	sample	NN
cord-003926-ycdaw2vh	50	27	sizes	size	NNS
cord-003926-ycdaw2vh	50	28	[	[	-LRB-
cord-003926-ycdaw2vh	50	29	6	6	CD
cord-003926-ycdaw2vh	50	30	]	]	-RRB-
cord-003926-ycdaw2vh	50	31	.	.	.
cord-003926-ycdaw2vh	51	1	The	the	DT
cord-003926-ycdaw2vh	51	2	WHO	who	WP
cord-003926-ycdaw2vh	51	3	removed	remove	VBD
cord-003926-ycdaw2vh	51	4	the	the	DT
cord-003926-ycdaw2vh	51	5	designation	designation	NN
cord-003926-ycdaw2vh	51	6	of	of	IN
cord-003926-ycdaw2vh	51	7	Zika	Zika	NNP
cord-003926-ycdaw2vh	51	8	a	a	DT
cord-003926-ycdaw2vh	51	9	virus	virus	NN
cord-003926-ycdaw2vh	51	10	of	of	IN
cord-003926-ycdaw2vh	51	11	global	global	JJ
cord-003926-ycdaw2vh	51	12	concern	concern	NN
cord-003926-ycdaw2vh	51	13	in	in	IN
cord-003926-ycdaw2vh	51	14	2018	2018	CD
cord-003926-ycdaw2vh	51	15	as	as	IN
cord-003926-ycdaw2vh	51	16	case	case	NN
cord-003926-ycdaw2vh	51	17	rates	rate	NNS
cord-003926-ycdaw2vh	51	18	have	have	VBP
cord-003926-ycdaw2vh	51	19	fallen	fall	VBN
cord-003926-ycdaw2vh	51	20	.	.	.
cord-003926-ycdaw2vh	52	1	In	in	IN
cord-003926-ycdaw2vh	52	2	March	March	NNP
cord-003926-ycdaw2vh	52	3	2018	2018	CD
cord-003926-ycdaw2vh	52	4	,	,	,
cord-003926-ycdaw2vh	52	5	the	the	DT
cord-003926-ycdaw2vh	52	6	WHO	WHO	NNP
cord-003926-ycdaw2vh	52	7	and	and	CC
cord-003926-ycdaw2vh	52	8	the	the	DT
cord-003926-ycdaw2vh	52	9	National	National	NNP
cord-003926-ycdaw2vh	52	10	Institutes	Institutes	NNPS
cord-003926-ycdaw2vh	52	11	of	of	IN
cord-003926-ycdaw2vh	52	12	Allergy	Allergy	NNP
cord-003926-ycdaw2vh	52	13	and	and	CC
cord-003926-ycdaw2vh	52	14	Infectious	Infectious	NNP
cord-003926-ycdaw2vh	52	15	Diseases	Diseases	NNPS
cord-003926-ycdaw2vh	52	16	(	(	-LRB-
cord-003926-ycdaw2vh	52	17	NIAID	NIAID	NNP
cord-003926-ycdaw2vh	52	18	)	)	-RRB-
cord-003926-ycdaw2vh	52	19	convened	convene	VBD
cord-003926-ycdaw2vh	52	20	a	a	DT
cord-003926-ycdaw2vh	52	21	meeting	meeting	NN
cord-003926-ycdaw2vh	52	22	of	of	IN
cord-003926-ycdaw2vh	52	23	academics	academic	NNS
cord-003926-ycdaw2vh	52	24	,	,	,
cord-003926-ycdaw2vh	52	25	representatives	representative	NNS
cord-003926-ycdaw2vh	52	26	from	from	IN
cord-003926-ycdaw2vh	52	27	industry	industry	NN
cord-003926-ycdaw2vh	52	28	,	,	,
cord-003926-ycdaw2vh	52	29	and	and	CC
cord-003926-ycdaw2vh	52	30	regulators	regulator	NNS
cord-003926-ycdaw2vh	52	31	to	to	TO
cord-003926-ycdaw2vh	52	32	discuss	discuss	VB
cord-003926-ycdaw2vh	52	33	the	the	DT
cord-003926-ycdaw2vh	52	34	approach	approach	NN
cord-003926-ycdaw2vh	52	35	to	to	IN
cord-003926-ycdaw2vh	52	36	Zika	Zika	NNP
cord-003926-ycdaw2vh	52	37	virus	virus	NN
cord-003926-ycdaw2vh	52	38	vaccine	vaccine	NN
cord-003926-ycdaw2vh	52	39	development	development	NN
cord-003926-ycdaw2vh	52	40	in	in	IN
cord-003926-ycdaw2vh	52	41	an	an	DT
cord-003926-ycdaw2vh	52	42	era	era	NN
cord-003926-ycdaw2vh	52	43	of	of	IN
cord-003926-ycdaw2vh	52	44	waning	wane	VBG
cord-003926-ycdaw2vh	52	45	incidence	incidence	NN
cord-003926-ycdaw2vh	52	46	[	[	-LRB-
cord-003926-ycdaw2vh	52	47	7	7	CD
cord-003926-ycdaw2vh	52	48	]	]	-RRB-
cord-003926-ycdaw2vh	52	49	.	.	.
cord-003926-ycdaw2vh	53	1	Although	although	IN
cord-003926-ycdaw2vh	53	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	53	3	virus	virus	NN
cord-003926-ycdaw2vh	53	4	remains	remain	VBZ
cord-003926-ycdaw2vh	53	5	endemic	endemic	JJ
cord-003926-ycdaw2vh	53	6	in	in	IN
cord-003926-ycdaw2vh	53	7	Asia	Asia	NNP
cord-003926-ycdaw2vh	53	8	,	,	,
cord-003926-ycdaw2vh	53	9	Africa	Africa	NNP
cord-003926-ycdaw2vh	53	10	,	,	,
cord-003926-ycdaw2vh	53	11	and	and	CC
cord-003926-ycdaw2vh	53	12	Central	Central	NNP
cord-003926-ycdaw2vh	53	13	and	and	CC
cord-003926-ycdaw2vh	53	14	South	South	NNP
cord-003926-ycdaw2vh	53	15	America	America	NNP
cord-003926-ycdaw2vh	53	16	,	,	,
cord-003926-ycdaw2vh	53	17	current	current	JJ
cord-003926-ycdaw2vh	53	18	transmission	transmission	NN
cord-003926-ycdaw2vh	53	19	rates	rate	NNS
cord-003926-ycdaw2vh	53	20	,	,	,
cord-003926-ycdaw2vh	53	21	coupled	couple	VBN
cord-003926-ycdaw2vh	53	22	with	with	IN
cord-003926-ycdaw2vh	53	23	high	high	JJ
cord-003926-ycdaw2vh	53	24	background	background	NN
cord-003926-ycdaw2vh	53	25	herd	herd	NN
cord-003926-ycdaw2vh	53	26	immunity	immunity	NN
cord-003926-ycdaw2vh	53	27	,	,	,
cord-003926-ycdaw2vh	53	28	would	would	MD
cord-003926-ycdaw2vh	53	29	require	require	VB
cord-003926-ycdaw2vh	53	30	an	an	DT
cord-003926-ycdaw2vh	53	31	extremely	extremely	RB
cord-003926-ycdaw2vh	53	32	large	large	JJ
cord-003926-ycdaw2vh	53	33	and	and	CC
cord-003926-ycdaw2vh	53	34	logistically	logistically	RB
cord-003926-ycdaw2vh	53	35	difficult	difficult	JJ
cord-003926-ycdaw2vh	53	36	study	study	NN
cord-003926-ycdaw2vh	53	37	.	.	.
cord-003926-ycdaw2vh	54	1	As	as	IN
cord-003926-ycdaw2vh	54	2	population	population	NN
cord-003926-ycdaw2vh	54	3	immunity	immunity	NN
cord-003926-ycdaw2vh	54	4	wanes	wane	VBZ
cord-003926-ycdaw2vh	54	5	,	,	,
cord-003926-ycdaw2vh	54	6	future	future	JJ
cord-003926-ycdaw2vh	54	7	outbreaks	outbreak	NNS
cord-003926-ycdaw2vh	54	8	are	be	VBP
cord-003926-ycdaw2vh	54	9	likely	likely	JJ
cord-003926-ycdaw2vh	54	10	.	.	.
cord-003926-ycdaw2vh	55	1	The	the	DT
cord-003926-ycdaw2vh	55	2	ability	ability	NN
cord-003926-ycdaw2vh	55	3	to	to	TO
cord-003926-ycdaw2vh	55	4	conduct	conduct	VB
cord-003926-ycdaw2vh	55	5	a	a	DT
cord-003926-ycdaw2vh	55	6	meaningful	meaningful	JJ
cord-003926-ycdaw2vh	55	7	future	future	JJ
cord-003926-ycdaw2vh	55	8	clinical	clinical	JJ
cord-003926-ycdaw2vh	55	9	trial	trial	NN
cord-003926-ycdaw2vh	55	10	may	may	MD
cord-003926-ycdaw2vh	55	11	be	be	VB
cord-003926-ycdaw2vh	55	12	dependent	dependent	JJ
cord-003926-ycdaw2vh	55	13	upon	upon	IN
cord-003926-ycdaw2vh	55	14	having	have	VBG
cord-003926-ycdaw2vh	55	15	pre	pre	JJ
cord-003926-ycdaw2vh	55	16	-	-	JJ
cord-003926-ycdaw2vh	55	17	existing	existing	JJ
cord-003926-ycdaw2vh	55	18	site	site	NN
cord-003926-ycdaw2vh	55	19	and	and	CC
cord-003926-ycdaw2vh	55	20	regulatory	regulatory	JJ
cord-003926-ycdaw2vh	55	21	approvals	approval	NNS
cord-003926-ycdaw2vh	55	22	with	with	IN
cord-003926-ycdaw2vh	55	23	an	an	DT
cord-003926-ycdaw2vh	55	24	established	establish	VBN
cord-003926-ycdaw2vh	55	25	vaccine	vaccine	NN
cord-003926-ycdaw2vh	55	26	network	network	NN
cord-003926-ycdaw2vh	55	27	to	to	TO
cord-003926-ycdaw2vh	55	28	enable	enable	VB
cord-003926-ycdaw2vh	55	29	rapid	rapid	JJ
cord-003926-ycdaw2vh	55	30	response	response	NN
cord-003926-ycdaw2vh	55	31	to	to	IN
cord-003926-ycdaw2vh	55	32	new	new	JJ
cord-003926-ycdaw2vh	55	33	reports	report	NNS
cord-003926-ycdaw2vh	55	34	suggesting	suggest	VBG
cord-003926-ycdaw2vh	55	35	increased	increase	VBN
cord-003926-ycdaw2vh	55	36	disease	disease	NN
cord-003926-ycdaw2vh	55	37	activity	activity	NN
cord-003926-ycdaw2vh	55	38	.	.	.
cord-003926-ycdaw2vh	56	1	Vaccine	vaccine	NN
cord-003926-ycdaw2vh	56	2	development	development	NN
cord-003926-ycdaw2vh	56	3	against	against	IN
cord-003926-ycdaw2vh	56	4	the	the	DT
cord-003926-ycdaw2vh	56	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	56	6	virus	virus	NN
cord-003926-ycdaw2vh	56	7	began	begin	VBD
cord-003926-ycdaw2vh	56	8	in	in	IN
cord-003926-ycdaw2vh	56	9	earnest	earnest	JJ
cord-003926-ycdaw2vh	56	10	in	in	IN
cord-003926-ycdaw2vh	56	11	late	late	JJ
cord-003926-ycdaw2vh	56	12	2015	2015	CD
cord-003926-ycdaw2vh	56	13	following	follow	VBG
cord-003926-ycdaw2vh	56	14	the	the	DT
cord-003926-ycdaw2vh	56	15	reports	report	NNS
cord-003926-ycdaw2vh	56	16	of	of	IN
cord-003926-ycdaw2vh	56	17	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	56	18	in	in	IN
cord-003926-ycdaw2vh	56	19	fetuses	fetus	NNS
cord-003926-ycdaw2vh	56	20	and	and	CC
cord-003926-ycdaw2vh	56	21	infants	infant	NNS
cord-003926-ycdaw2vh	56	22	in	in	IN
cord-003926-ycdaw2vh	56	23	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	56	24	.	.	.
cord-003926-ycdaw2vh	57	1	Of	of	IN
cord-003926-ycdaw2vh	57	2	note	note	NN
cord-003926-ycdaw2vh	57	3	,	,	,
cord-003926-ycdaw2vh	57	4	the	the	DT
cord-003926-ycdaw2vh	57	5	first	first	JJ
cord-003926-ycdaw2vh	57	6	demonstration	demonstration	NN
cord-003926-ycdaw2vh	57	7	of	of	IN
cord-003926-ycdaw2vh	57	8	immunoprotection	immunoprotection	NN
cord-003926-ycdaw2vh	57	9	was	be	VBD
cord-003926-ycdaw2vh	57	10	as	as	IN
cord-003926-ycdaw2vh	57	11	part	part	NN
cord-003926-ycdaw2vh	57	12	of	of	IN
cord-003926-ycdaw2vh	57	13	a	a	DT
cord-003926-ycdaw2vh	57	14	1953	1953	CD
cord-003926-ycdaw2vh	57	15	study	study	NN
cord-003926-ycdaw2vh	57	16	to	to	TO
cord-003926-ycdaw2vh	57	17	define	define	VB
cord-003926-ycdaw2vh	57	18	the	the	DT
cord-003926-ycdaw2vh	57	19	ultrastructural	ultrastructural	JJ
cord-003926-ycdaw2vh	57	20	characteristics	characteristic	NNS
cord-003926-ycdaw2vh	57	21	of	of	IN
cord-003926-ycdaw2vh	57	22	Zika	Zika	NNP
cord-003926-ycdaw2vh	57	23	virus	virus	NN
cord-003926-ycdaw2vh	57	24	,	,	,
cord-003926-ycdaw2vh	57	25	that	that	WDT
cord-003926-ycdaw2vh	57	26	found	find	VBD
cord-003926-ycdaw2vh	57	27	intramuscular	intramuscular	JJ
cord-003926-ycdaw2vh	57	28	vaccination	vaccination	NN
cord-003926-ycdaw2vh	57	29	of	of	IN
cord-003926-ycdaw2vh	57	30	mice	mouse	NNS
cord-003926-ycdaw2vh	57	31	with	with	IN
cord-003926-ycdaw2vh	57	32	infectious	infectious	JJ
cord-003926-ycdaw2vh	57	33	viral	viral	JJ
cord-003926-ycdaw2vh	57	34	filtrates	filtrate	NNS
cord-003926-ycdaw2vh	57	35	protected	protect	VBN
cord-003926-ycdaw2vh	57	36	against	against	IN
cord-003926-ycdaw2vh	57	37	cerebral	cerebral	JJ
cord-003926-ycdaw2vh	57	38	infection	infection	NN
cord-003926-ycdaw2vh	57	39	[	[	-LRB-
cord-003926-ycdaw2vh	57	40	36	36	CD
cord-003926-ycdaw2vh	57	41	]	]	-RRB-
cord-003926-ycdaw2vh	57	42	.	.	.
cord-003926-ycdaw2vh	58	1	Poland	Poland	NNP
cord-003926-ycdaw2vh	58	2	et	et	NNP
cord-003926-ycdaw2vh	58	3	al	al	NNP
cord-003926-ycdaw2vh	58	4	.	.	.
cord-003926-ycdaw2vh	59	1	provide	provide	VB
cord-003926-ycdaw2vh	59	2	a	a	DT
cord-003926-ycdaw2vh	59	3	comprehensive	comprehensive	JJ
cord-003926-ycdaw2vh	59	4	listing	listing	NN
cord-003926-ycdaw2vh	59	5	of	of	IN
cord-003926-ycdaw2vh	59	6	almost	almost	RB
cord-003926-ycdaw2vh	59	7	40	40	CD
cord-003926-ycdaw2vh	59	8	Zika	Zika	NNP
cord-003926-ycdaw2vh	59	9	virus	virus	NN
cord-003926-ycdaw2vh	59	10	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	59	11	in	in	IN
cord-003926-ycdaw2vh	59	12	development	development	NN
cord-003926-ycdaw2vh	59	13	as	as	IN
cord-003926-ycdaw2vh	59	14	of	of	IN
cord-003926-ycdaw2vh	59	15	2017	2017	CD
cord-003926-ycdaw2vh	59	16	[	[	-LRB-
cord-003926-ycdaw2vh	59	17	37	37	CD
cord-003926-ycdaw2vh	59	18	]	]	-RRB-
cord-003926-ycdaw2vh	59	19	.	.	.
cord-003926-ycdaw2vh	60	1	Diamond	Diamond	NNP
cord-003926-ycdaw2vh	60	2	et	et	NNP
cord-003926-ycdaw2vh	60	3	al	al	NNP
cord-003926-ycdaw2vh	60	4	.	.	.
cord-003926-ycdaw2vh	61	1	discuss	discuss	VB
cord-003926-ycdaw2vh	61	2	potential	potential	JJ
cord-003926-ycdaw2vh	61	3	immunoreactive	immunoreactive	JJ
cord-003926-ycdaw2vh	61	4	epitopes	epitope	NNS
cord-003926-ycdaw2vh	61	5	on	on	IN
cord-003926-ycdaw2vh	61	6	the	the	DT
cord-003926-ycdaw2vh	61	7	Zika	Zika	NNP
cord-003926-ycdaw2vh	61	8	envelope	envelope	NN
cord-003926-ycdaw2vh	61	9	and	and	CC
cord-003926-ycdaw2vh	61	10	provide	provide	VB
cord-003926-ycdaw2vh	61	11	further	further	JJ
cord-003926-ycdaw2vh	61	12	information	information	NN
cord-003926-ycdaw2vh	61	13	on	on	IN
cord-003926-ycdaw2vh	61	14	those	those	DT
cord-003926-ycdaw2vh	61	15	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	61	16	that	that	WDT
cord-003926-ycdaw2vh	61	17	progressed	progress	VBD
cord-003926-ycdaw2vh	61	18	into	into	IN
cord-003926-ycdaw2vh	61	19	clinical	clinical	JJ
cord-003926-ycdaw2vh	61	20	trials	trial	NNS
cord-003926-ycdaw2vh	61	21	[	[	-LRB-
cord-003926-ycdaw2vh	61	22	38	38	CD
cord-003926-ycdaw2vh	61	23	]	]	-RRB-
cord-003926-ycdaw2vh	61	24	.	.	.
cord-003926-ycdaw2vh	62	1	The	the	DT
cord-003926-ycdaw2vh	62	2	large	large	JJ
cord-003926-ycdaw2vh	62	3	number	number	NN
cord-003926-ycdaw2vh	62	4	of	of	IN
cord-003926-ycdaw2vh	62	5	delivery	delivery	NN
cord-003926-ycdaw2vh	62	6	platforms	platform	NNS
cord-003926-ycdaw2vh	62	7	include	include	VBP
cord-003926-ycdaw2vh	62	8	live	live	VBP
cord-003926-ycdaw2vh	62	9	attenuated	attenuated	JJ
cord-003926-ycdaw2vh	62	10	and	and	CC
cord-003926-ycdaw2vh	62	11	inactivated	inactivate	VBN
cord-003926-ycdaw2vh	62	12	whole	whole	JJ
cord-003926-ycdaw2vh	62	13	-	-	HYPH
cord-003926-ycdaw2vh	62	14	viruses	virus	NNS
cord-003926-ycdaw2vh	62	15	;	;	:
cord-003926-ycdaw2vh	62	16	viral	viral	RB
cord-003926-ycdaw2vh	62	17	-	-	HYPH
cord-003926-ycdaw2vh	62	18	vectored	vectore	VBN
cord-003926-ycdaw2vh	62	19	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	62	20	utilizing	utilize	VBG
cord-003926-ycdaw2vh	62	21	adeno	adeno	NN
cord-003926-ycdaw2vh	62	22	-	-	HYPH
cord-003926-ycdaw2vh	62	23	associated	associate	VBN
cord-003926-ycdaw2vh	62	24	virus	virus	NN
cord-003926-ycdaw2vh	62	25	,	,	,
cord-003926-ycdaw2vh	62	26	vesicular	vesicular	JJ
cord-003926-ycdaw2vh	62	27	stomatitis	stomatitis	NN
cord-003926-ycdaw2vh	62	28	virus	virus	NN
cord-003926-ycdaw2vh	62	29	,	,	,
cord-003926-ycdaw2vh	62	30	measles	measles	NN
cord-003926-ycdaw2vh	62	31	virus	virus	NN
cord-003926-ycdaw2vh	62	32	,	,	,
cord-003926-ycdaw2vh	62	33	and	and	CC
cord-003926-ycdaw2vh	62	34	dengue	dengue	NN
cord-003926-ycdaw2vh	62	35	or	or	CC
cord-003926-ycdaw2vh	62	36	Yellow	Yellow	NNP
cord-003926-ycdaw2vh	62	37	Fever	Fever	NNP
cord-003926-ycdaw2vh	62	38	chimeric	chimeric	JJ
cord-003926-ycdaw2vh	62	39	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	62	40	;	;	:
cord-003926-ycdaw2vh	62	41	DNA	DNA	NNP
cord-003926-ycdaw2vh	62	42	and	and	CC
cord-003926-ycdaw2vh	62	43	mRNA	mrna	NN
cord-003926-ycdaw2vh	62	44	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	62	45	;	;	:
cord-003926-ycdaw2vh	62	46	and	and	CC
cord-003926-ycdaw2vh	62	47	peptide	peptide	NN
cord-003926-ycdaw2vh	62	48	and	and	CC
cord-003926-ycdaw2vh	62	49	protein	protein	NN
cord-003926-ycdaw2vh	62	50	subunit	subunit	NN
cord-003926-ycdaw2vh	62	51	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	62	52	.	.	.
cord-003926-ycdaw2vh	63	1	Most	Most	JJS
cord-003926-ycdaw2vh	63	2	have	have	VBP
cord-003926-ycdaw2vh	63	3	been	be	VBN
cord-003926-ycdaw2vh	63	4	assessed	assess	VBN
cord-003926-ycdaw2vh	63	5	in	in	IN
cord-003926-ycdaw2vh	63	6	animal	animal	NN
cord-003926-ycdaw2vh	63	7	models	model	NNS
cord-003926-ycdaw2vh	63	8	utilizing	utilize	VBG
cord-003926-ycdaw2vh	63	9	non	non	JJ
cord-003926-ycdaw2vh	63	10	-	-	JJ
cord-003926-ycdaw2vh	63	11	human	human	JJ
cord-003926-ycdaw2vh	63	12	primates	primate	NNS
cord-003926-ycdaw2vh	63	13	and/or	and/or	CC
cord-003926-ycdaw2vh	63	14	lethal	lethal	JJ
cord-003926-ycdaw2vh	63	15	challenge	challenge	NN
cord-003926-ycdaw2vh	63	16	experiments	experiment	NNS
cord-003926-ycdaw2vh	63	17	involving	involve	VBG
cord-003926-ycdaw2vh	63	18	immunosuppressed	immunosuppressed	JJ
cord-003926-ycdaw2vh	63	19	mice	mouse	NNS
cord-003926-ycdaw2vh	63	20	[	[	-LRB-
cord-003926-ycdaw2vh	63	21	37	37	CD
cord-003926-ycdaw2vh	63	22	]	]	-RRB-
cord-003926-ycdaw2vh	63	23	.	.	.
cord-003926-ycdaw2vh	64	1	As	as	IN
cord-003926-ycdaw2vh	64	2	of	of	IN
cord-003926-ycdaw2vh	64	3	2017	2017	CD
cord-003926-ycdaw2vh	64	4	,	,	,
cord-003926-ycdaw2vh	64	5	six	six	CD
cord-003926-ycdaw2vh	64	6	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	64	7	had	have	VBD
cord-003926-ycdaw2vh	64	8	advanced	advance	VBN
cord-003926-ycdaw2vh	64	9	to	to	IN
cord-003926-ycdaw2vh	64	10	Phase	phase	NN
cord-003926-ycdaw2vh	65	1	I	-PRON-	PRP
cord-003926-ycdaw2vh	65	2	studies	study	VBZ
cord-003926-ycdaw2vh	65	3	[	[	-LRB-
cord-003926-ycdaw2vh	65	4	37	37	CD
cord-003926-ycdaw2vh	65	5	,	,	,
cord-003926-ycdaw2vh	65	6	39	39	CD
cord-003926-ycdaw2vh	65	7	,	,	,
cord-003926-ycdaw2vh	65	8	40	40	CD
cord-003926-ycdaw2vh	65	9	]	]	-RRB-
cord-003926-ycdaw2vh	65	10	.	.	.
cord-003926-ycdaw2vh	66	1	Since	since	IN
cord-003926-ycdaw2vh	66	2	that	that	DT
cord-003926-ycdaw2vh	66	3	time	time	NN
cord-003926-ycdaw2vh	66	4	,	,	,
cord-003926-ycdaw2vh	66	5	two	two	CD
cord-003926-ycdaw2vh	66	6	additional	additional	JJ
cord-003926-ycdaw2vh	66	7	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	66	8	have	have	VBP
cord-003926-ycdaw2vh	66	9	entered	enter	VBN
cord-003926-ycdaw2vh	66	10	into	into	IN
cord-003926-ycdaw2vh	66	11	clinical	clinical	JJ
cord-003926-ycdaw2vh	66	12	trials	trial	NNS
cord-003926-ycdaw2vh	66	13	(	(	-LRB-
cord-003926-ycdaw2vh	66	14	Table	table	NN
cord-003926-ycdaw2vh	66	15	1	1	CD
cord-003926-ycdaw2vh	66	16	)	)	-RRB-
cord-003926-ycdaw2vh	66	17	.	.	.
cord-003926-ycdaw2vh	67	1	A	a	DT
cord-003926-ycdaw2vh	67	2	total	total	NN
cord-003926-ycdaw2vh	67	3	of	of	IN
cord-003926-ycdaw2vh	67	4	three	three	CD
cord-003926-ycdaw2vh	67	5	DNA	dna	NN
cord-003926-ycdaw2vh	67	6	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	67	7	have	have	VBP
cord-003926-ycdaw2vh	67	8	entered	enter	VBN
cord-003926-ycdaw2vh	67	9	into	into	IN
cord-003926-ycdaw2vh	67	10	human	human	JJ
cord-003926-ycdaw2vh	67	11	testing	testing	NN
cord-003926-ycdaw2vh	67	12	[	[	-LRB-
cord-003926-ycdaw2vh	67	13	41	41	CD
cord-003926-ycdaw2vh	67	14	,	,	,
cord-003926-ycdaw2vh	67	15	42	42	CD
cord-003926-ycdaw2vh	67	16	]	]	-RRB-
cord-003926-ycdaw2vh	67	17	,	,	,
cord-003926-ycdaw2vh	67	18	including	include	VBG
cord-003926-ycdaw2vh	67	19	one	one	NN
cord-003926-ycdaw2vh	67	20	that	that	WDT
cord-003926-ycdaw2vh	67	21	has	have	VBZ
cord-003926-ycdaw2vh	67	22	advanced	advance	VBN
cord-003926-ycdaw2vh	67	23	to	to	IN
cord-003926-ycdaw2vh	67	24	Phase	Phase	NNP
cord-003926-ycdaw2vh	67	25	II	II	NNP
cord-003926-ycdaw2vh	67	26	(	(	-LRB-
cord-003926-ycdaw2vh	67	27	Table	table	NN
cord-003926-ycdaw2vh	67	28	1	1	CD
cord-003926-ycdaw2vh	67	29	)	)	-RRB-
cord-003926-ycdaw2vh	67	30	.	.	.
cord-003926-ycdaw2vh	68	1	GLS-5700	GLS-5700	NNP
cord-003926-ycdaw2vh	68	2	,	,	,
cord-003926-ycdaw2vh	68	3	a	a	DT
cord-003926-ycdaw2vh	68	4	DNA	dna	NN
cord-003926-ycdaw2vh	68	5	vaccine	vaccine	NN
cord-003926-ycdaw2vh	68	6	encoding	encoding	NN
cord-003926-ycdaw2vh	68	7	for	for	IN
cord-003926-ycdaw2vh	68	8	the	the	DT
cord-003926-ycdaw2vh	68	9	Zika	Zika	NNP
cord-003926-ycdaw2vh	68	10	virus	virus	NN
cord-003926-ycdaw2vh	68	11	prME	prME	VBZ
cord-003926-ycdaw2vh	68	12	genes	gene	NNS
cord-003926-ycdaw2vh	68	13	designed	design	VBN
cord-003926-ycdaw2vh	68	14	as	as	IN
cord-003926-ycdaw2vh	68	15	a	a	DT
cord-003926-ycdaw2vh	68	16	consensus	consensus	NN
cord-003926-ycdaw2vh	68	17	based	base	VBN
cord-003926-ycdaw2vh	68	18	on	on	IN
cord-003926-ycdaw2vh	68	19	available	available	JJ
cord-003926-ycdaw2vh	68	20	Zika	Zika	NNP
cord-003926-ycdaw2vh	68	21	virus	virus	NN
cord-003926-ycdaw2vh	68	22	sequences	sequence	NNS
cord-003926-ycdaw2vh	68	23	through	through	IN
cord-003926-ycdaw2vh	68	24	December	December	NNP
cord-003926-ycdaw2vh	68	25	2015	2015	CD
cord-003926-ycdaw2vh	68	26	[	[	-LRB-
cord-003926-ycdaw2vh	68	27	43	43	CD
cord-003926-ycdaw2vh	68	28	]	]	-RRB-
cord-003926-ycdaw2vh	68	29	,	,	,
cord-003926-ycdaw2vh	68	30	was	be	VBD
cord-003926-ycdaw2vh	68	31	the	the	DT
cord-003926-ycdaw2vh	68	32	first	first	JJ
cord-003926-ycdaw2vh	68	33	to	to	TO
cord-003926-ycdaw2vh	68	34	enter	enter	VB
cord-003926-ycdaw2vh	68	35	into	into	IN
cord-003926-ycdaw2vh	68	36	clinical	clinical	JJ
cord-003926-ycdaw2vh	68	37	trials	trial	NNS
cord-003926-ycdaw2vh	68	38	.	.	.
cord-003926-ycdaw2vh	69	1	In	in	IN
cord-003926-ycdaw2vh	69	2	pre	pre	JJ
cord-003926-ycdaw2vh	69	3	-	-	JJ
cord-003926-ycdaw2vh	69	4	clinical	clinical	JJ
cord-003926-ycdaw2vh	69	5	studies	study	NNS
cord-003926-ycdaw2vh	69	6	,	,	,
cord-003926-ycdaw2vh	69	7	vaccinated	vaccinate	VBD
cord-003926-ycdaw2vh	69	8	mice	mouse	NNS
cord-003926-ycdaw2vh	69	9	and	and	CC
cord-003926-ycdaw2vh	69	10	non	non	JJ
cord-003926-ycdaw2vh	69	11	-	-	JJ
cord-003926-ycdaw2vh	69	12	human	human	JJ
cord-003926-ycdaw2vh	69	13	primates	primate	NNS
cord-003926-ycdaw2vh	69	14	were	be	VBD
cord-003926-ycdaw2vh	69	15	shown	show	VBN
cord-003926-ycdaw2vh	69	16	to	to	TO
cord-003926-ycdaw2vh	69	17	develop	develop	VB
cord-003926-ycdaw2vh	69	18	B	b	NN
cord-003926-ycdaw2vh	69	19	and	and	CC
cord-003926-ycdaw2vh	69	20	T	t	NN
cord-003926-ycdaw2vh	69	21	-	-	HYPH
cord-003926-ycdaw2vh	69	22	cell	cell	NN
cord-003926-ycdaw2vh	69	23	immune	immune	JJ
cord-003926-ycdaw2vh	69	24	responses	response	NNS
cord-003926-ycdaw2vh	69	25	against	against	IN
cord-003926-ycdaw2vh	69	26	the	the	DT
cord-003926-ycdaw2vh	69	27	Zika	Zika	NNP
cord-003926-ycdaw2vh	69	28	virus	virus	NN
cord-003926-ycdaw2vh	69	29	envelope	envelope	NN
cord-003926-ycdaw2vh	69	30	and	and	CC
cord-003926-ycdaw2vh	69	31	protected	protect	VBN
cord-003926-ycdaw2vh	69	32	against	against	IN
cord-003926-ycdaw2vh	69	33	development	development	NN
cord-003926-ycdaw2vh	69	34	of	of	IN
cord-003926-ycdaw2vh	69	35	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	69	36	disease	disease	NN
cord-003926-ycdaw2vh	69	37	and	and	CC
cord-003926-ycdaw2vh	69	38	death	death	NN
cord-003926-ycdaw2vh	69	39	in	in	IN
cord-003926-ycdaw2vh	69	40	immunosuppressed	immunosuppressed	JJ
cord-003926-ycdaw2vh	69	41	,	,	,
cord-003926-ycdaw2vh	69	42	interferon	interferon	NN
cord-003926-ycdaw2vh	69	43	α	α	NN
cord-003926-ycdaw2vh	69	44	,	,	,
cord-003926-ycdaw2vh	69	45	β	β	NN
cord-003926-ycdaw2vh	69	46	receptor	receptor	NN
cord-003926-ycdaw2vh	69	47	deficient	deficient	JJ
cord-003926-ycdaw2vh	69	48	(	(	-LRB-
cord-003926-ycdaw2vh	69	49	IFNAR	IFNAR	NNP
cord-003926-ycdaw2vh	69	50	)	)	-RRB-
cord-003926-ycdaw2vh	69	51	mice	mouse	NNS
cord-003926-ycdaw2vh	69	52	[	[	-LRB-
cord-003926-ycdaw2vh	69	53	43	43	CD
cord-003926-ycdaw2vh	69	54	]	]	-RRB-
cord-003926-ycdaw2vh	69	55	.	.	.
cord-003926-ycdaw2vh	70	1	Moreover	moreover	RB
cord-003926-ycdaw2vh	70	2	,	,	,
cord-003926-ycdaw2vh	70	3	histologic	histologic	JJ
cord-003926-ycdaw2vh	70	4	sections	section	NNS
cord-003926-ycdaw2vh	70	5	of	of	IN
cord-003926-ycdaw2vh	70	6	brain	brain	NN
cord-003926-ycdaw2vh	70	7	tissue	tissue	NN
cord-003926-ycdaw2vh	70	8	showed	show	VBD
cord-003926-ycdaw2vh	70	9	that	that	IN
cord-003926-ycdaw2vh	70	10	vaccinated	vaccinate	VBN
cord-003926-ycdaw2vh	70	11	mice	mouse	NNS
cord-003926-ycdaw2vh	70	12	were	be	VBD
cord-003926-ycdaw2vh	70	13	without	without	IN
cord-003926-ycdaw2vh	70	14	inflammatory	inflammatory	JJ
cord-003926-ycdaw2vh	70	15	infiltrates	infiltrate	NNS
cord-003926-ycdaw2vh	70	16	evident	evident	JJ
cord-003926-ycdaw2vh	70	17	in	in	IN
cord-003926-ycdaw2vh	70	18	non	non	JJ
cord-003926-ycdaw2vh	70	19	-	-	JJ
cord-003926-ycdaw2vh	70	20	immunized	immunized	JJ
cord-003926-ycdaw2vh	70	21	mice	mouse	NNS
cord-003926-ycdaw2vh	70	22	[	[	-LRB-
cord-003926-ycdaw2vh	70	23	43	43	CD
cord-003926-ycdaw2vh	70	24	]	]	-RRB-
cord-003926-ycdaw2vh	70	25	.	.	.
cord-003926-ycdaw2vh	71	1	Subsequent	subsequent	JJ
cord-003926-ycdaw2vh	71	2	studies	study	NNS
cord-003926-ycdaw2vh	71	3	showed	show	VBD
cord-003926-ycdaw2vh	71	4	that	that	IN
cord-003926-ycdaw2vh	71	5	the	the	DT
cord-003926-ycdaw2vh	71	6	vaccine	vaccine	NN
cord-003926-ycdaw2vh	71	7	protected	protect	VBN
cord-003926-ycdaw2vh	71	8	against	against	IN
cord-003926-ycdaw2vh	71	9	testicular	testicular	JJ
cord-003926-ycdaw2vh	71	10	damage	damage	NN
cord-003926-ycdaw2vh	71	11	,	,	,
cord-003926-ycdaw2vh	71	12	testicular	testicular	JJ
cord-003926-ycdaw2vh	71	13	atrophy	atrophy	NN
cord-003926-ycdaw2vh	71	14	,	,	,
cord-003926-ycdaw2vh	71	15	spermatozoal	spermatozoal	NN
cord-003926-ycdaw2vh	71	16	damage	damage	NN
cord-003926-ycdaw2vh	71	17	,	,	,
cord-003926-ycdaw2vh	71	18	and	and	CC
cord-003926-ycdaw2vh	71	19	infertility	infertility	NN
cord-003926-ycdaw2vh	71	20	in	in	IN
cord-003926-ycdaw2vh	71	21	mice	mouse	NNS
cord-003926-ycdaw2vh	71	22	[	[	-LRB-
cord-003926-ycdaw2vh	71	23	28	28	CD
cord-003926-ycdaw2vh	71	24	,	,	,
cord-003926-ycdaw2vh	71	25	30	30	CD
cord-003926-ycdaw2vh	71	26	]	]	-RRB-
cord-003926-ycdaw2vh	71	27	.	.	.
cord-003926-ycdaw2vh	72	1	A	a	DT
cord-003926-ycdaw2vh	72	2	Phase	phase	NN
cord-003926-ycdaw2vh	72	3	I	-PRON-	PRP
cord-003926-ycdaw2vh	72	4	study	study	NN
cord-003926-ycdaw2vh	72	5	evaluated	evaluate	VBD
cord-003926-ycdaw2vh	72	6	GLS-5700	GLS-5700	NNP
cord-003926-ycdaw2vh	72	7	administered	administer	VBN
cord-003926-ycdaw2vh	72	8	via	via	IN
cord-003926-ycdaw2vh	72	9	intradermal	intradermal	JJ
cord-003926-ycdaw2vh	72	10	injection	injection	NN
cord-003926-ycdaw2vh	72	11	(	(	-LRB-
cord-003926-ycdaw2vh	72	12	ID	ID	NNP
cord-003926-ycdaw2vh	72	13	)	)	-RRB-
cord-003926-ycdaw2vh	72	14	,	,	,
cord-003926-ycdaw2vh	72	15	followed	follow	VBN
cord-003926-ycdaw2vh	72	16	by	by	IN
cord-003926-ycdaw2vh	72	17	electroporation	electroporation	NN
cord-003926-ycdaw2vh	72	18	(	(	-LRB-
cord-003926-ycdaw2vh	72	19	EP	EP	NNP
cord-003926-ycdaw2vh	72	20	)	)	-RRB-
cord-003926-ycdaw2vh	72	21	at	at	IN
cord-003926-ycdaw2vh	72	22	doses	dose	NNS
cord-003926-ycdaw2vh	72	23	of	of	IN
cord-003926-ycdaw2vh	72	24	either	either	DT
cord-003926-ycdaw2vh	72	25	1	1	CD
cord-003926-ycdaw2vh	72	26	or	or	CC
cord-003926-ycdaw2vh	72	27	2	2	CD
cord-003926-ycdaw2vh	72	28	mg	mg	NN
cord-003926-ycdaw2vh	72	29	per	per	IN
cord-003926-ycdaw2vh	72	30	vaccinations	vaccination	NNS
cord-003926-ycdaw2vh	72	31	followed	follow	VBN
cord-003926-ycdaw2vh	72	32	immediately	immediately	RB
cord-003926-ycdaw2vh	72	33	by	by	IN
cord-003926-ycdaw2vh	72	34	electroporation	electroporation	NN
cord-003926-ycdaw2vh	72	35	at	at	IN
cord-003926-ycdaw2vh	72	36	baseline	baseline	NN
cord-003926-ycdaw2vh	72	37	,	,	,
cord-003926-ycdaw2vh	72	38	4	4	CD
cord-003926-ycdaw2vh	72	39	weeks	week	NNS
cord-003926-ycdaw2vh	72	40	and	and	CC
cord-003926-ycdaw2vh	72	41	12	12	CD
cord-003926-ycdaw2vh	72	42	weeks	week	NNS
cord-003926-ycdaw2vh	72	43	[	[	-LRB-
cord-003926-ycdaw2vh	72	44	42	42	CD
cord-003926-ycdaw2vh	72	45	]	]	-RRB-
cord-003926-ycdaw2vh	72	46	.	.	.
cord-003926-ycdaw2vh	73	1	There	there	EX
cord-003926-ycdaw2vh	73	2	were	be	VBD
cord-003926-ycdaw2vh	73	3	no	no	DT
cord-003926-ycdaw2vh	73	4	serious	serious	JJ
cord-003926-ycdaw2vh	73	5	adverse	adverse	JJ
cord-003926-ycdaw2vh	73	6	events	event	NNS
cord-003926-ycdaw2vh	73	7	(	(	-LRB-
cord-003926-ycdaw2vh	73	8	SAE	SAE	NNP
cord-003926-ycdaw2vh	73	9	)	)	-RRB-
cord-003926-ycdaw2vh	73	10	reported	report	VBD
cord-003926-ycdaw2vh	73	11	as	as	IN
cord-003926-ycdaw2vh	73	12	part	part	NN
cord-003926-ycdaw2vh	73	13	of	of	IN
cord-003926-ycdaw2vh	73	14	the	the	DT
cord-003926-ycdaw2vh	73	15	study	study	NN
cord-003926-ycdaw2vh	73	16	,	,	,
cord-003926-ycdaw2vh	73	17	with	with	IN
cord-003926-ycdaw2vh	73	18	the	the	DT
cord-003926-ycdaw2vh	73	19	most	most	RBS
cord-003926-ycdaw2vh	73	20	frequent	frequent	JJ
cord-003926-ycdaw2vh	73	21	adverse	adverse	JJ
cord-003926-ycdaw2vh	73	22	events	event	NNS
cord-003926-ycdaw2vh	73	23	related	relate	VBN
cord-003926-ycdaw2vh	73	24	to	to	IN
cord-003926-ycdaw2vh	73	25	discomfort	discomfort	NN
cord-003926-ycdaw2vh	73	26	,	,	,
cord-003926-ycdaw2vh	73	27	pain	pain	NN
cord-003926-ycdaw2vh	73	28	,	,	,
cord-003926-ycdaw2vh	73	29	or	or	CC
cord-003926-ycdaw2vh	73	30	swelling	swell	VBG
cord-003926-ycdaw2vh	73	31	at	at	IN
cord-003926-ycdaw2vh	73	32	the	the	DT
cord-003926-ycdaw2vh	73	33	injection	injection	NN
cord-003926-ycdaw2vh	73	34	site	site	NN
cord-003926-ycdaw2vh	73	35	.	.	.
cord-003926-ycdaw2vh	74	1	Seroconversion	seroconversion	NN
cord-003926-ycdaw2vh	74	2	was	be	VBD
cord-003926-ycdaw2vh	74	3	observed	observe	VBN
cord-003926-ycdaw2vh	74	4	in	in	IN
cord-003926-ycdaw2vh	74	5	83	83	CD
cord-003926-ycdaw2vh	74	6	%	%	NN
cord-003926-ycdaw2vh	74	7	of	of	IN
cord-003926-ycdaw2vh	74	8	individuals	individual	NNS
cord-003926-ycdaw2vh	74	9	after	after	IN
cord-003926-ycdaw2vh	74	10	two	two	CD
cord-003926-ycdaw2vh	74	11	vaccinations	vaccination	NNS
cord-003926-ycdaw2vh	74	12	and	and	CC
cord-003926-ycdaw2vh	74	13	100	100	CD
cord-003926-ycdaw2vh	74	14	%	%	NN
cord-003926-ycdaw2vh	74	15	after	after	IN
cord-003926-ycdaw2vh	74	16	three	three	CD
cord-003926-ycdaw2vh	74	17	vaccinations	vaccination	NNS
cord-003926-ycdaw2vh	74	18	with	with	IN
cord-003926-ycdaw2vh	74	19	GLS-5700	GLS-5700	NNP
cord-003926-ycdaw2vh	74	20	[	[	-LRB-
cord-003926-ycdaw2vh	74	21	42	42	CD
cord-003926-ycdaw2vh	74	22	]	]	-RRB-
cord-003926-ycdaw2vh	74	23	.	.	.
cord-003926-ycdaw2vh	75	1	Neutralizing	neutralize	VBG
cord-003926-ycdaw2vh	75	2	antibodies	antibody	NNS
cord-003926-ycdaw2vh	75	3	were	be	VBD
cord-003926-ycdaw2vh	75	4	detected	detect	VBN
cord-003926-ycdaw2vh	75	5	for	for	IN
cord-003926-ycdaw2vh	75	6	62	62	CD
cord-003926-ycdaw2vh	75	7	%	%	NN
cord-003926-ycdaw2vh	75	8	of	of	IN
cord-003926-ycdaw2vh	75	9	participants	participant	NNS
cord-003926-ycdaw2vh	75	10	in	in	IN
cord-003926-ycdaw2vh	75	11	a	a	DT
cord-003926-ycdaw2vh	75	12	Vero	Vero	NNP
cord-003926-ycdaw2vh	75	13	-	-	HYPH
cord-003926-ycdaw2vh	75	14	cell	cell	NN
cord-003926-ycdaw2vh	75	15	(	(	-LRB-
cord-003926-ycdaw2vh	75	16	monkey	monkey	NN
cord-003926-ycdaw2vh	75	17	kidney	kidney	NN
cord-003926-ycdaw2vh	75	18	cell	cell	NN
cord-003926-ycdaw2vh	75	19	)	)	-RRB-
cord-003926-ycdaw2vh	75	20	assay	assay	NN
cord-003926-ycdaw2vh	75	21	,	,	,
cord-003926-ycdaw2vh	75	22	however	however	RB
cord-003926-ycdaw2vh	75	23	,	,	,
cord-003926-ycdaw2vh	75	24	95	95	CD
cord-003926-ycdaw2vh	75	25	%	%	NN
cord-003926-ycdaw2vh	75	26	of	of	IN
cord-003926-ycdaw2vh	75	27	participants	participant	NNS
cord-003926-ycdaw2vh	75	28	demonstrated	demonstrate	VBD
cord-003926-ycdaw2vh	75	29	the	the	DT
cord-003926-ycdaw2vh	75	30	ability	ability	NN
cord-003926-ycdaw2vh	75	31	to	to	TO
cord-003926-ycdaw2vh	75	32	neutralize	neutralize	VB
cord-003926-ycdaw2vh	75	33	infection	infection	NN
cord-003926-ycdaw2vh	75	34	of	of	IN
cord-003926-ycdaw2vh	75	35	U87MG	U87MG	NNP
cord-003926-ycdaw2vh	75	36	neuroblastoma	neuroblastoma	NN
cord-003926-ycdaw2vh	75	37	cells	cell	NNS
cord-003926-ycdaw2vh	75	38	[	[	-LRB-
cord-003926-ycdaw2vh	75	39	42	42	CD
cord-003926-ycdaw2vh	75	40	]	]	-RRB-
cord-003926-ycdaw2vh	75	41	.	.	.
cord-003926-ycdaw2vh	76	1	Vaccine	vaccine	NN
cord-003926-ycdaw2vh	76	2	responses	response	NNS
cord-003926-ycdaw2vh	76	3	were	be	VBD
cord-003926-ycdaw2vh	76	4	maintained	maintain	VBN
cord-003926-ycdaw2vh	76	5	through	through	IN
cord-003926-ycdaw2vh	76	6	a	a	DT
cord-003926-ycdaw2vh	76	7	year	year	NN
cord-003926-ycdaw2vh	76	8	of	of	IN
cord-003926-ycdaw2vh	76	9	follow	follow	NN
cord-003926-ycdaw2vh	76	10	-	-	HYPH
cord-003926-ycdaw2vh	76	11	up	up	NN
cord-003926-ycdaw2vh	76	12	.	.	.
cord-003926-ycdaw2vh	77	1	There	there	EX
cord-003926-ycdaw2vh	77	2	was	be	VBD
cord-003926-ycdaw2vh	77	3	no	no	DT
cord-003926-ycdaw2vh	77	4	difference	difference	NN
cord-003926-ycdaw2vh	77	5	in	in	IN
cord-003926-ycdaw2vh	77	6	responses	response	NNS
cord-003926-ycdaw2vh	77	7	based	base	VBN
cord-003926-ycdaw2vh	77	8	on	on	IN
cord-003926-ycdaw2vh	77	9	dose	dose	JJ
cord-003926-ycdaw2vh	77	10	level	level	NN
cord-003926-ycdaw2vh	77	11	.	.	.
cord-003926-ycdaw2vh	78	1	Notably	notably	RB
cord-003926-ycdaw2vh	78	2	,	,	,
cord-003926-ycdaw2vh	78	3	passive	passive	JJ
cord-003926-ycdaw2vh	78	4	transfer	transfer	NN
cord-003926-ycdaw2vh	78	5	of	of	IN
cord-003926-ycdaw2vh	78	6	immune	immune	JJ
cord-003926-ycdaw2vh	78	7	serum	serum	NN
cord-003926-ycdaw2vh	78	8	from	from	IN
cord-003926-ycdaw2vh	78	9	vaccinated	vaccinated	JJ
cord-003926-ycdaw2vh	78	10	participants	participant	NNS
cord-003926-ycdaw2vh	78	11	was	be	VBD
cord-003926-ycdaw2vh	78	12	able	able	JJ
cord-003926-ycdaw2vh	78	13	to	to	TO
cord-003926-ycdaw2vh	78	14	protect	protect	VB
cord-003926-ycdaw2vh	78	15	92	92	CD
cord-003926-ycdaw2vh	78	16	%	%	NN
cord-003926-ycdaw2vh	78	17	of	of	IN
cord-003926-ycdaw2vh	78	18	IFNAR	IFNAR	NNP
cord-003926-ycdaw2vh	78	19	mice	mouse	NNS
cord-003926-ycdaw2vh	78	20	against	against	IN
cord-003926-ycdaw2vh	78	21	lethal	lethal	JJ
cord-003926-ycdaw2vh	78	22	infection	infection	NN
cord-003926-ycdaw2vh	78	23	independent	independent	JJ
cord-003926-ycdaw2vh	78	24	of	of	IN
cord-003926-ycdaw2vh	78	25	the	the	DT
cord-003926-ycdaw2vh	78	26	presence	presence	NN
cord-003926-ycdaw2vh	78	27	of	of	IN
cord-003926-ycdaw2vh	78	28	Vero	Vero	NNP
cord-003926-ycdaw2vh	78	29	cell	cell	NN
cord-003926-ycdaw2vh	78	30	neutralizing	neutralize	VBG
cord-003926-ycdaw2vh	78	31	antibodies	antibody	NNS
cord-003926-ycdaw2vh	78	32	[	[	-LRB-
cord-003926-ycdaw2vh	78	33	42	42	CD
cord-003926-ycdaw2vh	78	34	]	]	-RRB-
cord-003926-ycdaw2vh	78	35	.	.	.
cord-003926-ycdaw2vh	79	1	GLS-5700	GLS-5700	NNP
cord-003926-ycdaw2vh	79	2	is	be	VBZ
cord-003926-ycdaw2vh	79	3	being	be	VBG
cord-003926-ycdaw2vh	79	4	evaluated	evaluate	VBN
cord-003926-ycdaw2vh	79	5	as	as	IN
cord-003926-ycdaw2vh	79	6	part	part	NN
cord-003926-ycdaw2vh	79	7	of	of	IN
cord-003926-ycdaw2vh	79	8	a	a	DT
cord-003926-ycdaw2vh	79	9	second	second	JJ
cord-003926-ycdaw2vh	79	10	double	double	JJ
cord-003926-ycdaw2vh	79	11	-	-	HYPH
cord-003926-ycdaw2vh	79	12	blind	blind	JJ
cord-003926-ycdaw2vh	79	13	,	,	,
cord-003926-ycdaw2vh	79	14	placebo	placebo	NN
cord-003926-ycdaw2vh	79	15	-	-	HYPH
cord-003926-ycdaw2vh	79	16	controlled	control	VBN
cord-003926-ycdaw2vh	79	17	clinical	clinical	JJ
cord-003926-ycdaw2vh	79	18	trial	trial	NN
cord-003926-ycdaw2vh	79	19	(	(	-LRB-
cord-003926-ycdaw2vh	79	20	NCT02887482	NCT02887482	NNP
cord-003926-ycdaw2vh	79	21	)	)	-RRB-
cord-003926-ycdaw2vh	79	22	performed	perform	VBN
cord-003926-ycdaw2vh	79	23	in	in	IN
cord-003926-ycdaw2vh	79	24	Puerto	Puerto	NNP
cord-003926-ycdaw2vh	79	25	Rico	Rico	NNP
cord-003926-ycdaw2vh	79	26	.	.	.
cord-003926-ycdaw2vh	80	1	Analysis	analysis	NN
cord-003926-ycdaw2vh	80	2	of	of	IN
cord-003926-ycdaw2vh	80	3	the	the	DT
cord-003926-ycdaw2vh	80	4	latter	latter	JJ
cord-003926-ycdaw2vh	80	5	study	study	NN
cord-003926-ycdaw2vh	80	6	is	be	VBZ
cord-003926-ycdaw2vh	80	7	in	in	IN
cord-003926-ycdaw2vh	80	8	progress	progress	NN
cord-003926-ycdaw2vh	80	9	.	.	.
cord-003926-ycdaw2vh	81	1	Two	two	CD
cord-003926-ycdaw2vh	81	2	additional	additional	JJ
cord-003926-ycdaw2vh	81	3	DNA	dna	NN
cord-003926-ycdaw2vh	81	4	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	81	5	,	,	,
cord-003926-ycdaw2vh	81	6	based	base	VBN
cord-003926-ycdaw2vh	81	7	on	on	IN
cord-003926-ycdaw2vh	81	8	the	the	DT
cord-003926-ycdaw2vh	81	9	French	french	JJ
cord-003926-ycdaw2vh	81	10	Polynesian	Polynesian	NNP
cord-003926-ycdaw2vh	81	11	H	H	NNP
cord-003926-ycdaw2vh	81	12	/	/	SYM
cord-003926-ycdaw2vh	81	13	PF/2013	PF/2013	NNP
cord-003926-ycdaw2vh	81	14	strain	strain	NN
cord-003926-ycdaw2vh	81	15	were	be	VBD
cord-003926-ycdaw2vh	81	16	developed	develop	VBN
cord-003926-ycdaw2vh	81	17	as	as	IN
cord-003926-ycdaw2vh	81	18	chimeras	chimera	NNS
cord-003926-ycdaw2vh	81	19	that	that	WDT
cord-003926-ycdaw2vh	81	20	included	include	VBD
cord-003926-ycdaw2vh	81	21	the	the	DT
cord-003926-ycdaw2vh	81	22	JEV	JEV	NNP
cord-003926-ycdaw2vh	81	23	prM	prm	JJ
cord-003926-ycdaw2vh	81	24	signal	signal	NN
cord-003926-ycdaw2vh	81	25	sequence	sequence	NN
cord-003926-ycdaw2vh	81	26	followed	follow	VBN
cord-003926-ycdaw2vh	81	27	by	by	IN
cord-003926-ycdaw2vh	81	28	the	the	DT
cord-003926-ycdaw2vh	81	29	Zika	Zika	NNP
cord-003926-ycdaw2vh	81	30	envelope	envelope	NN
cord-003926-ycdaw2vh	81	31	(	(	-LRB-
cord-003926-ycdaw2vh	81	32	E	e	NN
cord-003926-ycdaw2vh	81	33	)	)	-RRB-
cord-003926-ycdaw2vh	81	34	gene	gene	NN
cord-003926-ycdaw2vh	81	35	(	(	-LRB-
cord-003926-ycdaw2vh	81	36	VRC5283	VRC5283	NNP
cord-003926-ycdaw2vh	81	37	)	)	-RRB-
cord-003926-ycdaw2vh	81	38	or	or	CC
cord-003926-ycdaw2vh	81	39	a	a	DT
cord-003926-ycdaw2vh	81	40	similar	similar	JJ
cord-003926-ycdaw2vh	81	41	construct	construct	NN
cord-003926-ycdaw2vh	81	42	with	with	IN
cord-003926-ycdaw2vh	81	43	the	the	DT
cord-003926-ycdaw2vh	81	44	terminal	terminal	JJ
cord-003926-ycdaw2vh	81	45	98	98	CD
cord-003926-ycdaw2vh	81	46	amino	amino	NN
cord-003926-ycdaw2vh	81	47	acids	acid	NNS
cord-003926-ycdaw2vh	81	48	of	of	IN
cord-003926-ycdaw2vh	81	49	E	e	NN
cord-003926-ycdaw2vh	81	50	,	,	,
cord-003926-ycdaw2vh	81	51	representing	represent	VBG
cord-003926-ycdaw2vh	81	52	the	the	DT
cord-003926-ycdaw2vh	81	53	stem	stem	NN
cord-003926-ycdaw2vh	81	54	and	and	CC
cord-003926-ycdaw2vh	81	55	transmembrane	transmembrane	NN
cord-003926-ycdaw2vh	81	56	regions	region	NNS
cord-003926-ycdaw2vh	81	57	,	,	,
cord-003926-ycdaw2vh	81	58	exchanged	exchange	VBD
cord-003926-ycdaw2vh	81	59	for	for	IN
cord-003926-ycdaw2vh	81	60	the	the	DT
cord-003926-ycdaw2vh	81	61	analogous	analogous	JJ
cord-003926-ycdaw2vh	81	62	JEV	JEV	NNP
cord-003926-ycdaw2vh	81	63	sequence	sequence	NN
cord-003926-ycdaw2vh	81	64	(	(	-LRB-
cord-003926-ycdaw2vh	81	65	VRC5288	VRC5288	NNP
cord-003926-ycdaw2vh	81	66	)	)	-RRB-
cord-003926-ycdaw2vh	81	67	[	[	-LRB-
cord-003926-ycdaw2vh	81	68	44	44	CD
cord-003926-ycdaw2vh	81	69	]	]	-RRB-
cord-003926-ycdaw2vh	81	70	.	.	.
cord-003926-ycdaw2vh	82	1	Both	both	DT
cord-003926-ycdaw2vh	82	2	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	82	3	were	be	VBD
cord-003926-ycdaw2vh	82	4	immunogenic	immunogenic	JJ
cord-003926-ycdaw2vh	82	5	for	for	IN
cord-003926-ycdaw2vh	82	6	mice	mouse	NNS
cord-003926-ycdaw2vh	82	7	and	and	CC
cord-003926-ycdaw2vh	82	8	NHPs	nhp	NNS
cord-003926-ycdaw2vh	82	9	and	and	CC
cord-003926-ycdaw2vh	82	10	protected	protect	VBN
cord-003926-ycdaw2vh	82	11	>	>	XX
cord-003926-ycdaw2vh	82	12	90	90	CD
cord-003926-ycdaw2vh	82	13	%	%	NN
cord-003926-ycdaw2vh	82	14	of	of	IN
cord-003926-ycdaw2vh	82	15	NHPs	nhp	NNS
cord-003926-ycdaw2vh	82	16	against	against	IN
cord-003926-ycdaw2vh	82	17	viremia	viremia	NN
cord-003926-ycdaw2vh	82	18	at	at	IN
cord-003926-ycdaw2vh	82	19	a	a	DT
cord-003926-ycdaw2vh	82	20	dose	dose	NN
cord-003926-ycdaw2vh	82	21	of	of	IN
cord-003926-ycdaw2vh	83	1	either	either	CC
cord-003926-ycdaw2vh	83	2	1	1	CD
cord-003926-ycdaw2vh	83	3	or	or	CC
cord-003926-ycdaw2vh	83	4	4	4	CD
cord-003926-ycdaw2vh	83	5	mg	mg	NNS
cord-003926-ycdaw2vh	83	6	given	give	VBN
cord-003926-ycdaw2vh	83	7	twice	twice	PDT
cord-003926-ycdaw2vh	83	8	[	[	-LRB-
cord-003926-ycdaw2vh	83	9	44	44	CD
cord-003926-ycdaw2vh	83	10	]	]	-RRB-
cord-003926-ycdaw2vh	83	11	.	.	.
cord-003926-ycdaw2vh	84	1	Both	both	DT
cord-003926-ycdaw2vh	84	2	vaccine	vaccine	NN
cord-003926-ycdaw2vh	84	3	candidates	candidate	NNS
cord-003926-ycdaw2vh	84	4	were	be	VBD
cord-003926-ycdaw2vh	84	5	advanced	advance	VBN
cord-003926-ycdaw2vh	84	6	into	into	IN
cord-003926-ycdaw2vh	84	7	clinical	clinical	JJ
cord-003926-ycdaw2vh	84	8	trials	trial	NNS
cord-003926-ycdaw2vh	84	9	with	with	IN
cord-003926-ycdaw2vh	84	10	4	4	CD
cord-003926-ycdaw2vh	84	11	mg	mg	NN
cord-003926-ycdaw2vh	84	12	of	of	IN
cord-003926-ycdaw2vh	84	13	administered	administer	VBN
cord-003926-ycdaw2vh	84	14	intramuscularly	intramuscularly	RB
cord-003926-ycdaw2vh	84	15	at	at	IN
cord-003926-ycdaw2vh	84	16	weeks	week	NNS
cord-003926-ycdaw2vh	84	17	0	0	CD
cord-003926-ycdaw2vh	84	18	,	,	,
cord-003926-ycdaw2vh	84	19	4	4	CD
cord-003926-ycdaw2vh	84	20	and	and	CC
cord-003926-ycdaw2vh	84	21	8	8	CD
cord-003926-ycdaw2vh	84	22	with	with	IN
cord-003926-ycdaw2vh	84	23	vaccine	vaccine	NN
cord-003926-ycdaw2vh	84	24	VRC5288	VRC5288	NNP
cord-003926-ycdaw2vh	84	25	administered	administer	VBN
cord-003926-ycdaw2vh	84	26	by	by	IN
cord-003926-ycdaw2vh	84	27	needle	needle	NN
cord-003926-ycdaw2vh	84	28	and	and	CC
cord-003926-ycdaw2vh	84	29	syringe	syringe	NN
cord-003926-ycdaw2vh	84	30	while	while	IN
cord-003926-ycdaw2vh	84	31	VRC5283	VRC5283	NNP
cord-003926-ycdaw2vh	84	32	was	be	VBD
cord-003926-ycdaw2vh	84	33	administered	administer	VBN
cord-003926-ycdaw2vh	84	34	either	either	CC
cord-003926-ycdaw2vh	84	35	as	as	IN
cord-003926-ycdaw2vh	84	36	a	a	DT
cord-003926-ycdaw2vh	84	37	single	single	JJ
cord-003926-ycdaw2vh	84	38	dose	dose	NN
cord-003926-ycdaw2vh	84	39	or	or	CC
cord-003926-ycdaw2vh	84	40	split	split	JJ
cord-003926-ycdaw2vh	84	41	dose	dose	NN
cord-003926-ycdaw2vh	84	42	by	by	IN
cord-003926-ycdaw2vh	84	43	needle	needle	NN
cord-003926-ycdaw2vh	84	44	and	and	CC
cord-003926-ycdaw2vh	84	45	syringe	syringe	NN
cord-003926-ycdaw2vh	84	46	or	or	CC
cord-003926-ycdaw2vh	84	47	as	as	IN
cord-003926-ycdaw2vh	84	48	a	a	DT
cord-003926-ycdaw2vh	84	49	split	split	NN
cord-003926-ycdaw2vh	84	50	dose	dose	NN
cord-003926-ycdaw2vh	84	51	given	give	VBN
cord-003926-ycdaw2vh	84	52	by	by	IN
cord-003926-ycdaw2vh	84	53	the	the	DT
cord-003926-ycdaw2vh	84	54	Pharmajet	Pharmajet	NNP
cord-003926-ycdaw2vh	84	55	needle	needle	NN
cord-003926-ycdaw2vh	84	56	-	-	HYPH
cord-003926-ycdaw2vh	84	57	free	free	JJ
cord-003926-ycdaw2vh	84	58	device	device	NN
cord-003926-ycdaw2vh	84	59	[	[	-LRB-
cord-003926-ycdaw2vh	84	60	41	41	CD
cord-003926-ycdaw2vh	84	61	]	]	-RRB-
cord-003926-ycdaw2vh	84	62	.	.	.
cord-003926-ycdaw2vh	85	1	Seroconversion	seroconversion	NN
cord-003926-ycdaw2vh	85	2	was	be	VBD
cord-003926-ycdaw2vh	85	3	100	100	CD
cord-003926-ycdaw2vh	85	4	%	%	NN
cord-003926-ycdaw2vh	85	5	in	in	IN
cord-003926-ycdaw2vh	85	6	the	the	DT
cord-003926-ycdaw2vh	85	7	group	group	NN
cord-003926-ycdaw2vh	85	8	administered	administer	VBD
cord-003926-ycdaw2vh	85	9	vaccine	vaccine	NN
cord-003926-ycdaw2vh	85	10	with	with	IN
cord-003926-ycdaw2vh	85	11	the	the	DT
cord-003926-ycdaw2vh	85	12	needle	needle	NN
cord-003926-ycdaw2vh	85	13	-	-	HYPH
cord-003926-ycdaw2vh	85	14	free	free	JJ
cord-003926-ycdaw2vh	85	15	device	device	NN
cord-003926-ycdaw2vh	85	16	,	,	,
cord-003926-ycdaw2vh	85	17	less	less	JJR
cord-003926-ycdaw2vh	85	18	for	for	IN
cord-003926-ycdaw2vh	85	19	vaccine	vaccine	NN
cord-003926-ycdaw2vh	85	20	administered	administer	VBN
cord-003926-ycdaw2vh	85	21	as	as	IN
cord-003926-ycdaw2vh	85	22	split	split	NN
cord-003926-ycdaw2vh	85	23	-	-	HYPH
cord-003926-ycdaw2vh	85	24	dose	dose	NN
cord-003926-ycdaw2vh	85	25	by	by	IN
cord-003926-ycdaw2vh	85	26	needle	needle	NN
cord-003926-ycdaw2vh	85	27	and	and	CC
cord-003926-ycdaw2vh	85	28	syringe	syringe	NN
cord-003926-ycdaw2vh	85	29	,	,	,
cord-003926-ycdaw2vh	85	30	and	and	CC
cord-003926-ycdaw2vh	85	31	lowest	low	JJS
cord-003926-ycdaw2vh	85	32	for	for	IN
cord-003926-ycdaw2vh	85	33	vaccine	vaccine	NN
cord-003926-ycdaw2vh	85	34	given	give	VBN
cord-003926-ycdaw2vh	85	35	as	as	IN
cord-003926-ycdaw2vh	85	36	a	a	DT
cord-003926-ycdaw2vh	85	37	single	single	JJ
cord-003926-ycdaw2vh	85	38	injection	injection	NN
cord-003926-ycdaw2vh	85	39	with	with	IN
cord-003926-ycdaw2vh	85	40	needle	needle	NN
cord-003926-ycdaw2vh	85	41	and	and	CC
cord-003926-ycdaw2vh	85	42	syringe	syringe	NN
cord-003926-ycdaw2vh	85	43	.	.	.
cord-003926-ycdaw2vh	86	1	The	the	DT
cord-003926-ycdaw2vh	86	2	VRC5283	VRC5283	NNP
cord-003926-ycdaw2vh	86	3	vaccine	vaccine	NN
cord-003926-ycdaw2vh	86	4	was	be	VBD
cord-003926-ycdaw2vh	86	5	advanced	advance	VBN
cord-003926-ycdaw2vh	86	6	into	into	IN
cord-003926-ycdaw2vh	86	7	Phase	Phase	NNP
cord-003926-ycdaw2vh	86	8	II	II	NNP
cord-003926-ycdaw2vh	86	9	studies	study	NNS
cord-003926-ycdaw2vh	86	10	in	in	IN
cord-003926-ycdaw2vh	86	11	the	the	DT
cord-003926-ycdaw2vh	86	12	Americas	Americas	NNPS
cord-003926-ycdaw2vh	86	13	that	that	WDT
cord-003926-ycdaw2vh	86	14	utilized	utilize	VBD
cord-003926-ycdaw2vh	86	15	140	140	CD
cord-003926-ycdaw2vh	86	16	clinical	clinical	JJ
cord-003926-ycdaw2vh	86	17	sites	site	NNS
cord-003926-ycdaw2vh	86	18	with	with	IN
cord-003926-ycdaw2vh	86	19	clinical	clinical	JJ
cord-003926-ycdaw2vh	86	20	site	site	NN
cord-003926-ycdaw2vh	86	21	selection	selection	NN
cord-003926-ycdaw2vh	86	22	guided	guide	VBN
cord-003926-ycdaw2vh	86	23	by	by	IN
cord-003926-ycdaw2vh	86	24	epidemiologic	epidemiologic	JJ
cord-003926-ycdaw2vh	86	25	modeling	modeling	NN
cord-003926-ycdaw2vh	86	26	[	[	-LRB-
cord-003926-ycdaw2vh	86	27	38	38	CD
cord-003926-ycdaw2vh	86	28	]	]	-RRB-
cord-003926-ycdaw2vh	86	29	.	.	.
cord-003926-ycdaw2vh	87	1	Long	long	JJ
cord-003926-ycdaw2vh	87	2	-	-	HYPH
cord-003926-ycdaw2vh	87	3	term	term	NN
cord-003926-ycdaw2vh	87	4	follow	follow	NN
cord-003926-ycdaw2vh	87	5	-	-	HYPH
cord-003926-ycdaw2vh	87	6	up	up	NN
cord-003926-ycdaw2vh	87	7	has	have	VBZ
cord-003926-ycdaw2vh	87	8	not	not	RB
cord-003926-ycdaw2vh	87	9	been	be	VBN
cord-003926-ycdaw2vh	87	10	reported	report	VBN
cord-003926-ycdaw2vh	87	11	.	.	.
cord-003926-ycdaw2vh	88	1	Three	three	CD
cord-003926-ycdaw2vh	88	2	inactivated	inactivate	VBN
cord-003926-ycdaw2vh	88	3	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	88	4	have	have	VBP
cord-003926-ycdaw2vh	88	5	entered	enter	VBN
cord-003926-ycdaw2vh	88	6	into	into	IN
cord-003926-ycdaw2vh	88	7	clinical	clinical	JJ
cord-003926-ycdaw2vh	88	8	studies	study	NNS
cord-003926-ycdaw2vh	88	9	,	,	,
cord-003926-ycdaw2vh	88	10	of	of	IN
cord-003926-ycdaw2vh	88	11	which	which	WDT
cord-003926-ycdaw2vh	88	12	clinical	clinical	JJ
cord-003926-ycdaw2vh	88	13	data	datum	NNS
cord-003926-ycdaw2vh	88	14	for	for	IN
cord-003926-ycdaw2vh	88	15	only	only	JJ
cord-003926-ycdaw2vh	88	16	ZPIV	ZPIV	NNP
cord-003926-ycdaw2vh	88	17	vaccine	vaccine	NN
cord-003926-ycdaw2vh	88	18	has	have	VBZ
cord-003926-ycdaw2vh	88	19	been	be	VBN
cord-003926-ycdaw2vh	88	20	published	publish	VBN
cord-003926-ycdaw2vh	88	21	[	[	-LRB-
cord-003926-ycdaw2vh	88	22	45	45	CD
cord-003926-ycdaw2vh	88	23	]	]	-RRB-
cord-003926-ycdaw2vh	88	24	.	.	.
cord-003926-ycdaw2vh	89	1	ZPIV	ZPIV	NNP
cord-003926-ycdaw2vh	89	2	is	be	VBZ
cord-003926-ycdaw2vh	89	3	a	a	DT
cord-003926-ycdaw2vh	89	4	whole	whole	JJ
cord-003926-ycdaw2vh	89	5	inactivated	inactivate	VBN
cord-003926-ycdaw2vh	89	6	virus	virus	NN
cord-003926-ycdaw2vh	89	7	vaccine	vaccine	NN
cord-003926-ycdaw2vh	89	8	of	of	IN
cord-003926-ycdaw2vh	89	9	Puerto	puerto	JJ
cord-003926-ycdaw2vh	89	10	Rican	rican	JJ
cord-003926-ycdaw2vh	89	11	strain	strain	NN
cord-003926-ycdaw2vh	90	1	PRVABC59	PRVABC59	NNP
cord-003926-ycdaw2vh	90	2	[	[	-LRB-
cord-003926-ycdaw2vh	90	3	46	46	CD
cord-003926-ycdaw2vh	90	4	]	]	-RRB-
cord-003926-ycdaw2vh	90	5	.	.	.
cord-003926-ycdaw2vh	91	1	Studies	study	NNS
cord-003926-ycdaw2vh	91	2	in	in	IN
cord-003926-ycdaw2vh	91	3	mice	mouse	NNS
cord-003926-ycdaw2vh	91	4	showed	show	VBD
cord-003926-ycdaw2vh	91	5	that	that	IN
cord-003926-ycdaw2vh	91	6	a	a	DT
cord-003926-ycdaw2vh	91	7	single	single	JJ
cord-003926-ycdaw2vh	91	8	vaccination	vaccination	NN
cord-003926-ycdaw2vh	91	9	given	give	VBN
cord-003926-ycdaw2vh	91	10	intramuscularly	intramuscularly	RB
cord-003926-ycdaw2vh	91	11	with	with	IN
cord-003926-ycdaw2vh	91	12	alum	alum	NN
cord-003926-ycdaw2vh	91	13	generated	generate	VBD
cord-003926-ycdaw2vh	91	14	antibody	antibody	NN
cord-003926-ycdaw2vh	91	15	titers	titer	NNS
cord-003926-ycdaw2vh	91	16	of	of	IN
cord-003926-ycdaw2vh	91	17	approximately	approximately	RB
cord-003926-ycdaw2vh	91	18	3.7	3.7	CD
cord-003926-ycdaw2vh	91	19	log10	log10	NNS
cord-003926-ycdaw2vh	91	20	and	and	CC
cord-003926-ycdaw2vh	91	21	fully	fully	RB
cord-003926-ycdaw2vh	91	22	protected	protect	VBN
cord-003926-ycdaw2vh	91	23	Balb	Balb	NNP
cord-003926-ycdaw2vh	91	24	/	/	SYM
cord-003926-ycdaw2vh	91	25	C	c	NN
cord-003926-ycdaw2vh	91	26	immunocompetent	immunocompetent	JJ
cord-003926-ycdaw2vh	91	27	mice	mouse	NNS
cord-003926-ycdaw2vh	91	28	from	from	IN
cord-003926-ycdaw2vh	91	29	viremia	viremia	NN
cord-003926-ycdaw2vh	91	30	,	,	,
cord-003926-ycdaw2vh	91	31	whereas	whereas	IN
cord-003926-ycdaw2vh	91	32	unvaccinated	unvaccinated	JJ
cord-003926-ycdaw2vh	91	33	mice	mouse	NNS
cord-003926-ycdaw2vh	91	34	were	be	VBD
cord-003926-ycdaw2vh	91	35	unprotected	unprotected	JJ
cord-003926-ycdaw2vh	91	36	and	and	CC
cord-003926-ycdaw2vh	91	37	subcutaneously	subcutaneously	RB
cord-003926-ycdaw2vh	91	38	vaccinated	vaccinate	VBN
cord-003926-ycdaw2vh	91	39	mice	mouse	NNS
cord-003926-ycdaw2vh	91	40	were	be	VBD
cord-003926-ycdaw2vh	91	41	only	only	RB
cord-003926-ycdaw2vh	91	42	partially	partially	RB
cord-003926-ycdaw2vh	91	43	protected	protect	VBN
cord-003926-ycdaw2vh	91	44	against	against	IN
cord-003926-ycdaw2vh	91	45	the	the	DT
cord-003926-ycdaw2vh	91	46	Zika	Zika	NNP
cord-003926-ycdaw2vh	91	47	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	91	48	strain	strain	VBP
cord-003926-ycdaw2vh	91	49	[	[	-LRB-
cord-003926-ycdaw2vh	91	50	46	46	CD
cord-003926-ycdaw2vh	91	51	]	]	-RRB-
cord-003926-ycdaw2vh	91	52	.	.	.
cord-003926-ycdaw2vh	92	1	A	a	DT
cord-003926-ycdaw2vh	92	2	subsequent	subsequent	JJ
cord-003926-ycdaw2vh	92	3	study	study	NN
cord-003926-ycdaw2vh	92	4	in	in	IN
cord-003926-ycdaw2vh	92	5	non	non	JJ
cord-003926-ycdaw2vh	92	6	-	-	JJ
cord-003926-ycdaw2vh	92	7	human	human	JJ
cord-003926-ycdaw2vh	92	8	primates	primate	NNS
cord-003926-ycdaw2vh	92	9	vaccinated	vaccinate	VBN
cord-003926-ycdaw2vh	92	10	twice	twice	RB
cord-003926-ycdaw2vh	92	11	at	at	IN
cord-003926-ycdaw2vh	92	12	four	four	CD
cord-003926-ycdaw2vh	92	13	-	-	HYPH
cord-003926-ycdaw2vh	92	14	week	week	NN
cord-003926-ycdaw2vh	92	15	intervals	interval	NNS
cord-003926-ycdaw2vh	92	16	with	with	IN
cord-003926-ycdaw2vh	92	17	alum	alum	NN
cord-003926-ycdaw2vh	92	18	generated	generate	VBD
cord-003926-ycdaw2vh	92	19	binding	binding	NN
cord-003926-ycdaw2vh	92	20	and	and	CC
cord-003926-ycdaw2vh	92	21	microneutralization	microneutralization	NN
cord-003926-ycdaw2vh	92	22	antibody	antibody	NN
cord-003926-ycdaw2vh	92	23	titers	titer	NNS
cord-003926-ycdaw2vh	92	24	of	of	IN
cord-003926-ycdaw2vh	92	25	3.54	3.54	CD
cord-003926-ycdaw2vh	92	26	and	and	CC
cord-003926-ycdaw2vh	92	27	3.55	3.55	CD
cord-003926-ycdaw2vh	92	28	log10	log10	NNS
cord-003926-ycdaw2vh	92	29	,	,	,
cord-003926-ycdaw2vh	92	30	respectively	respectively	RB
cord-003926-ycdaw2vh	92	31	,	,	,
cord-003926-ycdaw2vh	92	32	and	and	CC
cord-003926-ycdaw2vh	92	33	complete	complete	JJ
cord-003926-ycdaw2vh	92	34	protection	protection	NN
cord-003926-ycdaw2vh	92	35	against	against	IN
cord-003926-ycdaw2vh	92	36	viremia	viremia	NN
cord-003926-ycdaw2vh	92	37	and	and	CC
cord-003926-ycdaw2vh	92	38	viruria	viruria	NN
cord-003926-ycdaw2vh	92	39	following	follow	VBG
cord-003926-ycdaw2vh	92	40	challenge	challenge	NN
cord-003926-ycdaw2vh	92	41	with	with	IN
cord-003926-ycdaw2vh	92	42	either	either	CC
cord-003926-ycdaw2vh	92	43	Brazilian	brazilian	JJ
cord-003926-ycdaw2vh	92	44	or	or	CC
cord-003926-ycdaw2vh	92	45	Puerto	puerto	JJ
cord-003926-ycdaw2vh	92	46	Rican	rican	JJ
cord-003926-ycdaw2vh	92	47	strains	strain	NNS
cord-003926-ycdaw2vh	92	48	of	of	IN
cord-003926-ycdaw2vh	92	49	Zika	Zika	NNP
cord-003926-ycdaw2vh	92	50	virus	virus	NN
cord-003926-ycdaw2vh	92	51	[	[	-LRB-
cord-003926-ycdaw2vh	92	52	47	47	CD
cord-003926-ycdaw2vh	92	53	]	]	-RRB-
cord-003926-ycdaw2vh	92	54	.	.	.
cord-003926-ycdaw2vh	93	1	ZPIV	ZPIV	NNP
cord-003926-ycdaw2vh	93	2	safety	safety	NN
cord-003926-ycdaw2vh	93	3	and	and	CC
cord-003926-ycdaw2vh	93	4	immunogenicity	immunogenicity	NN
cord-003926-ycdaw2vh	93	5	was	be	VBD
cord-003926-ycdaw2vh	93	6	tested	test	VBN
cord-003926-ycdaw2vh	93	7	in	in	IN
cord-003926-ycdaw2vh	93	8	three	three	CD
cord-003926-ycdaw2vh	93	9	clinical	clinical	JJ
cord-003926-ycdaw2vh	93	10	trials	trial	NNS
cord-003926-ycdaw2vh	93	11	to	to	TO
cord-003926-ycdaw2vh	93	12	assess	assess	VB
cord-003926-ycdaw2vh	93	13	Zika	Zika	NNP
cord-003926-ycdaw2vh	93	14	vaccine	vaccine	NN
cord-003926-ycdaw2vh	93	15	responses	response	NNS
cord-003926-ycdaw2vh	93	16	relative	relative	JJ
cord-003926-ycdaw2vh	93	17	to	to	IN
cord-003926-ycdaw2vh	93	18	dose	dose	JJ
cord-003926-ycdaw2vh	93	19	level	level	NN
cord-003926-ycdaw2vh	93	20	,	,	,
cord-003926-ycdaw2vh	93	21	vaccination	vaccination	NN
cord-003926-ycdaw2vh	93	22	schedule	schedule	NN
cord-003926-ycdaw2vh	93	23	,	,	,
cord-003926-ycdaw2vh	93	24	or	or	CC
cord-003926-ycdaw2vh	93	25	following	follow	VBG
cord-003926-ycdaw2vh	93	26	vaccination	vaccination	NN
cord-003926-ycdaw2vh	93	27	with	with	IN
cord-003926-ycdaw2vh	93	28	either	either	CC
cord-003926-ycdaw2vh	93	29	the	the	DT
cord-003926-ycdaw2vh	93	30	Yellow	Yellow	NNP
cord-003926-ycdaw2vh	93	31	Fever	Fever	NNP
cord-003926-ycdaw2vh	93	32	YF	YF	NNP
cord-003926-ycdaw2vh	93	33	-	-	HYPH
cord-003926-ycdaw2vh	93	34	VAX	VAX	NNP
cord-003926-ycdaw2vh	93	35	or	or	CC
cord-003926-ycdaw2vh	93	36	Japanese	japanese	JJ
cord-003926-ycdaw2vh	93	37	encephalitis	encephalitis	NN
cord-003926-ycdaw2vh	93	38	virus	virus	NN
cord-003926-ycdaw2vh	93	39	(	(	-LRB-
cord-003926-ycdaw2vh	93	40	JEV	JEV	NNP
cord-003926-ycdaw2vh	93	41	)	)	-RRB-
cord-003926-ycdaw2vh	94	1	IXARO	IXARO	NNP
cord-003926-ycdaw2vh	94	2	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	95	1	to	to	TO
cord-003926-ycdaw2vh	95	2	assess	assess	VB
cord-003926-ycdaw2vh	95	3	responses	response	NNS
cord-003926-ycdaw2vh	95	4	in	in	IN
cord-003926-ycdaw2vh	95	5	a	a	DT
cord-003926-ycdaw2vh	95	6	flavivirus	flavivirus	JJ
cord-003926-ycdaw2vh	95	7	-	-	HYPH
cord-003926-ycdaw2vh	95	8	exposed	expose	VBN
cord-003926-ycdaw2vh	95	9	population	population	NN
cord-003926-ycdaw2vh	95	10	[	[	-LRB-
cord-003926-ycdaw2vh	95	11	45	45	CD
cord-003926-ycdaw2vh	95	12	]	]	-RRB-
cord-003926-ycdaw2vh	95	13	.	.	.
cord-003926-ycdaw2vh	96	1	There	there	EX
cord-003926-ycdaw2vh	96	2	were	be	VBD
cord-003926-ycdaw2vh	96	3	no	no	DT
cord-003926-ycdaw2vh	96	4	vaccine	vaccine	NN
cord-003926-ycdaw2vh	96	5	-	-	HYPH
cord-003926-ycdaw2vh	96	6	associated	associate	VBN
cord-003926-ycdaw2vh	96	7	SAEs	SAEs	NNP
cord-003926-ycdaw2vh	96	8	reported	report	VBD
cord-003926-ycdaw2vh	96	9	.	.	.
cord-003926-ycdaw2vh	97	1	The	the	DT
cord-003926-ycdaw2vh	97	2	most	most	RBS
cord-003926-ycdaw2vh	97	3	common	common	JJ
cord-003926-ycdaw2vh	97	4	adverse	adverse	JJ
cord-003926-ycdaw2vh	97	5	events	event	NNS
cord-003926-ycdaw2vh	97	6	were	be	VBD
cord-003926-ycdaw2vh	97	7	pain	pain	NN
cord-003926-ycdaw2vh	97	8	and	and	CC
cord-003926-ycdaw2vh	97	9	tenderness	tenderness	NN
cord-003926-ycdaw2vh	97	10	at	at	IN
cord-003926-ycdaw2vh	97	11	the	the	DT
cord-003926-ycdaw2vh	97	12	injection	injection	NN
cord-003926-ycdaw2vh	97	13	site	site	NN
cord-003926-ycdaw2vh	97	14	;	;	:
cord-003926-ycdaw2vh	97	15	no	no	DT
cord-003926-ycdaw2vh	97	16	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	97	17	events	event	NNS
cord-003926-ycdaw2vh	97	18	were	be	VBD
cord-003926-ycdaw2vh	97	19	reported	report	VBN
cord-003926-ycdaw2vh	97	20	.	.	.
cord-003926-ycdaw2vh	98	1	Seroconversion	seroconversion	NN
cord-003926-ycdaw2vh	98	2	was	be	VBD
cord-003926-ycdaw2vh	98	3	92	92	CD
cord-003926-ycdaw2vh	98	4	%	%	NN
cord-003926-ycdaw2vh	98	5	using	use	VBG
cord-003926-ycdaw2vh	98	6	a	a	DT
cord-003926-ycdaw2vh	98	7	cutoff	cutoff	NN
cord-003926-ycdaw2vh	98	8	for	for	IN
cord-003926-ycdaw2vh	98	9	peak	peak	NN
cord-003926-ycdaw2vh	99	1	geometric	geometric	JJ
cord-003926-ycdaw2vh	99	2	mean	mean	JJ
cord-003926-ycdaw2vh	99	3	titer	titer	NN
cord-003926-ycdaw2vh	99	4	of	of	IN
cord-003926-ycdaw2vh	99	5	1:10	1:10	CD
cord-003926-ycdaw2vh	99	6	and	and	CC
cord-003926-ycdaw2vh	99	7	77	77	CD
cord-003926-ycdaw2vh	99	8	%	%	NN
cord-003926-ycdaw2vh	99	9	using	use	VBG
cord-003926-ycdaw2vh	99	10	a	a	DT
cord-003926-ycdaw2vh	99	11	titer	titer	NN
cord-003926-ycdaw2vh	99	12	of	of	IN
cord-003926-ycdaw2vh	99	13	1:100	1:100	CD
cord-003926-ycdaw2vh	99	14	.	.	.
cord-003926-ycdaw2vh	100	1	Response	response	NN
cord-003926-ycdaw2vh	100	2	rates	rate	NNS
cord-003926-ycdaw2vh	100	3	after	after	IN
cord-003926-ycdaw2vh	100	4	a	a	DT
cord-003926-ycdaw2vh	100	5	single	single	JJ
cord-003926-ycdaw2vh	100	6	immunization	immunization	NN
cord-003926-ycdaw2vh	100	7	were	be	VBD
cord-003926-ycdaw2vh	100	8	11	11	CD
cord-003926-ycdaw2vh	100	9	%	%	NN
cord-003926-ycdaw2vh	100	10	and	and	CC
cord-003926-ycdaw2vh	100	11	5.5	5.5	CD
cord-003926-ycdaw2vh	100	12	%	%	NN
cord-003926-ycdaw2vh	100	13	using	use	VBG
cord-003926-ycdaw2vh	100	14	cutoffs	cutoff	NNS
cord-003926-ycdaw2vh	100	15	of	of	IN
cord-003926-ycdaw2vh	100	16	1:10	1:10	CD
cord-003926-ycdaw2vh	100	17	or	or	CC
cord-003926-ycdaw2vh	100	18	1:100	1:100	CD
cord-003926-ycdaw2vh	100	19	,	,	,
cord-003926-ycdaw2vh	100	20	respectively	respectively	RB
cord-003926-ycdaw2vh	100	21	.	.	.
cord-003926-ycdaw2vh	101	1	Vaccine	vaccine	NN
cord-003926-ycdaw2vh	101	2	responses	response	NNS
cord-003926-ycdaw2vh	101	3	were	be	VBD
cord-003926-ycdaw2vh	101	4	observed	observe	VBN
cord-003926-ycdaw2vh	101	5	through	through	IN
cord-003926-ycdaw2vh	101	6	day	day	NN
cord-003926-ycdaw2vh	101	7	57	57	CD
cord-003926-ycdaw2vh	101	8	.	.	.
cord-003926-ycdaw2vh	102	1	Passive	passive	JJ
cord-003926-ycdaw2vh	102	2	transfer	transfer	NN
cord-003926-ycdaw2vh	102	3	of	of	IN
cord-003926-ycdaw2vh	102	4	purified	purify	VBN
cord-003926-ycdaw2vh	102	5	IgG	igg	NN
cord-003926-ycdaw2vh	102	6	derived	derive	VBN
cord-003926-ycdaw2vh	102	7	from	from	IN
cord-003926-ycdaw2vh	102	8	10	10	CD
cord-003926-ycdaw2vh	102	9	Zika	Zika	NNP
cord-003926-ycdaw2vh	102	10	immunized	immunize	VBD
cord-003926-ycdaw2vh	102	11	participants	participant	NNS
cord-003926-ycdaw2vh	102	12	to	to	IN
cord-003926-ycdaw2vh	102	13	groups	group	NNS
cord-003926-ycdaw2vh	102	14	of	of	IN
cord-003926-ycdaw2vh	102	15	5	5	CD
cord-003926-ycdaw2vh	102	16	Balb	Balb	NNP
cord-003926-ycdaw2vh	102	17	/	/	SYM
cord-003926-ycdaw2vh	102	18	C	c	NN
cord-003926-ycdaw2vh	102	19	mice	mouse	NNS
cord-003926-ycdaw2vh	102	20	per	per	IN
cord-003926-ycdaw2vh	102	21	participant	participant	NN
cord-003926-ycdaw2vh	102	22	provided	provide	VBD
cord-003926-ycdaw2vh	102	23	sterilizing	sterilize	VBG
cord-003926-ycdaw2vh	102	24	immunity	immunity	NN
cord-003926-ycdaw2vh	102	25	against	against	IN
cord-003926-ycdaw2vh	102	26	viremia	viremia	NN
cord-003926-ycdaw2vh	102	27	for	for	IN
cord-003926-ycdaw2vh	102	28	82	82	CD
cord-003926-ycdaw2vh	102	29	%	%	NN
cord-003926-ycdaw2vh	102	30	(	(	-LRB-
cord-003926-ycdaw2vh	102	31	41	41	CD
cord-003926-ycdaw2vh	102	32	of	of	IN
cord-003926-ycdaw2vh	102	33	50	50	CD
cord-003926-ycdaw2vh	102	34	)	)	-RRB-
cord-003926-ycdaw2vh	102	35	of	of	IN
cord-003926-ycdaw2vh	102	36	mice	mouse	NNS
cord-003926-ycdaw2vh	102	37	overall	overall	RB
cord-003926-ycdaw2vh	102	38	,	,	,
cord-003926-ycdaw2vh	102	39	with	with	IN
cord-003926-ycdaw2vh	102	40	viremia	viremia	NN
cord-003926-ycdaw2vh	102	41	observed	observe	VBN
cord-003926-ycdaw2vh	102	42	for	for	IN
cord-003926-ycdaw2vh	102	43	one	one	CD
cord-003926-ycdaw2vh	102	44	or	or	CC
cord-003926-ycdaw2vh	102	45	more	more	JJR
cord-003926-ycdaw2vh	102	46	mice	mouse	NNS
cord-003926-ycdaw2vh	102	47	per	per	IN
cord-003926-ycdaw2vh	102	48	group	group	NN
cord-003926-ycdaw2vh	102	49	inoculated	inoculate	VBN
cord-003926-ycdaw2vh	102	50	with	with	IN
cord-003926-ycdaw2vh	102	51	sera	sera	NNP
cord-003926-ycdaw2vh	102	52	from	from	IN
cord-003926-ycdaw2vh	102	53	five	five	CD
cord-003926-ycdaw2vh	102	54	(	(	-LRB-
cord-003926-ycdaw2vh	102	55	50	50	CD
cord-003926-ycdaw2vh	102	56	%	%	NN
cord-003926-ycdaw2vh	102	57	)	)	-RRB-
cord-003926-ycdaw2vh	102	58	individuals	individual	NNS
cord-003926-ycdaw2vh	102	59	[	[	-LRB-
cord-003926-ycdaw2vh	102	60	45	45	CD
cord-003926-ycdaw2vh	102	61	]	]	-RRB-
cord-003926-ycdaw2vh	102	62	.	.	.
cord-003926-ycdaw2vh	103	1	Clinical	clinical	JJ
cord-003926-ycdaw2vh	103	2	trial	trial	NN
cord-003926-ycdaw2vh	103	3	data	datum	NNS
cord-003926-ycdaw2vh	103	4	for	for	IN
cord-003926-ycdaw2vh	103	5	the	the	DT
cord-003926-ycdaw2vh	103	6	other	other	JJ
cord-003926-ycdaw2vh	103	7	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	103	8	has	have	VBZ
cord-003926-ycdaw2vh	103	9	not	not	RB
cord-003926-ycdaw2vh	103	10	yet	yet	RB
cord-003926-ycdaw2vh	103	11	been	be	VBN
cord-003926-ycdaw2vh	103	12	reported	report	VBN
cord-003926-ycdaw2vh	103	13	as	as	IN
cord-003926-ycdaw2vh	103	14	of	of	IN
cord-003926-ycdaw2vh	103	15	the	the	DT
cord-003926-ycdaw2vh	103	16	date	date	NN
cord-003926-ycdaw2vh	103	17	of	of	IN
cord-003926-ycdaw2vh	103	18	this	this	DT
cord-003926-ycdaw2vh	103	19	monograph	monograph	NN
cord-003926-ycdaw2vh	103	20	,	,	,
cord-003926-ycdaw2vh	103	21	however	however	RB
cord-003926-ycdaw2vh	103	22	,	,	,
cord-003926-ycdaw2vh	103	23	pre	pre	JJ
cord-003926-ycdaw2vh	103	24	-	-	JJ
cord-003926-ycdaw2vh	103	25	clinical	clinical	JJ
cord-003926-ycdaw2vh	103	26	data	datum	NNS
cord-003926-ycdaw2vh	103	27	has	have	VBZ
cord-003926-ycdaw2vh	103	28	been	be	VBN
cord-003926-ycdaw2vh	103	29	reported	report	VBN
cord-003926-ycdaw2vh	103	30	for	for	IN
cord-003926-ycdaw2vh	103	31	three	three	CD
cord-003926-ycdaw2vh	103	32	candidate	candidate	NN
cord-003926-ycdaw2vh	103	33	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	103	34	.	.	.
cord-003926-ycdaw2vh	104	1	An	an	DT
cord-003926-ycdaw2vh	104	2	mRNA	mrna	NN
cord-003926-ycdaw2vh	104	3	vaccine	vaccine	NN
cord-003926-ycdaw2vh	104	4	that	that	WDT
cord-003926-ycdaw2vh	104	5	incorporates	incorporate	VBZ
cord-003926-ycdaw2vh	104	6	the	the	DT
cord-003926-ycdaw2vh	104	7	prM	prm	JJ
cord-003926-ycdaw2vh	104	8	-	-	HYPH
cord-003926-ycdaw2vh	104	9	E	e	NN
cord-003926-ycdaw2vh	104	10	genes	gene	NNS
cord-003926-ycdaw2vh	104	11	of	of	IN
cord-003926-ycdaw2vh	104	12	a	a	DT
cord-003926-ycdaw2vh	104	13	Micronesian	micronesian	JJ
cord-003926-ycdaw2vh	104	14	strain	strain	NN
cord-003926-ycdaw2vh	104	15	of	of	IN
cord-003926-ycdaw2vh	104	16	Zika	Zika	NNP
cord-003926-ycdaw2vh	104	17	virus	virus	NN
cord-003926-ycdaw2vh	104	18	was	be	VBD
cord-003926-ycdaw2vh	104	19	created	create	VBN
cord-003926-ycdaw2vh	104	20	incorporating	incorporate	VBG
cord-003926-ycdaw2vh	104	21	with	with	IN
cord-003926-ycdaw2vh	104	22	or	or	CC
cord-003926-ycdaw2vh	104	23	without	without	IN
cord-003926-ycdaw2vh	104	24	four	four	CD
cord-003926-ycdaw2vh	104	25	-	-	HYPH
cord-003926-ycdaw2vh	104	26	point	point	NN
cord-003926-ycdaw2vh	104	27	mutations	mutation	NNS
cord-003926-ycdaw2vh	104	28	in	in	IN
cord-003926-ycdaw2vh	104	29	the	the	DT
cord-003926-ycdaw2vh	104	30	fusion	fusion	NN
cord-003926-ycdaw2vh	104	31	-	-	HYPH
cord-003926-ycdaw2vh	104	32	loop	loop	NN
cord-003926-ycdaw2vh	104	33	segment	segment	NN
cord-003926-ycdaw2vh	104	34	of	of	IN
cord-003926-ycdaw2vh	104	35	the	the	DT
cord-003926-ycdaw2vh	104	36	DII	DII	NNP
cord-003926-ycdaw2vh	104	37	region	region	NN
cord-003926-ycdaw2vh	104	38	of	of	IN
cord-003926-ycdaw2vh	104	39	the	the	DT
cord-003926-ycdaw2vh	104	40	envelope	envelope	NN
cord-003926-ycdaw2vh	104	41	gene	gene	NN
cord-003926-ycdaw2vh	104	42	that	that	WDT
cord-003926-ycdaw2vh	104	43	abolished	abolish	VBD
cord-003926-ycdaw2vh	104	44	binding	binding	NN
cord-003926-ycdaw2vh	104	45	of	of	IN
cord-003926-ycdaw2vh	104	46	antibodies	antibody	NNS
cord-003926-ycdaw2vh	104	47	directed	direct	VBN
cord-003926-ycdaw2vh	104	48	against	against	IN
cord-003926-ycdaw2vh	104	49	the	the	DT
cord-003926-ycdaw2vh	104	50	fusion	fusion	NN
cord-003926-ycdaw2vh	104	51	-	-	HYPH
cord-003926-ycdaw2vh	104	52	loop	loop	NN
cord-003926-ycdaw2vh	104	53	region	region	NN
cord-003926-ycdaw2vh	104	54	to	to	TO
cord-003926-ycdaw2vh	104	55	reduce	reduce	VB
cord-003926-ycdaw2vh	104	56	the	the	DT
cord-003926-ycdaw2vh	104	57	potential	potential	JJ
cord-003926-ycdaw2vh	104	58	risk	risk	NN
cord-003926-ycdaw2vh	104	59	for	for	IN
cord-003926-ycdaw2vh	104	60	antibody	antibody	NN
cord-003926-ycdaw2vh	104	61	-	-	HYPH
cord-003926-ycdaw2vh	104	62	dependent	dependent	JJ
cord-003926-ycdaw2vh	104	63	enhancement	enhancement	NN
cord-003926-ycdaw2vh	104	64	of	of	IN
cord-003926-ycdaw2vh	104	65	infection	infection	NN
cord-003926-ycdaw2vh	104	66	[	[	-LRB-
cord-003926-ycdaw2vh	104	67	48	48	CD
cord-003926-ycdaw2vh	104	68	]	]	-RRB-
cord-003926-ycdaw2vh	104	69	.	.	.
cord-003926-ycdaw2vh	105	1	Immunization	Immunization	NNP
cord-003926-ycdaw2vh	105	2	of	of	IN
cord-003926-ycdaw2vh	105	3	AG129	AG129	NNP
cord-003926-ycdaw2vh	105	4	mice	mouse	NNS
cord-003926-ycdaw2vh	105	5	with	with	IN
cord-003926-ycdaw2vh	105	6	un	un	NNP
cord-003926-ycdaw2vh	105	7	-	-	JJ
cord-003926-ycdaw2vh	105	8	modified	modify	VBN
cord-003926-ycdaw2vh	105	9	lipid	lipid	NN
cord-003926-ycdaw2vh	105	10	nanoparticle	nanoparticle	NN
cord-003926-ycdaw2vh	105	11	-	-	HYPH
cord-003926-ycdaw2vh	105	12	encapsulated	encapsulate	VBN
cord-003926-ycdaw2vh	105	13	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	105	14	mRNA	mrna	NN
cord-003926-ycdaw2vh	105	15	was	be	VBD
cord-003926-ycdaw2vh	105	16	immunogenic	immunogenic	JJ
cord-003926-ycdaw2vh	105	17	and	and	CC
cord-003926-ycdaw2vh	105	18	protective	protective	JJ
cord-003926-ycdaw2vh	105	19	against	against	IN
cord-003926-ycdaw2vh	105	20	lethal	lethal	JJ
cord-003926-ycdaw2vh	105	21	infection	infection	NN
cord-003926-ycdaw2vh	105	22	;	;	:
cord-003926-ycdaw2vh	105	23	immunization	immunization	NN
cord-003926-ycdaw2vh	105	24	of	of	IN
cord-003926-ycdaw2vh	105	25	C57BL/6	C57BL/6	NNP
cord-003926-ycdaw2vh	105	26	immunocompetent	immunocompetent	JJ
cord-003926-ycdaw2vh	105	27	mice	mouse	NNS
cord-003926-ycdaw2vh	105	28	followed	follow	VBN
cord-003926-ycdaw2vh	105	29	by	by	IN
cord-003926-ycdaw2vh	105	30	treatment	treatment	NN
cord-003926-ycdaw2vh	105	31	with	with	IN
cord-003926-ycdaw2vh	105	32	anti	anti	JJ
cord-003926-ycdaw2vh	105	33	-	-	JJ
cord-003926-ycdaw2vh	105	34	ifnar1	ifnar1	JJ
cord-003926-ycdaw2vh	105	35	blocking	block	VBG
cord-003926-ycdaw2vh	105	36	antibody	antibody	NN
cord-003926-ycdaw2vh	105	37	showed	show	VBD
cord-003926-ycdaw2vh	105	38	protection	protection	NN
cord-003926-ycdaw2vh	105	39	against	against	IN
cord-003926-ycdaw2vh	105	40	viremia	viremia	NN
cord-003926-ycdaw2vh	105	41	in	in	IN
cord-003926-ycdaw2vh	105	42	approximately	approximately	RB
cord-003926-ycdaw2vh	105	43	60	60	CD
cord-003926-ycdaw2vh	105	44	%	%	NN
cord-003926-ycdaw2vh	105	45	of	of	IN
cord-003926-ycdaw2vh	105	46	animals	animal	NNS
cord-003926-ycdaw2vh	105	47	[	[	-LRB-
cord-003926-ycdaw2vh	105	48	48	48	CD
cord-003926-ycdaw2vh	105	49	]	]	-RRB-
cord-003926-ycdaw2vh	105	50	.	.	.
cord-003926-ycdaw2vh	106	1	PIZV	PIZV	NNP
cord-003926-ycdaw2vh	106	2	,	,	,
cord-003926-ycdaw2vh	106	3	an	an	DT
cord-003926-ycdaw2vh	106	4	inactivated	inactivate	VBN
cord-003926-ycdaw2vh	106	5	vaccine	vaccine	NN
cord-003926-ycdaw2vh	106	6	derived	derive	VBN
cord-003926-ycdaw2vh	106	7	from	from	IN
cord-003926-ycdaw2vh	106	8	Puerto	puerto	JJ
cord-003926-ycdaw2vh	106	9	Rican	rican	JJ
cord-003926-ycdaw2vh	106	10	strain	strain	NN
cord-003926-ycdaw2vh	106	11	PRVABC59	PRVABC59	NNP
cord-003926-ycdaw2vh	106	12	selected	select	VBN
cord-003926-ycdaw2vh	106	13	as	as	IN
cord-003926-ycdaw2vh	106	14	without	without	IN
cord-003926-ycdaw2vh	106	15	passage	passage	NN
cord-003926-ycdaw2vh	106	16	-	-	HYPH
cord-003926-ycdaw2vh	106	17	related	relate	VBN
cord-003926-ycdaw2vh	106	18	mutations	mutation	NNS
cord-003926-ycdaw2vh	106	19	,	,	,
cord-003926-ycdaw2vh	106	20	protected	protect	VBN
cord-003926-ycdaw2vh	106	21	against	against	IN
cord-003926-ycdaw2vh	106	22	lethal	lethal	JJ
cord-003926-ycdaw2vh	106	23	Zika	Zika	NNP
cord-003926-ycdaw2vh	106	24	virus	virus	NN
cord-003926-ycdaw2vh	106	25	challenge	challenge	NN
cord-003926-ycdaw2vh	106	26	in	in	IN
cord-003926-ycdaw2vh	106	27	AG129	AG129	NNP
cord-003926-ycdaw2vh	106	28	mice	mouse	NNS
cord-003926-ycdaw2vh	106	29	when	when	WRB
cord-003926-ycdaw2vh	106	30	administered	administer	VBN
cord-003926-ycdaw2vh	106	31	with	with	IN
cord-003926-ycdaw2vh	106	32	alum	alum	NN
cord-003926-ycdaw2vh	106	33	adjuvant	adjuvant	JJ
cord-003926-ycdaw2vh	106	34	[	[	-LRB-
cord-003926-ycdaw2vh	106	35	49	49	CD
cord-003926-ycdaw2vh	106	36	]	]	-RRB-
cord-003926-ycdaw2vh	106	37	.	.	.
cord-003926-ycdaw2vh	107	1	A	a	DT
cord-003926-ycdaw2vh	107	2	measles	measles	NN
cord-003926-ycdaw2vh	107	3	-	-	HYPH
cord-003926-ycdaw2vh	107	4	vectored	vectore	VBN
cord-003926-ycdaw2vh	107	5	vaccine	vaccine	NN
cord-003926-ycdaw2vh	107	6	encoding	encode	VBG
cord-003926-ycdaw2vh	107	7	the	the	DT
cord-003926-ycdaw2vh	107	8	Zika	Zika	NNP
cord-003926-ycdaw2vh	107	9	virus	virus	NN
cord-003926-ycdaw2vh	107	10	prME	prME	NNS
cord-003926-ycdaw2vh	107	11	was	be	VBD
cord-003926-ycdaw2vh	107	12	shown	show	VBN
cord-003926-ycdaw2vh	107	13	to	to	TO
cord-003926-ycdaw2vh	107	14	lessen	lessen	VB
cord-003926-ycdaw2vh	107	15	viremia	viremia	NN
cord-003926-ycdaw2vh	107	16	in	in	IN
cord-003926-ycdaw2vh	107	17	pregnant	pregnant	JJ
cord-003926-ycdaw2vh	107	18	IFNAR	IFNAR	NNP
cord-003926-ycdaw2vh	107	19	mice	mouse	NNS
cord-003926-ycdaw2vh	107	20	and	and	CC
cord-003926-ycdaw2vh	107	21	prevented	prevent	VBD
cord-003926-ycdaw2vh	107	22	clinical	clinical	JJ
cord-003926-ycdaw2vh	107	23	disease	disease	NN
cord-003926-ycdaw2vh	107	24	in	in	IN
cord-003926-ycdaw2vh	107	25	mouse	mouse	NN
cord-003926-ycdaw2vh	107	26	pups	pup	NNS
cord-003926-ycdaw2vh	107	27	[	[	-LRB-
cord-003926-ycdaw2vh	107	28	50	50	CD
cord-003926-ycdaw2vh	107	29	]	]	-RRB-
cord-003926-ycdaw2vh	107	30	.	.	.
cord-003926-ycdaw2vh	108	1	Preclinical	preclinical	JJ
cord-003926-ycdaw2vh	108	2	data	datum	NNS
cord-003926-ycdaw2vh	108	3	for	for	IN
cord-003926-ycdaw2vh	108	4	VLA-1601	VLA-1601	NNS
cord-003926-ycdaw2vh	108	5	inactivated	inactivate	VBD
cord-003926-ycdaw2vh	108	6	viral	viral	JJ
cord-003926-ycdaw2vh	108	7	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	108	8	and	and	CC
cord-003926-ycdaw2vh	108	9	the	the	DT
cord-003926-ycdaw2vh	108	10	rZIKV	rZIKV	NNP
cord-003926-ycdaw2vh	108	11	/	/	SYM
cord-003926-ycdaw2vh	108	12	D4∆30	D4∆30	NNP
cord-003926-ycdaw2vh	108	13	-	-	HYPH
cord-003926-ycdaw2vh	108	14	713	713	CD
cord-003926-ycdaw2vh	108	15	live	live	JJ
cord-003926-ycdaw2vh	108	16	virus	virus	NN
cord-003926-ycdaw2vh	108	17	vaccine	vaccine	NN
cord-003926-ycdaw2vh	108	18	has	have	VBZ
cord-003926-ycdaw2vh	108	19	not	not	RB
cord-003926-ycdaw2vh	108	20	yet	yet	RB
cord-003926-ycdaw2vh	108	21	been	be	VBN
cord-003926-ycdaw2vh	108	22	reported	report	VBN
cord-003926-ycdaw2vh	108	23	.	.	.
cord-003926-ycdaw2vh	109	1	A	a	DT
cord-003926-ycdaw2vh	109	2	number	number	NN
cord-003926-ycdaw2vh	109	3	of	of	IN
cord-003926-ycdaw2vh	109	4	animal	animal	NN
cord-003926-ycdaw2vh	109	5	models	model	NNS
cord-003926-ycdaw2vh	109	6	have	have	VBP
cord-003926-ycdaw2vh	109	7	been	be	VBN
cord-003926-ycdaw2vh	109	8	assessed	assess	VBN
cord-003926-ycdaw2vh	109	9	for	for	IN
cord-003926-ycdaw2vh	109	10	vaccine	vaccine	NN
cord-003926-ycdaw2vh	109	11	development	development	NN
cord-003926-ycdaw2vh	109	12	and	and	CC
cord-003926-ycdaw2vh	109	13	have	have	VBP
cord-003926-ycdaw2vh	109	14	been	be	VBN
cord-003926-ycdaw2vh	109	15	reviewed	review	VBN
cord-003926-ycdaw2vh	109	16	elsewhere	elsewhere	RB
cord-003926-ycdaw2vh	109	17	[	[	-LRB-
cord-003926-ycdaw2vh	109	18	51	51	CD
cord-003926-ycdaw2vh	109	19	]	]	-RRB-
cord-003926-ycdaw2vh	109	20	.	.	.
cord-003926-ycdaw2vh	110	1	Immunocompetent	immunocompetent	NN
cord-003926-ycdaw2vh	110	2	mice	mouse	NNS
cord-003926-ycdaw2vh	110	3	can	can	MD
cord-003926-ycdaw2vh	110	4	develop	develop	VB
cord-003926-ycdaw2vh	110	5	transient	transient	JJ
cord-003926-ycdaw2vh	110	6	viremia	viremia	NN
cord-003926-ycdaw2vh	110	7	following	follow	VBG
cord-003926-ycdaw2vh	110	8	infection	infection	NN
cord-003926-ycdaw2vh	110	9	and	and	CC
cord-003926-ycdaw2vh	110	10	may	may	MD
cord-003926-ycdaw2vh	110	11	represent	represent	VB
cord-003926-ycdaw2vh	110	12	models	model	NNS
cord-003926-ycdaw2vh	110	13	to	to	TO
cord-003926-ycdaw2vh	110	14	test	test	VB
cord-003926-ycdaw2vh	110	15	sterilizing	sterilize	VBG
cord-003926-ycdaw2vh	110	16	immunity	immunity	NN
cord-003926-ycdaw2vh	110	17	.	.	.
cord-003926-ycdaw2vh	111	1	Interferon	interferon	NN
cord-003926-ycdaw2vh	111	2	α	α	NNP
cord-003926-ycdaw2vh	111	3	/	/	SYM
cord-003926-ycdaw2vh	111	4	β	β	NN
cord-003926-ycdaw2vh	111	5	receptor	receptor	NN
cord-003926-ycdaw2vh	111	6	knockout	knockout	NN
cord-003926-ycdaw2vh	111	7	mice	mouse	NNS
cord-003926-ycdaw2vh	112	1	(	(	-LRB-
cord-003926-ycdaw2vh	112	2	AG129	AG129	NNP
cord-003926-ycdaw2vh	112	3	or	or	CC
cord-003926-ycdaw2vh	112	4	IFNAR	IFNAR	NNP
cord-003926-ycdaw2vh	112	5	-/-	-/-	ADD
cord-003926-ycdaw2vh	112	6	)	)	-RRB-
cord-003926-ycdaw2vh	112	7	develop	develop	VB
cord-003926-ycdaw2vh	112	8	lethal	lethal	JJ
cord-003926-ycdaw2vh	112	9	infection	infection	NN
cord-003926-ycdaw2vh	112	10	following	follow	VBG
cord-003926-ycdaw2vh	112	11	Zika	Zika	NNP
cord-003926-ycdaw2vh	112	12	virus	virus	NN
cord-003926-ycdaw2vh	112	13	infection	infection	NN
cord-003926-ycdaw2vh	112	14	and	and	CC
cord-003926-ycdaw2vh	112	15	have	have	VBP
cord-003926-ycdaw2vh	112	16	been	be	VBN
cord-003926-ycdaw2vh	112	17	used	use	VBN
cord-003926-ycdaw2vh	112	18	as	as	IN
cord-003926-ycdaw2vh	112	19	a	a	DT
cord-003926-ycdaw2vh	112	20	more	more	RBR
cord-003926-ycdaw2vh	112	21	stringent	stringent	JJ
cord-003926-ycdaw2vh	112	22	measure	measure	NN
cord-003926-ycdaw2vh	112	23	of	of	IN
cord-003926-ycdaw2vh	112	24	protection	protection	NN
cord-003926-ycdaw2vh	112	25	.	.	.
cord-003926-ycdaw2vh	113	1	Non	non	JJ
cord-003926-ycdaw2vh	113	2	-	-	JJ
cord-003926-ycdaw2vh	113	3	human	human	JJ
cord-003926-ycdaw2vh	113	4	primates	primate	NNS
cord-003926-ycdaw2vh	113	5	develop	develop	VBP
cord-003926-ycdaw2vh	113	6	a	a	DT
cord-003926-ycdaw2vh	113	7	self	self	NN
cord-003926-ycdaw2vh	113	8	-	-	HYPH
cord-003926-ycdaw2vh	113	9	limited	limit	VBN
cord-003926-ycdaw2vh	113	10	mild	mild	JJ
cord-003926-ycdaw2vh	113	11	illness	illness	NN
cord-003926-ycdaw2vh	113	12	associated	associate	VBN
cord-003926-ycdaw2vh	113	13	with	with	IN
cord-003926-ycdaw2vh	113	14	viremia	viremia	NN
cord-003926-ycdaw2vh	113	15	and	and	CC
cord-003926-ycdaw2vh	113	16	can	can	MD
cord-003926-ycdaw2vh	113	17	transmit	transmit	VB
cord-003926-ycdaw2vh	113	18	virus	virus	NN
cord-003926-ycdaw2vh	113	19	in	in	IN
cord-003926-ycdaw2vh	113	20	utero	utero	NNS
cord-003926-ycdaw2vh	113	21	to	to	IN
cord-003926-ycdaw2vh	113	22	primate	primate	JJ
cord-003926-ycdaw2vh	113	23	fetus	fetus	NN
cord-003926-ycdaw2vh	113	24	[	[	-LRB-
cord-003926-ycdaw2vh	113	25	52	52	CD
cord-003926-ycdaw2vh	113	26	]	]	-RRB-
cord-003926-ycdaw2vh	113	27	.	.	.
cord-003926-ycdaw2vh	114	1	The	the	DT
cord-003926-ycdaw2vh	114	2	logistical	logistical	JJ
cord-003926-ycdaw2vh	114	3	difficulties	difficulty	NNS
cord-003926-ycdaw2vh	114	4	in	in	IN
cord-003926-ycdaw2vh	114	5	pursuing	pursue	VBG
cord-003926-ycdaw2vh	114	6	standard	standard	JJ
cord-003926-ycdaw2vh	114	7	vaccine	vaccine	NN
cord-003926-ycdaw2vh	114	8	evaluation	evaluation	NN
cord-003926-ycdaw2vh	114	9	have	have	VBP
cord-003926-ycdaw2vh	114	10	created	create	VBN
cord-003926-ycdaw2vh	114	11	significant	significant	JJ
cord-003926-ycdaw2vh	114	12	interest	interest	NN
cord-003926-ycdaw2vh	114	13	in	in	IN
cord-003926-ycdaw2vh	114	14	the	the	DT
cord-003926-ycdaw2vh	114	15	possibility	possibility	NN
cord-003926-ycdaw2vh	114	16	of	of	IN
cord-003926-ycdaw2vh	114	17	controlled	control	VBN
cord-003926-ycdaw2vh	114	18	human	human	JJ
cord-003926-ycdaw2vh	114	19	infection	infection	NN
cord-003926-ycdaw2vh	114	20	models	model	NNS
cord-003926-ycdaw2vh	114	21	(	(	-LRB-
cord-003926-ycdaw2vh	114	22	CHIM	CHIM	NNP
cord-003926-ycdaw2vh	114	23	)	)	-RRB-
cord-003926-ycdaw2vh	114	24	.	.	.
cord-003926-ycdaw2vh	115	1	The	the	DT
cord-003926-ycdaw2vh	115	2	conduct	conduct	NN
cord-003926-ycdaw2vh	115	3	and	and	CC
cord-003926-ycdaw2vh	115	4	planning	plan	VBG
cord-003926-ycdaw2vh	115	5	for	for	IN
cord-003926-ycdaw2vh	115	6	human	human	JJ
cord-003926-ycdaw2vh	115	7	challenge	challenge	NN
cord-003926-ycdaw2vh	115	8	trials	trial	NNS
cord-003926-ycdaw2vh	115	9	raises	raise	VBZ
cord-003926-ycdaw2vh	115	10	unique	unique	JJ
cord-003926-ycdaw2vh	115	11	medical	medical	JJ
cord-003926-ycdaw2vh	115	12	and	and	CC
cord-003926-ycdaw2vh	115	13	ethical	ethical	JJ
cord-003926-ycdaw2vh	115	14	considerations	consideration	NNS
cord-003926-ycdaw2vh	115	15	.	.	.
cord-003926-ycdaw2vh	116	1	For	for	IN
cord-003926-ycdaw2vh	116	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	116	3	virus	virus	NN
cord-003926-ycdaw2vh	116	4	trials	trial	NNS
cord-003926-ycdaw2vh	116	5	,	,	,
cord-003926-ycdaw2vh	116	6	one	one	PRP
cord-003926-ycdaw2vh	116	7	must	must	MD
cord-003926-ycdaw2vh	116	8	balance	balance	VB
cord-003926-ycdaw2vh	116	9	the	the	DT
cord-003926-ycdaw2vh	116	10	relative	relative	JJ
cord-003926-ycdaw2vh	116	11	benign	benign	JJ
cord-003926-ycdaw2vh	116	12	and	and	CC
cord-003926-ycdaw2vh	116	13	self	self	NN
cord-003926-ycdaw2vh	116	14	-	-	HYPH
cord-003926-ycdaw2vh	116	15	limited	limit	VBN
cord-003926-ycdaw2vh	116	16	infection	infection	NN
cord-003926-ycdaw2vh	116	17	experienced	experience	VBN
cord-003926-ycdaw2vh	116	18	by	by	IN
cord-003926-ycdaw2vh	116	19	the	the	DT
cord-003926-ycdaw2vh	116	20	vast	vast	JJ
cord-003926-ycdaw2vh	116	21	majority	majority	NN
cord-003926-ycdaw2vh	116	22	against	against	IN
cord-003926-ycdaw2vh	116	23	the	the	DT
cord-003926-ycdaw2vh	116	24	risk	risk	NN
cord-003926-ycdaw2vh	116	25	for	for	IN
cord-003926-ycdaw2vh	116	26	less	less	RBR
cord-003926-ycdaw2vh	116	27	benign	benign	JJ
cord-003926-ycdaw2vh	116	28	complications	complication	NNS
cord-003926-ycdaw2vh	116	29	and	and	CC
cord-003926-ycdaw2vh	116	30	transmission	transmission	NN
cord-003926-ycdaw2vh	116	31	risks	risk	NNS
cord-003926-ycdaw2vh	116	32	.	.	.
cord-003926-ycdaw2vh	117	1	As	as	IN
cord-003926-ycdaw2vh	117	2	reviewed	review	VBN
cord-003926-ycdaw2vh	117	3	above	above	RB
cord-003926-ycdaw2vh	117	4	,	,	,
cord-003926-ycdaw2vh	117	5	published	publish	VBN
cord-003926-ycdaw2vh	117	6	studies	study	NNS
cord-003926-ycdaw2vh	117	7	provide	provide	VBP
cord-003926-ycdaw2vh	117	8	estimates	estimate	NNS
cord-003926-ycdaw2vh	117	9	that	that	IN
cord-003926-ycdaw2vh	117	10	Zika	Zika	NNP
cord-003926-ycdaw2vh	117	11	virus	virus	NN
cord-003926-ycdaw2vh	117	12	infection	infection	NN
cord-003926-ycdaw2vh	117	13	is	be	VBZ
cord-003926-ycdaw2vh	117	14	relatively	relatively	RB
cord-003926-ycdaw2vh	117	15	asymptomatic	asymptomatic	JJ
cord-003926-ycdaw2vh	117	16	and	and	CC
cord-003926-ycdaw2vh	117	17	self	self	NN
cord-003926-ycdaw2vh	117	18	-	-	HYPH
cord-003926-ycdaw2vh	117	19	limited	limit	VBN
cord-003926-ycdaw2vh	117	20	for	for	IN
cord-003926-ycdaw2vh	117	21	the	the	DT
cord-003926-ycdaw2vh	117	22	majority	majority	NN
cord-003926-ycdaw2vh	117	23	of	of	IN
cord-003926-ycdaw2vh	117	24	individuals	individual	NNS
cord-003926-ycdaw2vh	117	25	,	,	,
cord-003926-ycdaw2vh	117	26	however	however	RB
cord-003926-ycdaw2vh	117	27	,	,	,
cord-003926-ycdaw2vh	117	28	methodology	methodology	NN
cord-003926-ycdaw2vh	117	29	in	in	IN
cord-003926-ycdaw2vh	117	30	these	these	DT
cord-003926-ycdaw2vh	117	31	studies	study	NNS
cord-003926-ycdaw2vh	117	32	varies	vary	VBZ
cord-003926-ycdaw2vh	117	33	widely	widely	RB
cord-003926-ycdaw2vh	117	34	.	.	.
cord-003926-ycdaw2vh	118	1	In	in	IN
cord-003926-ycdaw2vh	118	2	adults	adult	NNS
cord-003926-ycdaw2vh	118	3	,	,	,
cord-003926-ycdaw2vh	118	4	two	two	CD
cord-003926-ycdaw2vh	118	5	sets	set	NNS
cord-003926-ycdaw2vh	118	6	of	of	IN
cord-003926-ycdaw2vh	118	7	complications	complication	NNS
cord-003926-ycdaw2vh	118	8	warrant	warrant	VBP
cord-003926-ycdaw2vh	118	9	consideration	consideration	NN
cord-003926-ycdaw2vh	118	10	for	for	IN
cord-003926-ycdaw2vh	118	11	a	a	DT
cord-003926-ycdaw2vh	118	12	proposed	propose	VBN
cord-003926-ycdaw2vh	118	13	CHIM	CHIM	NNP
cord-003926-ycdaw2vh	118	14	study	study	NN
cord-003926-ycdaw2vh	118	15	.	.	.
cord-003926-ycdaw2vh	119	1	As	as	IN
cord-003926-ycdaw2vh	119	2	reviewed	review	VBN
cord-003926-ycdaw2vh	119	3	above	above	RB
cord-003926-ycdaw2vh	119	4	,	,	,
cord-003926-ycdaw2vh	119	5	a	a	DT
cord-003926-ycdaw2vh	119	6	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	119	7	-	-	HYPH
cord-003926-ycdaw2vh	119	8	Barre	Barre	NNP
cord-003926-ycdaw2vh	119	9	-	-	HYPH
cord-003926-ycdaw2vh	119	10	like	like	JJ
cord-003926-ycdaw2vh	119	11	syndrome	syndrome	NN
cord-003926-ycdaw2vh	119	12	occurs	occur	VBZ
cord-003926-ycdaw2vh	119	13	in	in	IN
cord-003926-ycdaw2vh	119	14	approximately	approximately	RB
cord-003926-ycdaw2vh	119	15	1	1	CD
cord-003926-ycdaw2vh	119	16	of	of	IN
cord-003926-ycdaw2vh	119	17	5000	5000	CD
cord-003926-ycdaw2vh	119	18	Zika	Zika	NNP
cord-003926-ycdaw2vh	119	19	virus	virus	NN
cord-003926-ycdaw2vh	119	20	infections	infection	NNS
cord-003926-ycdaw2vh	119	21	[	[	-LRB-
cord-003926-ycdaw2vh	119	22	13	13	CD
cord-003926-ycdaw2vh	119	23	]	]	-RRB-
cord-003926-ycdaw2vh	119	24	,	,	,
cord-003926-ycdaw2vh	119	25	whereas	whereas	IN
cord-003926-ycdaw2vh	119	26	other	other	JJ
cord-003926-ycdaw2vh	119	27	neurologic	neurologic	JJ
cord-003926-ycdaw2vh	119	28	complications	complication	NNS
cord-003926-ycdaw2vh	119	29	such	such	JJ
cord-003926-ycdaw2vh	119	30	as	as	IN
cord-003926-ycdaw2vh	119	31	meningoencephalitis	meningoencephalitis	NNP
cord-003926-ycdaw2vh	119	32	,	,	,
cord-003926-ycdaw2vh	119	33	myelitis	myelitis	NNP
cord-003926-ycdaw2vh	119	34	[	[	-LRB-
cord-003926-ycdaw2vh	119	35	15	15	CD
cord-003926-ycdaw2vh	119	36	,	,	,
cord-003926-ycdaw2vh	119	37	53	53	CD
cord-003926-ycdaw2vh	119	38	,	,	,
cord-003926-ycdaw2vh	119	39	54	54	CD
cord-003926-ycdaw2vh	119	40	]	]	-RRB-
cord-003926-ycdaw2vh	119	41	,	,	,
cord-003926-ycdaw2vh	119	42	and	and	CC
cord-003926-ycdaw2vh	119	43	acute	acute	JJ
cord-003926-ycdaw2vh	119	44	disseminated	disseminate	VBN
cord-003926-ycdaw2vh	119	45	encephalomyelitis	encephalomyelitis	NN
cord-003926-ycdaw2vh	119	46	[	[	-LRB-
cord-003926-ycdaw2vh	119	47	54	54	CD
cord-003926-ycdaw2vh	119	48	]	]	-RRB-
cord-003926-ycdaw2vh	119	49	are	be	VBP
cord-003926-ycdaw2vh	119	50	rare	rare	JJ
cord-003926-ycdaw2vh	119	51	.	.	.
cord-003926-ycdaw2vh	120	1	Second	second	JJ
cord-003926-ycdaw2vh	120	2	,	,	,
cord-003926-ycdaw2vh	120	3	and	and	CC
cord-003926-ycdaw2vh	120	4	perhaps	perhaps	RB
cord-003926-ycdaw2vh	120	5	more	more	RBR
cord-003926-ycdaw2vh	120	6	important	important	JJ
cord-003926-ycdaw2vh	120	7	,	,	,
cord-003926-ycdaw2vh	120	8	is	be	VBZ
cord-003926-ycdaw2vh	120	9	the	the	DT
cord-003926-ycdaw2vh	120	10	risk	risk	NN
cord-003926-ycdaw2vh	120	11	of	of	IN
cord-003926-ycdaw2vh	120	12	transmission	transmission	NN
cord-003926-ycdaw2vh	120	13	to	to	IN
cord-003926-ycdaw2vh	120	14	a	a	DT
cord-003926-ycdaw2vh	120	15	sexual	sexual	JJ
cord-003926-ycdaw2vh	120	16	partner	partner	NN
cord-003926-ycdaw2vh	120	17	and	and	CC
cord-003926-ycdaw2vh	120	18	the	the	DT
cord-003926-ycdaw2vh	120	19	potential	potential	NN
cord-003926-ycdaw2vh	120	20	for	for	IN
cord-003926-ycdaw2vh	120	21	infection	infection	NN
cord-003926-ycdaw2vh	120	22	during	during	IN
cord-003926-ycdaw2vh	120	23	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	120	24	.	.	.
cord-003926-ycdaw2vh	121	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	121	2	virus	virus	NN
cord-003926-ycdaw2vh	121	3	commonly	commonly	RB
cord-003926-ycdaw2vh	121	4	persists	persist	VBZ
cord-003926-ycdaw2vh	121	5	in	in	IN
cord-003926-ycdaw2vh	121	6	the	the	DT
cord-003926-ycdaw2vh	121	7	male	male	JJ
cord-003926-ycdaw2vh	121	8	urogenital	urogenital	JJ
cord-003926-ycdaw2vh	121	9	tract	tract	NN
cord-003926-ycdaw2vh	121	10	for	for	IN
cord-003926-ycdaw2vh	121	11	3	3	CD
cord-003926-ycdaw2vh	121	12	months	month	NNS
cord-003926-ycdaw2vh	121	13	,	,	,
cord-003926-ycdaw2vh	121	14	and	and	CC
cord-003926-ycdaw2vh	121	15	may	may	MD
cord-003926-ycdaw2vh	121	16	persist	persist	VB
cord-003926-ycdaw2vh	121	17	in	in	IN
cord-003926-ycdaw2vh	121	18	some	some	DT
cord-003926-ycdaw2vh	121	19	individuals	individual	NNS
cord-003926-ycdaw2vh	121	20	for	for	IN
cord-003926-ycdaw2vh	121	21	up	up	IN
cord-003926-ycdaw2vh	121	22	to	to	TO
cord-003926-ycdaw2vh	121	23	8	8	CD
cord-003926-ycdaw2vh	121	24	months	month	NNS
cord-003926-ycdaw2vh	121	25	[	[	-LRB-
cord-003926-ycdaw2vh	121	26	27	27	CD
cord-003926-ycdaw2vh	121	27	]	]	-RRB-
cord-003926-ycdaw2vh	121	28	.	.	.
cord-003926-ycdaw2vh	122	1	Some	some	DT
cord-003926-ycdaw2vh	122	2	have	have	VBP
cord-003926-ycdaw2vh	122	3	considered	consider	VBN
cord-003926-ycdaw2vh	122	4	limiting	limit	VBG
cord-003926-ycdaw2vh	122	5	studies	study	NNS
cord-003926-ycdaw2vh	122	6	to	to	IN
cord-003926-ycdaw2vh	122	7	non	non	JJ
cord-003926-ycdaw2vh	122	8	-	-	JJ
cord-003926-ycdaw2vh	122	9	pregnant	pregnant	JJ
cord-003926-ycdaw2vh	122	10	females	female	NNS
cord-003926-ycdaw2vh	122	11	as	as	IN
cord-003926-ycdaw2vh	122	12	Zika	Zika	NNP
cord-003926-ycdaw2vh	122	13	virus	virus	NN
cord-003926-ycdaw2vh	122	14	colonization	colonization	NN
cord-003926-ycdaw2vh	122	15	of	of	IN
cord-003926-ycdaw2vh	122	16	the	the	DT
cord-003926-ycdaw2vh	122	17	female	female	JJ
cord-003926-ycdaw2vh	122	18	genital	genital	JJ
cord-003926-ycdaw2vh	122	19	tract	tract	NN
cord-003926-ycdaw2vh	122	20	may	may	MD
cord-003926-ycdaw2vh	122	21	be	be	VB
cord-003926-ycdaw2vh	122	22	temporally	temporally	RB
cord-003926-ycdaw2vh	122	23	limited	limited	JJ
cord-003926-ycdaw2vh	122	24	.	.	.
cord-003926-ycdaw2vh	123	1	The	the	DT
cord-003926-ycdaw2vh	123	2	fact	fact	NN
cord-003926-ycdaw2vh	123	3	that	that	IN
cord-003926-ycdaw2vh	123	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	123	5	virus	virus	NN
cord-003926-ycdaw2vh	123	6	is	be	VBZ
cord-003926-ycdaw2vh	123	7	known	know	VBN
cord-003926-ycdaw2vh	123	8	to	to	TO
cord-003926-ycdaw2vh	123	9	cause	cause	VB
cord-003926-ycdaw2vh	123	10	testicular	testicular	JJ
cord-003926-ycdaw2vh	123	11	atrophy	atrophy	NN
cord-003926-ycdaw2vh	123	12	in	in	IN
cord-003926-ycdaw2vh	123	13	mice	mouse	NNS
cord-003926-ycdaw2vh	123	14	[	[	-LRB-
cord-003926-ycdaw2vh	123	15	28	28	CD
cord-003926-ycdaw2vh	123	16	]	]	-RRB-
cord-003926-ycdaw2vh	123	17	[	[	-LRB-
cord-003926-ycdaw2vh	123	18	29	29	CD
cord-003926-ycdaw2vh	123	19	]	]	-RRB-
cord-003926-ycdaw2vh	123	20	[	[	-LRB-
cord-003926-ycdaw2vh	123	21	30	30	CD
cord-003926-ycdaw2vh	123	22	]	]	-RRB-
cord-003926-ycdaw2vh	123	23	,	,	,
cord-003926-ycdaw2vh	123	24	raises	raise	VBZ
cord-003926-ycdaw2vh	123	25	yet	yet	RB
cord-003926-ycdaw2vh	123	26	another	another	DT
cord-003926-ycdaw2vh	123	27	as	as	RB
cord-003926-ycdaw2vh	123	28	yet	yet	RB
cord-003926-ycdaw2vh	123	29	theoretical	theoretical	JJ
cord-003926-ycdaw2vh	123	30	concern	concern	NN
cord-003926-ycdaw2vh	123	31	for	for	IN
cord-003926-ycdaw2vh	123	32	humans	human	NNS
cord-003926-ycdaw2vh	123	33	.	.	.
cord-003926-ycdaw2vh	124	1	These	these	DT
cord-003926-ycdaw2vh	124	2	questions	question	NNS
cord-003926-ycdaw2vh	124	3	as	as	RB
cord-003926-ycdaw2vh	124	4	well	well	RB
cord-003926-ycdaw2vh	124	5	as	as	IN
cord-003926-ycdaw2vh	124	6	the	the	DT
cord-003926-ycdaw2vh	124	7	theoretical	theoretical	JJ
cord-003926-ycdaw2vh	124	8	potential	potential	NN
cord-003926-ycdaw2vh	124	9	for	for	IN
cord-003926-ycdaw2vh	124	10	vector	vector	NN
cord-003926-ycdaw2vh	124	11	-	-	HYPH
cord-003926-ycdaw2vh	124	12	borne	bear	VBN
cord-003926-ycdaw2vh	124	13	transmission	transmission	NN
cord-003926-ycdaw2vh	124	14	were	be	VBD
cord-003926-ycdaw2vh	124	15	debated	debate	VBN
cord-003926-ycdaw2vh	124	16	in	in	IN
cord-003926-ycdaw2vh	124	17	detail	detail	NN
cord-003926-ycdaw2vh	124	18	in	in	IN
cord-003926-ycdaw2vh	124	19	late	late	JJ
cord-003926-ycdaw2vh	124	20	2016	2016	CD
cord-003926-ycdaw2vh	124	21	with	with	IN
cord-003926-ycdaw2vh	124	22	the	the	DT
cord-003926-ycdaw2vh	124	23	conclusion	conclusion	NN
cord-003926-ycdaw2vh	124	24	that	that	IN
cord-003926-ycdaw2vh	124	25	the	the	DT
cord-003926-ycdaw2vh	124	26	benefits	benefit	NNS
cord-003926-ycdaw2vh	124	27	of	of	IN
cord-003926-ycdaw2vh	124	28	a	a	DT
cord-003926-ycdaw2vh	124	29	human	human	JJ
cord-003926-ycdaw2vh	124	30	challenge	challenge	NN
cord-003926-ycdaw2vh	124	31	infection	infection	NN
cord-003926-ycdaw2vh	124	32	did	do	VBD
cord-003926-ycdaw2vh	124	33	not	not	RB
cord-003926-ycdaw2vh	124	34	outweigh	outweigh	VB
cord-003926-ycdaw2vh	124	35	the	the	DT
cord-003926-ycdaw2vh	124	36	risks	risk	NNS
cord-003926-ycdaw2vh	124	37	[	[	-LRB-
cord-003926-ycdaw2vh	124	38	55	55	CD
cord-003926-ycdaw2vh	124	39	]	]	-RRB-
cord-003926-ycdaw2vh	124	40	,	,	,
cord-003926-ycdaw2vh	124	41	however	however	RB
cord-003926-ycdaw2vh	124	42	,	,	,
cord-003926-ycdaw2vh	124	43	this	this	DT
cord-003926-ycdaw2vh	124	44	analysis	analysis	NN
cord-003926-ycdaw2vh	124	45	was	be	VBD
cord-003926-ycdaw2vh	124	46	performed	perform	VBN
cord-003926-ycdaw2vh	124	47	just	just	RB
cord-003926-ycdaw2vh	124	48	as	as	IN
cord-003926-ycdaw2vh	124	49	the	the	DT
cord-003926-ycdaw2vh	124	50	initial	initial	JJ
cord-003926-ycdaw2vh	124	51	epidemic	epidemic	NN
cord-003926-ycdaw2vh	124	52	wave	wave	NN
cord-003926-ycdaw2vh	124	53	in	in	IN
cord-003926-ycdaw2vh	124	54	the	the	DT
cord-003926-ycdaw2vh	124	55	Americas	Americas	NNPS
cord-003926-ycdaw2vh	124	56	was	be	VBD
cord-003926-ycdaw2vh	124	57	ending	end	VBG
cord-003926-ycdaw2vh	124	58	.	.	.
cord-003926-ycdaw2vh	125	1	The	the	DT
cord-003926-ycdaw2vh	125	2	group	group	NN
cord-003926-ycdaw2vh	125	3	published	publish	VBD
cord-003926-ycdaw2vh	125	4	a	a	DT
cord-003926-ycdaw2vh	125	5	follow	follow	NN
cord-003926-ycdaw2vh	125	6	-	-	HYPH
cord-003926-ycdaw2vh	125	7	up	up	NN
cord-003926-ycdaw2vh	125	8	in	in	IN
cord-003926-ycdaw2vh	125	9	2018	2018	CD
cord-003926-ycdaw2vh	125	10	[	[	-LRB-
cord-003926-ycdaw2vh	125	11	56	56	CD
cord-003926-ycdaw2vh	125	12	]	]	-RRB-
cord-003926-ycdaw2vh	125	13	.	.	.
cord-003926-ycdaw2vh	126	1	Despite	despite	IN
cord-003926-ycdaw2vh	126	2	the	the	DT
cord-003926-ycdaw2vh	126	3	recognition	recognition	NN
cord-003926-ycdaw2vh	126	4	that	that	IN
cord-003926-ycdaw2vh	126	5	conducting	conduct	VBG
cord-003926-ycdaw2vh	126	6	a	a	DT
cord-003926-ycdaw2vh	126	7	placebo	placebo	NN
cord-003926-ycdaw2vh	126	8	-	-	HYPH
cord-003926-ycdaw2vh	126	9	controlled	control	VBN
cord-003926-ycdaw2vh	126	10	vaccine	vaccine	NN
cord-003926-ycdaw2vh	126	11	trial	trial	NN
cord-003926-ycdaw2vh	126	12	had	have	VBD
cord-003926-ycdaw2vh	126	13	become	become	VBN
cord-003926-ycdaw2vh	126	14	significantly	significantly	RB
cord-003926-ycdaw2vh	126	15	more	more	RBR
cord-003926-ycdaw2vh	126	16	difficult	difficult	JJ
cord-003926-ycdaw2vh	126	17	due	due	IN
cord-003926-ycdaw2vh	126	18	to	to	IN
cord-003926-ycdaw2vh	126	19	declining	decline	VBG
cord-003926-ycdaw2vh	126	20	case	case	NN
cord-003926-ycdaw2vh	126	21	rates	rate	NNS
cord-003926-ycdaw2vh	126	22	,	,	,
cord-003926-ycdaw2vh	126	23	the	the	DT
cord-003926-ycdaw2vh	126	24	group	group	NN
cord-003926-ycdaw2vh	126	25	's	's	POS
cord-003926-ycdaw2vh	126	26	conclusion	conclusion	NN
cord-003926-ycdaw2vh	126	27	was	be	VBD
cord-003926-ycdaw2vh	126	28	essentially	essentially	RB
cord-003926-ycdaw2vh	126	29	unchanged	unchanged	JJ
cord-003926-ycdaw2vh	126	30	.	.	.
cord-003926-ycdaw2vh	127	1	To	to	TO
cord-003926-ycdaw2vh	127	2	address	address	VB
cord-003926-ycdaw2vh	127	3	safety	safety	NN
cord-003926-ycdaw2vh	127	4	concerns	concern	NNS
cord-003926-ycdaw2vh	127	5	,	,	,
cord-003926-ycdaw2vh	127	6	there	there	EX
cord-003926-ycdaw2vh	127	7	has	have	VBZ
cord-003926-ycdaw2vh	127	8	been	be	VBN
cord-003926-ycdaw2vh	127	9	work	work	NN
cord-003926-ycdaw2vh	127	10	to	to	TO
cord-003926-ycdaw2vh	127	11	develop	develop	VB
cord-003926-ycdaw2vh	127	12	attenuated	attenuated	JJ
cord-003926-ycdaw2vh	127	13	viral	viral	JJ
cord-003926-ycdaw2vh	127	14	strains	strain	NNS
cord-003926-ycdaw2vh	127	15	deleted	delete	VBN
cord-003926-ycdaw2vh	127	16	for	for	IN
cord-003926-ycdaw2vh	127	17	potential	potential	JJ
cord-003926-ycdaw2vh	127	18	neurotropic	neurotropic	JJ
cord-003926-ycdaw2vh	127	19	regions	region	NNS
cord-003926-ycdaw2vh	127	20	[	[	-LRB-
cord-003926-ycdaw2vh	127	21	57	57	CD
cord-003926-ycdaw2vh	127	22	]	]	-RRB-
cord-003926-ycdaw2vh	127	23	with	with	IN
cord-003926-ycdaw2vh	127	24	a	a	DT
cord-003926-ycdaw2vh	127	25	goal	goal	NN
cord-003926-ycdaw2vh	127	26	to	to	TO
cord-003926-ycdaw2vh	127	27	prevent	prevent	VB
cord-003926-ycdaw2vh	127	28	viremia	viremia	NN
cord-003926-ycdaw2vh	127	29	.	.	.
cord-003926-ycdaw2vh	128	1	Whether	whether	IN
cord-003926-ycdaw2vh	128	2	the	the	DT
cord-003926-ycdaw2vh	128	3	attenuated	attenuated	JJ
cord-003926-ycdaw2vh	128	4	viral	viral	JJ
cord-003926-ycdaw2vh	128	5	strain	strain	NN
cord-003926-ycdaw2vh	128	6	(	(	-LRB-
cord-003926-ycdaw2vh	128	7	rZIKV	rZIKV	NNP
cord-003926-ycdaw2vh	128	8	/	/	SYM
cord-003926-ycdaw2vh	128	9	D4∆30	D4∆30	NNP
cord-003926-ycdaw2vh	128	10	-	-	HYPH
cord-003926-ycdaw2vh	128	11	713	713	CD
cord-003926-ycdaw2vh	128	12	)	)	-RRB-
cord-003926-ycdaw2vh	128	13	being	be	VBG
cord-003926-ycdaw2vh	128	14	tested	test	VBN
cord-003926-ycdaw2vh	128	15	in	in	IN
cord-003926-ycdaw2vh	128	16	a	a	DT
cord-003926-ycdaw2vh	128	17	Phase	phase	NN
cord-003926-ycdaw2vh	128	18	I	-PRON-	PRP
cord-003926-ycdaw2vh	128	19	study	study	NN
cord-003926-ycdaw2vh	128	20	will	will	MD
cord-003926-ycdaw2vh	128	21	serve	serve	VB
cord-003926-ycdaw2vh	128	22	as	as	IN
cord-003926-ycdaw2vh	128	23	putative	putative	JJ
cord-003926-ycdaw2vh	128	24	challenge	challenge	NN
cord-003926-ycdaw2vh	128	25	strain	strain	NN
cord-003926-ycdaw2vh	128	26	is	be	VBZ
cord-003926-ycdaw2vh	128	27	as	as	RB
cord-003926-ycdaw2vh	128	28	yet	yet	RB
cord-003926-ycdaw2vh	128	29	undetermined	undetermined	JJ
cord-003926-ycdaw2vh	128	30	.	.	.
cord-003926-ycdaw2vh	129	1	In	in	IN
cord-003926-ycdaw2vh	129	2	summary	summary	NN
cord-003926-ycdaw2vh	129	3	,	,	,
cord-003926-ycdaw2vh	129	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	129	5	vaccine	vaccine	NN
cord-003926-ycdaw2vh	129	6	development	development	NN
cord-003926-ycdaw2vh	129	7	continues	continue	VBZ
cord-003926-ycdaw2vh	129	8	with	with	IN
cord-003926-ycdaw2vh	129	9	multiple	multiple	JJ
cord-003926-ycdaw2vh	129	10	candidate	candidate	NN
cord-003926-ycdaw2vh	129	11	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	129	12	in	in	IN
cord-003926-ycdaw2vh	129	13	clinical	clinical	JJ
cord-003926-ycdaw2vh	129	14	trials	trial	NNS
cord-003926-ycdaw2vh	129	15	.	.	.
cord-003926-ycdaw2vh	130	1	Because	because	IN
cord-003926-ycdaw2vh	130	2	of	of	IN
cord-003926-ycdaw2vh	130	3	the	the	DT
cord-003926-ycdaw2vh	130	4	significant	significant	JJ
cord-003926-ycdaw2vh	130	5	decline	decline	NN
cord-003926-ycdaw2vh	130	6	in	in	IN
cord-003926-ycdaw2vh	130	7	incidence	incidence	NN
cord-003926-ycdaw2vh	130	8	,	,	,
cord-003926-ycdaw2vh	130	9	evaluation	evaluation	NN
cord-003926-ycdaw2vh	130	10	of	of	IN
cord-003926-ycdaw2vh	130	11	vaccine	vaccine	NN
cord-003926-ycdaw2vh	130	12	efficacy	efficacy	NN
cord-003926-ycdaw2vh	130	13	is	be	VBZ
cord-003926-ycdaw2vh	130	14	increasingly	increasingly	RB
cord-003926-ycdaw2vh	130	15	difficult	difficult	JJ
cord-003926-ycdaw2vh	130	16	.	.	.
cord-003926-ycdaw2vh	131	1	There	there	EX
cord-003926-ycdaw2vh	131	2	has	have	VBZ
cord-003926-ycdaw2vh	131	3	been	be	VBN
cord-003926-ycdaw2vh	131	4	renewed	renew	VBN
cord-003926-ycdaw2vh	131	5	interest	interest	NN
cord-003926-ycdaw2vh	131	6	in	in	IN
cord-003926-ycdaw2vh	131	7	animal	animal	NN
cord-003926-ycdaw2vh	131	8	model	model	NN
cord-003926-ycdaw2vh	131	9	and	and	CC
cord-003926-ycdaw2vh	131	10	human	human	JJ
cord-003926-ycdaw2vh	131	11	infection	infection	NN
cord-003926-ycdaw2vh	131	12	models	model	NNS
cord-003926-ycdaw2vh	131	13	of	of	IN
cord-003926-ycdaw2vh	131	14	infection	infection	NN
cord-003926-ycdaw2vh	131	15	.	.	.
cord-003926-ycdaw2vh	131	16	 	 	_SP
cord-003926-ycdaw2vh	132	1	The	the	DT
cord-003926-ycdaw2vh	132	2	author	author	NN
cord-003926-ycdaw2vh	132	3	is	be	VBZ
cord-003926-ycdaw2vh	132	4	an	an	DT
cord-003926-ycdaw2vh	132	5	employee	employee	NN
cord-003926-ycdaw2vh	132	6	of	of	IN
cord-003926-ycdaw2vh	132	7	GeneOne	GeneOne	NNP
cord-003926-ycdaw2vh	132	8	Life	Life	NNP
cord-003926-ycdaw2vh	132	9	Science	Science	NNP
cord-003926-ycdaw2vh	132	10	,	,	,
cord-003926-ycdaw2vh	132	11	Inc.	Inc.	NNP
cord-003926-ycdaw2vh	132	12	,	,	,
cord-003926-ycdaw2vh	132	13	a	a	DT
cord-003926-ycdaw2vh	132	14	developer	developer	NN
cord-003926-ycdaw2vh	132	15	of	of	IN
cord-003926-ycdaw2vh	132	16	DNA	dna	NN
cord-003926-ycdaw2vh	132	17	-	-	HYPH
cord-003926-ycdaw2vh	132	18	based	base	VBN
cord-003926-ycdaw2vh	132	19	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	132	20	including	include	VBG
cord-003926-ycdaw2vh	132	21	a	a	DT
cord-003926-ycdaw2vh	132	22	vaccine	vaccine	NN
cord-003926-ycdaw2vh	132	23	against	against	IN
cord-003926-ycdaw2vh	132	24	the	the	DT
cord-003926-ycdaw2vh	132	25	Zika	Zika	NNP
cord-003926-ycdaw2vh	132	26	virus	virus	NN
cord-003926-ycdaw2vh	132	27	.	.	.
cord-003926-ycdaw2vh	133	1	Walter	Walter	NNP
cord-003926-ycdaw2vh	133	2	Reed	Reed	NNP
cord-003926-ycdaw2vh	133	3	Army	Army	NNP
cord-003926-ycdaw2vh	133	4	Institute	Institute	NNP
cord-003926-ycdaw2vh	133	5	of	of	IN
cord-003926-ycdaw2vh	133	6	Research	Research	NNP
cord-003926-ycdaw2vh	133	7	NIAID	NIAID	NNP
cord-003926-ycdaw2vh	133	8	National	National	NNP
cord-003926-ycdaw2vh	133	9	Institutes	Institutes	NNPS
cord-003926-ycdaw2vh	133	10	of	of	IN
cord-003926-ycdaw2vh	133	11	Allergy	Allergy	NNP
cord-003926-ycdaw2vh	133	12	and	and	CC
cord-003926-ycdaw2vh	133	13	Infectious	Infectious	NNP
cord-003926-ycdaw2vh	133	14	Disease	Disease	NNP
cord-003926-ycdaw2vh	134	1	VRC	VRC	NNP
cord-003926-ycdaw2vh	134	2	Vaccine	Vaccine	NNP
cord-003926-ycdaw2vh	134	3	Research	Research	NNP
cord-003926-ycdaw2vh	134	4	Center	Center	NNP
cord-003926-ycdaw2vh	134	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	134	6	virus	virus	NN
cord-003926-ycdaw2vh	134	7	:	:	:
cord-003926-ycdaw2vh	134	8	(	(	-LRB-
cord-003926-ycdaw2vh	134	9	I	i	NN
cord-003926-ycdaw2vh	134	10	)	)	-RRB-
cord-003926-ycdaw2vh	134	11	.	.	.
cord-003926-ycdaw2vh	135	1	Isolations	isolation	NNS
cord-003926-ycdaw2vh	135	2	and	and	CC
cord-003926-ycdaw2vh	135	3	serological	serological	JJ
cord-003926-ycdaw2vh	135	4	specificity	specificity	NN
cord-003926-ycdaw2vh	135	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	135	6	virus	virus	NN
cord-003926-ycdaw2vh	135	7	:	:	:
cord-003926-ycdaw2vh	135	8	Following	follow	VBG
cord-003926-ycdaw2vh	135	9	the	the	DT
cord-003926-ycdaw2vh	135	10	path	path	NN
cord-003926-ycdaw2vh	135	11	of	of	IN
cord-003926-ycdaw2vh	135	12	dengue	dengue	NN
cord-003926-ycdaw2vh	135	13	and	and	CC
cord-003926-ycdaw2vh	135	14	chikungunya	chikungunya	NN
cord-003926-ycdaw2vh	135	15	?	?	.
cord-003926-ycdaw2vh	136	1	Lancet	Lancet	NNP
cord-003926-ycdaw2vh	136	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	136	3	virus	virus	NN
cord-003926-ycdaw2vh	136	4	outbreak	outbreak	NN
cord-003926-ycdaw2vh	136	5	on	on	IN
cord-003926-ycdaw2vh	136	6	Yap	Yap	NNP
cord-003926-ycdaw2vh	136	7	Island	Island	NNP
cord-003926-ycdaw2vh	136	8	,	,	,
cord-003926-ycdaw2vh	136	9	Federated	Federated	NNP
cord-003926-ycdaw2vh	136	10	States	States	NNP
cord-003926-ycdaw2vh	136	11	of	of	IN
cord-003926-ycdaw2vh	136	12	Micronesia	Micronesia	NNP
cord-003926-ycdaw2vh	136	13	European	European	NNP
cord-003926-ycdaw2vh	136	14	Centre	Centre	NNP
cord-003926-ycdaw2vh	136	15	for	for	IN
cord-003926-ycdaw2vh	136	16	Disease	Disease	NNP
cord-003926-ycdaw2vh	136	17	Prevention	Prevention	NNP
cord-003926-ycdaw2vh	136	18	and	and	CC
cord-003926-ycdaw2vh	136	19	Control	Control	NNP
cord-003926-ycdaw2vh	136	20	.	.	.
cord-003926-ycdaw2vh	137	1	Rapid	rapid	JJ
cord-003926-ycdaw2vh	137	2	risk	risk	NN
cord-003926-ycdaw2vh	137	3	assessment	assessment	NN
cord-003926-ycdaw2vh	137	4	:	:	:
cord-003926-ycdaw2vh	138	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	138	2	virus	virus	NN
cord-003926-ycdaw2vh	138	3	infection	infection	NN
cord-003926-ycdaw2vh	138	4	outbreak	outbreak	NN
cord-003926-ycdaw2vh	138	5	,	,	,
cord-003926-ycdaw2vh	138	6	French	French	NNP
cord-003926-ycdaw2vh	138	7	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	138	8	Zika	Zika	NNP
cord-003926-ycdaw2vh	138	9	virus	virus	NN
cord-003926-ycdaw2vh	138	10	in	in	IN
cord-003926-ycdaw2vh	138	11	the	the	DT
cord-003926-ycdaw2vh	138	12	Americas-	Americas-	NNP
cord-003926-ycdaw2vh	139	1	Yet	yet	RB
cord-003926-ycdaw2vh	139	2	another	another	DT
cord-003926-ycdaw2vh	139	3	arbovirus	arbovirus	NN
cord-003926-ycdaw2vh	139	4	threat	threat	NN
cord-003926-ycdaw2vh	139	5	Steep	Steep	NNP
cord-003926-ycdaw2vh	139	6	drop	drop	NN
cord-003926-ycdaw2vh	139	7	in	in	IN
cord-003926-ycdaw2vh	139	8	Zika	Zika	NNP
cord-003926-ycdaw2vh	139	9	cases	case	NNS
cord-003926-ycdaw2vh	139	10	undermines	undermine	VBZ
cord-003926-ycdaw2vh	139	11	vaccine	vaccine	NN
cord-003926-ycdaw2vh	139	12	trial	trial	NN
cord-003926-ycdaw2vh	139	13	Demonstrating	demonstrate	VBG
cord-003926-ycdaw2vh	139	14	vaccine	vaccine	NN
cord-003926-ycdaw2vh	139	15	effectiveness	effectiveness	NN
cord-003926-ycdaw2vh	139	16	during	during	IN
cord-003926-ycdaw2vh	139	17	a	a	DT
cord-003926-ycdaw2vh	139	18	waning	wane	VBG
cord-003926-ycdaw2vh	139	19	epidemic	epidemic	NN
cord-003926-ycdaw2vh	139	20	:	:	:
cord-003926-ycdaw2vh	140	1	A	a	DT
cord-003926-ycdaw2vh	140	2	WHO	WHO	NNP
cord-003926-ycdaw2vh	140	3	/	/	SYM
cord-003926-ycdaw2vh	140	4	NIH	NIH	NNP
cord-003926-ycdaw2vh	140	5	meeting	meeting	NN
cord-003926-ycdaw2vh	140	6	report	report	NN
cord-003926-ycdaw2vh	140	7	on	on	IN
cord-003926-ycdaw2vh	140	8	approaches	approach	NNS
cord-003926-ycdaw2vh	140	9	to	to	IN
cord-003926-ycdaw2vh	140	10	development	development	NN
cord-003926-ycdaw2vh	140	11	and	and	CC
cord-003926-ycdaw2vh	140	12	licensure	licensure	NN
cord-003926-ycdaw2vh	140	13	of	of	IN
cord-003926-ycdaw2vh	140	14	Zika	Zika	NNP
cord-003926-ycdaw2vh	140	15	vaccine	vaccine	NN
cord-003926-ycdaw2vh	140	16	candidates	candidate	NNS
cord-003926-ycdaw2vh	140	17	Bilan	Bilan	NNP
cord-003926-ycdaw2vh	140	18	de	de	NNP
cord-003926-ycdaw2vh	140	19	l'épidémie	l'épidémie	NNP
cord-003926-ycdaw2vh	140	20	à	à	,
cord-003926-ycdaw2vh	140	21	virus	virus	NN
cord-003926-ycdaw2vh	140	22	Zika	Zika	NNP
cord-003926-ycdaw2vh	140	23	survenue	survenue	NNP
cord-003926-ycdaw2vh	140	24	en	en	IN
cord-003926-ycdaw2vh	140	25	Polynésie	Polynésie	NNP
cord-003926-ycdaw2vh	140	26	française	française	NNP
cord-003926-ycdaw2vh	140	27	entre	entre	FW
cord-003926-ycdaw2vh	140	28	octobre	octobre	NNP
cord-003926-ycdaw2vh	140	29	2013	2013	CD
cord-003926-ycdaw2vh	141	1	et	et	NNP
cord-003926-ycdaw2vh	141	2	mars	mars	NNP
cord-003926-ycdaw2vh	141	3	2014	2014	CD
cord-003926-ycdaw2vh	141	4	.	.	.
cord-003926-ycdaw2vh	142	1	De	De	NNP
cord-003926-ycdaw2vh	142	2	la	la	NNP
cord-003926-ycdaw2vh	142	3	description	description	NN
cord-003926-ycdaw2vh	142	4	de	de	FW
cord-003926-ycdaw2vh	142	5	l'épidémie	l'épidémie	NNP
cord-003926-ycdaw2vh	142	6	aux	aux	NNP
cord-003926-ycdaw2vh	142	7	connaissances	connaissances	NNP
cord-003926-ycdaw2vh	142	8	acquises	acquises	NNP
cord-003926-ycdaw2vh	142	9	après	après	NNP
cord-003926-ycdaw2vh	142	10	l'évènement	l'évènement	NNP
cord-003926-ycdaw2vh	142	11	Potential	Potential	NNP
cord-003926-ycdaw2vh	142	12	for	for	IN
cord-003926-ycdaw2vh	142	13	Zika	Zika	NNP
cord-003926-ycdaw2vh	142	14	virus	virus	NN
cord-003926-ycdaw2vh	142	15	transmission	transmission	NN
cord-003926-ycdaw2vh	142	16	through	through	IN
cord-003926-ycdaw2vh	142	17	blood	blood	NN
cord-003926-ycdaw2vh	142	18	transfusion	transfusion	NN
cord-003926-ycdaw2vh	142	19	demonstrated	demonstrate	VBD
cord-003926-ycdaw2vh	142	20	during	during	IN
cord-003926-ycdaw2vh	142	21	an	an	DT
cord-003926-ycdaw2vh	142	22	outbreak	outbreak	NN
cord-003926-ycdaw2vh	142	23	in	in	IN
cord-003926-ycdaw2vh	142	24	French	French	NNP
cord-003926-ycdaw2vh	142	25	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	142	26	Zika	Zika	NNP
cord-003926-ycdaw2vh	142	27	virus	virus	NN
cord-003926-ycdaw2vh	142	28	seroprevalence	seroprevalence	NN
cord-003926-ycdaw2vh	142	29	Prevalence	prevalence	NN
cord-003926-ycdaw2vh	142	30	of	of	IN
cord-003926-ycdaw2vh	142	31	asymptomatic	asymptomatic	JJ
cord-003926-ycdaw2vh	142	32	Zika	Zika	NNP
cord-003926-ycdaw2vh	142	33	virus	virus	NN
cord-003926-ycdaw2vh	142	34	infection	infection	NN
cord-003926-ycdaw2vh	142	35	:	:	:
cord-003926-ycdaw2vh	142	36	A	a	DT
cord-003926-ycdaw2vh	142	37	systematic	systematic	JJ
cord-003926-ycdaw2vh	142	38	review	review	NN
cord-003926-ycdaw2vh	142	39	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	142	40	-	-	HYPH
cord-003926-ycdaw2vh	142	41	Barre	Barre	NNP
cord-003926-ycdaw2vh	142	42	Syndrome	Syndrome	NNP
cord-003926-ycdaw2vh	142	43	outbreak	outbreak	NN
cord-003926-ycdaw2vh	142	44	associated	associate	VBN
cord-003926-ycdaw2vh	142	45	with	with	IN
cord-003926-ycdaw2vh	142	46	Zika	Zika	NNP
cord-003926-ycdaw2vh	142	47	virus	virus	NN
cord-003926-ycdaw2vh	142	48	infection	infection	NN
cord-003926-ycdaw2vh	142	49	in	in	IN
cord-003926-ycdaw2vh	142	50	French	French	NNP
cord-003926-ycdaw2vh	142	51	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	142	52	:	:	:
cord-003926-ycdaw2vh	143	1	A	a	DT
cord-003926-ycdaw2vh	143	2	case	case	NN
cord-003926-ycdaw2vh	143	3	-	-	HYPH
cord-003926-ycdaw2vh	143	4	control	control	NN
cord-003926-ycdaw2vh	143	5	study	study	NN
cord-003926-ycdaw2vh	143	6	Zika	Zika	NNP
cord-003926-ycdaw2vh	143	7	virus	virus	NN
cord-003926-ycdaw2vh	143	8	infection	infection	NN
cord-003926-ycdaw2vh	143	9	and	and	CC
cord-003926-ycdaw2vh	143	10	risk	risk	NN
cord-003926-ycdaw2vh	143	11	of	of	IN
cord-003926-ycdaw2vh	143	12	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	143	13	-	-	HYPH
cord-003926-ycdaw2vh	143	14	Barre	Barre	NNP
cord-003926-ycdaw2vh	143	15	syndrome	syndrome	NN
cord-003926-ycdaw2vh	143	16	:	:	:
cord-003926-ycdaw2vh	143	17	A	a	DT
cord-003926-ycdaw2vh	143	18	meta	meta	JJ
cord-003926-ycdaw2vh	143	19	-	-	HYPH
cord-003926-ycdaw2vh	143	20	analysis	analysis	NN
cord-003926-ycdaw2vh	143	21	Leparc	Leparc	NNP
cord-003926-ycdaw2vh	143	22	-	-	HYPH
cord-003926-ycdaw2vh	143	23	Goffart	Goffart	NNP
cord-003926-ycdaw2vh	143	24	,	,	,
cord-003926-ycdaw2vh	143	25	I.	I.	NNP
cord-003926-ycdaw2vh	143	26	;	;	:
cord-003926-ycdaw2vh	143	27	et	et	NNP
cord-003926-ycdaw2vh	143	28	al	al	NNP
cord-003926-ycdaw2vh	143	29	.	.	.
cord-003926-ycdaw2vh	144	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	144	2	virus	virus	NN
cord-003926-ycdaw2vh	144	3	associated	associate	VBN
cord-003926-ycdaw2vh	144	4	with	with	IN
cord-003926-ycdaw2vh	144	5	meningoencephalitis	meningoencephalitis	NNP
cord-003926-ycdaw2vh	144	6	Congenital	congenital	JJ
cord-003926-ycdaw2vh	144	7	cerebral	cerebral	JJ
cord-003926-ycdaw2vh	144	8	malformations	malformation	NNS
cord-003926-ycdaw2vh	144	9	and	and	CC
cord-003926-ycdaw2vh	144	10	dysfunction	dysfunction	NN
cord-003926-ycdaw2vh	144	11	in	in	IN
cord-003926-ycdaw2vh	144	12	fetuses	fetus	NNS
cord-003926-ycdaw2vh	144	13	and	and	CC
cord-003926-ycdaw2vh	144	14	newborns	newborn	NNS
cord-003926-ycdaw2vh	144	15	following	follow	VBG
cord-003926-ycdaw2vh	144	16	the	the	DT
cord-003926-ycdaw2vh	144	17	2013	2013	CD
cord-003926-ycdaw2vh	144	18	to	to	IN
cord-003926-ycdaw2vh	144	19	2014	2014	CD
cord-003926-ycdaw2vh	144	20	Zika	Zika	NNP
cord-003926-ycdaw2vh	144	21	virus	virus	NN
cord-003926-ycdaw2vh	144	22	epidemic	epidemic	NN
cord-003926-ycdaw2vh	144	23	in	in	IN
cord-003926-ycdaw2vh	144	24	French	French	NNP
cord-003926-ycdaw2vh	144	25	Polynesia	Polynesia	NNP
cord-003926-ycdaw2vh	144	26	Zika	Zika	NNP
cord-003926-ycdaw2vh	144	27	virus	virus	NN
cord-003926-ycdaw2vh	144	28	infection	infection	NN
cord-003926-ycdaw2vh	144	29	in	in	IN
cord-003926-ycdaw2vh	144	30	pregnant	pregnant	JJ
cord-003926-ycdaw2vh	144	31	women	woman	NNS
cord-003926-ycdaw2vh	144	32	in	in	IN
cord-003926-ycdaw2vh	144	33	Rio	Rio	NNP
cord-003926-ycdaw2vh	144	34	de	de	NNP
cord-003926-ycdaw2vh	144	35	Janeiro	Janeiro	NNP
cord-003926-ycdaw2vh	144	36	European	European	NNP
cord-003926-ycdaw2vh	144	37	Centre	Centre	NNP
cord-003926-ycdaw2vh	144	38	for	for	IN
cord-003926-ycdaw2vh	144	39	Disease	Disease	NNP
cord-003926-ycdaw2vh	144	40	Prevention	Prevention	NNP
cord-003926-ycdaw2vh	144	41	and	and	CC
cord-003926-ycdaw2vh	144	42	Control	Control	NNP
cord-003926-ycdaw2vh	144	43	.	.	.
cord-003926-ycdaw2vh	145	1	Rapid	rapid	JJ
cord-003926-ycdaw2vh	145	2	risk	risk	NN
cord-003926-ycdaw2vh	145	3	assessment	assessment	NN
cord-003926-ycdaw2vh	145	4	:	:	:
cord-003926-ycdaw2vh	146	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	2	virus	virus	NN
cord-003926-ycdaw2vh	146	3	epidemic	epidemic	NN
cord-003926-ycdaw2vh	146	4	in	in	IN
cord-003926-ycdaw2vh	146	5	the	the	DT
cord-003926-ycdaw2vh	146	6	Americas	Americas	NNPS
cord-003926-ycdaw2vh	146	7	:	:	:
cord-003926-ycdaw2vh	146	8	Potential	potential	JJ
cord-003926-ycdaw2vh	146	9	association	association	NN
cord-003926-ycdaw2vh	146	10	with	with	IN
cord-003926-ycdaw2vh	146	11	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	146	12	and	and	CC
cord-003926-ycdaw2vh	146	13	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	146	14	-	-	HYPH
cord-003926-ycdaw2vh	146	15	Barre	Barre	NNP
cord-003926-ycdaw2vh	146	16	syndrome	syndrome	NN
cord-003926-ycdaw2vh	146	17	Birth	birth	NN
cord-003926-ycdaw2vh	146	18	defects	defect	NNS
cord-003926-ycdaw2vh	146	19	among	among	IN
cord-003926-ycdaw2vh	146	20	fetuses	fetus	NNS
cord-003926-ycdaw2vh	146	21	and	and	CC
cord-003926-ycdaw2vh	146	22	infants	infant	NNS
cord-003926-ycdaw2vh	146	23	of	of	IN
cord-003926-ycdaw2vh	146	24	US	US	NNP
cord-003926-ycdaw2vh	146	25	women	woman	NNS
cord-003926-ycdaw2vh	146	26	with	with	IN
cord-003926-ycdaw2vh	146	27	evidence	evidence	NN
cord-003926-ycdaw2vh	146	28	of	of	IN
cord-003926-ycdaw2vh	146	29	possible	possible	JJ
cord-003926-ycdaw2vh	146	30	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	31	virus	virus	NN
cord-003926-ycdaw2vh	146	32	infection	infection	NN
cord-003926-ycdaw2vh	146	33	during	during	IN
cord-003926-ycdaw2vh	146	34	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	146	35	Hearing	hear	VBG
cord-003926-ycdaw2vh	146	36	loss	loss	NN
cord-003926-ycdaw2vh	146	37	in	in	IN
cord-003926-ycdaw2vh	146	38	infants	infant	NNS
cord-003926-ycdaw2vh	146	39	with	with	IN
cord-003926-ycdaw2vh	146	40	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	146	41	and	and	CC
cord-003926-ycdaw2vh	146	42	evidence	evidence	NN
cord-003926-ycdaw2vh	146	43	of	of	IN
cord-003926-ycdaw2vh	146	44	congenital	congenital	JJ
cord-003926-ycdaw2vh	146	45	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	46	virus	virus	NN
cord-003926-ycdaw2vh	146	47	infection	infection	NN
cord-003926-ycdaw2vh	146	48	-	-	:
cord-003926-ycdaw2vh	146	49	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	146	50	Risk	risk	NN
cord-003926-ycdaw2vh	146	51	factors	factor	NNS
cord-003926-ycdaw2vh	146	52	associated	associate	VBN
cord-003926-ycdaw2vh	146	53	with	with	IN
cord-003926-ycdaw2vh	146	54	the	the	DT
cord-003926-ycdaw2vh	146	55	ophthalmoscopic	ophthalmoscopic	NNP
cord-003926-ycdaw2vh	146	56	findings	finding	NNS
cord-003926-ycdaw2vh	146	57	identifed	identife	VBN
cord-003926-ycdaw2vh	146	58	in	in	IN
cord-003926-ycdaw2vh	146	59	infants	infant	NNS
cord-003926-ycdaw2vh	146	60	with	with	IN
cord-003926-ycdaw2vh	146	61	presumed	presume	VBN
cord-003926-ycdaw2vh	146	62	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	63	virus	virus	NN
cord-003926-ycdaw2vh	146	64	congenital	congenital	JJ
cord-003926-ycdaw2vh	146	65	infection	infection	NN
cord-003926-ycdaw2vh	146	66	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	67	virus	virus	NN
cord-003926-ycdaw2vh	146	68	infection	infection	NN
cord-003926-ycdaw2vh	146	69	with	with	IN
cord-003926-ycdaw2vh	146	70	prolonged	prolong	VBN
cord-003926-ycdaw2vh	146	71	maternal	maternal	JJ
cord-003926-ycdaw2vh	146	72	viremia	viremia	NN
cord-003926-ycdaw2vh	146	73	and	and	CC
cord-003926-ycdaw2vh	146	74	fetal	fetal	JJ
cord-003926-ycdaw2vh	146	75	brain	brain	NN
cord-003926-ycdaw2vh	146	76	abnormalities	abnormality	NNS
cord-003926-ycdaw2vh	146	77	Prolonged	prolong	VBD
cord-003926-ycdaw2vh	146	78	detection	detection	NN
cord-003926-ycdaw2vh	146	79	of	of	IN
cord-003926-ycdaw2vh	146	80	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	81	virus	virus	NN
cord-003926-ycdaw2vh	146	82	RNA	RNA	NNP
cord-003926-ycdaw2vh	146	83	in	in	IN
cord-003926-ycdaw2vh	146	84	pregnant	pregnant	JJ
cord-003926-ycdaw2vh	146	85	women	woman	NNS
cord-003926-ycdaw2vh	146	86	Zika	Zika	NNP
cord-003926-ycdaw2vh	146	87	virus	virus	NN
cord-003926-ycdaw2vh	146	88	intrauterine	intrauterine	JJ
cord-003926-ycdaw2vh	146	89	infection	infection	NN
cord-003926-ycdaw2vh	146	90	causes	cause	VBZ
cord-003926-ycdaw2vh	146	91	fetal	fetal	JJ
cord-003926-ycdaw2vh	146	92	brain	brain	NN
cord-003926-ycdaw2vh	146	93	abnormality	abnormality	NN
cord-003926-ycdaw2vh	146	94	and	and	CC
cord-003926-ycdaw2vh	146	95	microcephaly	microcephaly	NNS
cord-003926-ycdaw2vh	146	96	:	:	:
cord-003926-ycdaw2vh	147	1	Tip	tip	NN
cord-003926-ycdaw2vh	147	2	of	of	IN
cord-003926-ycdaw2vh	147	3	the	the	DT
cord-003926-ycdaw2vh	147	4	iceberg	iceberg	NN
cord-003926-ycdaw2vh	147	5	?	?	.
cord-003926-ycdaw2vh	148	1	Probable	probable	JJ
cord-003926-ycdaw2vh	148	2	non	non	JJ
cord-003926-ycdaw2vh	148	3	-	-	JJ
cord-003926-ycdaw2vh	148	4	vector	vector	NN
cord-003926-ycdaw2vh	148	5	-	-	HYPH
cord-003926-ycdaw2vh	148	6	borne	bear	VBN
cord-003926-ycdaw2vh	148	7	transmission	transmission	NN
cord-003926-ycdaw2vh	148	8	of	of	IN
cord-003926-ycdaw2vh	148	9	Zika	Zika	NNP
cord-003926-ycdaw2vh	148	10	virus	virus	NN
cord-003926-ycdaw2vh	148	11	Frequent	Frequent	NNP
cord-003926-ycdaw2vh	148	12	Zika	Zika	NNP
cord-003926-ycdaw2vh	148	13	virus	virus	NN
cord-003926-ycdaw2vh	148	14	sexual	sexual	JJ
cord-003926-ycdaw2vh	148	15	transmission	transmission	NN
cord-003926-ycdaw2vh	148	16	and	and	CC
cord-003926-ycdaw2vh	148	17	prolonged	prolong	VBN
cord-003926-ycdaw2vh	148	18	viral	viral	JJ
cord-003926-ycdaw2vh	148	19	RNA	rna	NN
cord-003926-ycdaw2vh	148	20	shedding	shed	VBG
cord-003926-ycdaw2vh	148	21	in	in	IN
cord-003926-ycdaw2vh	148	22	an	an	DT
cord-003926-ycdaw2vh	148	23	immunodeficient	immunodeficient	JJ
cord-003926-ycdaw2vh	148	24	mouse	mouse	NN
cord-003926-ycdaw2vh	148	25	model	model	NN
cord-003926-ycdaw2vh	148	26	Zika	Zika	NNP
cord-003926-ycdaw2vh	148	27	virus	virus	NN
cord-003926-ycdaw2vh	148	28	shedding	shed	VBG
cord-003926-ycdaw2vh	148	29	in	in	IN
cord-003926-ycdaw2vh	148	30	semen	semen	NN
cord-003926-ycdaw2vh	148	31	of	of	IN
cord-003926-ycdaw2vh	148	32	symptomatic	symptomatic	JJ
cord-003926-ycdaw2vh	148	33	infected	infected	JJ
cord-003926-ycdaw2vh	148	34	men	man	NNS
cord-003926-ycdaw2vh	148	35	Zika	Zika	NNP
cord-003926-ycdaw2vh	148	36	-	-	HYPH
cord-003926-ycdaw2vh	148	37	induced	induce	VBN
cord-003926-ycdaw2vh	148	38	male	male	JJ
cord-003926-ycdaw2vh	148	39	infertility	infertility	NN
cord-003926-ycdaw2vh	148	40	in	in	IN
cord-003926-ycdaw2vh	148	41	mice	mice	NN
cord-003926-ycdaw2vh	148	42	Is	be	VBZ
cord-003926-ycdaw2vh	148	43	potentially	potentially	RB
cord-003926-ycdaw2vh	148	44	reversible	reversible	JJ
cord-003926-ycdaw2vh	148	45	and	and	CC
cord-003926-ycdaw2vh	148	46	preventable	preventable	JJ
cord-003926-ycdaw2vh	148	47	by	by	IN
cord-003926-ycdaw2vh	148	48	deoxyribonucleic	deoxyribonucleic	NN
cord-003926-ycdaw2vh	148	49	acid	acid	NN
cord-003926-ycdaw2vh	148	50	immunization	immunization	NN
cord-003926-ycdaw2vh	148	51	Zika	Zika	NNP
cord-003926-ycdaw2vh	148	52	virus	virus	NN
cord-003926-ycdaw2vh	148	53	infection	infection	NN
cord-003926-ycdaw2vh	148	54	damages	damage	VBZ
cord-003926-ycdaw2vh	148	55	the	the	DT
cord-003926-ycdaw2vh	148	56	testes	testis	NNS
cord-003926-ycdaw2vh	148	57	in	in	IN
cord-003926-ycdaw2vh	148	58	mice	mouse	NNS
cord-003926-ycdaw2vh	148	59	DNA	dna	NN
cord-003926-ycdaw2vh	148	60	vaccination	vaccination	NN
cord-003926-ycdaw2vh	148	61	protects	protect	VBZ
cord-003926-ycdaw2vh	148	62	mice	mouse	NNS
cord-003926-ycdaw2vh	148	63	against	against	IN
cord-003926-ycdaw2vh	148	64	Zika	Zika	NNP
cord-003926-ycdaw2vh	148	65	virus	virus	NN
cord-003926-ycdaw2vh	148	66	-	-	HYPH
cord-003926-ycdaw2vh	148	67	induced	induce	VBN
cord-003926-ycdaw2vh	148	68	damage	damage	NN
cord-003926-ycdaw2vh	148	69	to	to	IN
cord-003926-ycdaw2vh	148	70	the	the	DT
cord-003926-ycdaw2vh	148	71	testes	testis	NNS
cord-003926-ycdaw2vh	149	1	Prolonged	prolonged	JJ
cord-003926-ycdaw2vh	149	2	shedding	shedding	NN
cord-003926-ycdaw2vh	149	3	of	of	IN
cord-003926-ycdaw2vh	149	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	149	5	virus	virus	NN
cord-003926-ycdaw2vh	149	6	RNA	RNA	NNP
cord-003926-ycdaw2vh	149	7	in	in	IN
cord-003926-ycdaw2vh	149	8	vaginal	vaginal	JJ
cord-003926-ycdaw2vh	149	9	secretions	secretion	NNS
cord-003926-ycdaw2vh	150	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	150	2	virus	virus	NN
cord-003926-ycdaw2vh	150	3	causes	cause	VBZ
cord-003926-ycdaw2vh	150	4	acute	acute	JJ
cord-003926-ycdaw2vh	150	5	infection	infection	NN
cord-003926-ycdaw2vh	150	6	and	and	CC
cord-003926-ycdaw2vh	150	7	inflammation	inflammation	NN
cord-003926-ycdaw2vh	150	8	in	in	IN
cord-003926-ycdaw2vh	150	9	the	the	DT
cord-003926-ycdaw2vh	150	10	ovary	ovary	NN
cord-003926-ycdaw2vh	150	11	of	of	IN
cord-003926-ycdaw2vh	150	12	mice	mouse	NNS
cord-003926-ycdaw2vh	150	13	without	without	IN
cord-003926-ycdaw2vh	150	14	apparent	apparent	JJ
cord-003926-ycdaw2vh	150	15	defects	defect	NNS
cord-003926-ycdaw2vh	150	16	in	in	IN
cord-003926-ycdaw2vh	150	17	fertility	fertility	NN
cord-003926-ycdaw2vh	150	18	Zika	Zika	NNP
cord-003926-ycdaw2vh	150	19	virus	virus	NN
cord-003926-ycdaw2vh	150	20	persistence	persistence	NN
cord-003926-ycdaw2vh	150	21	in	in	IN
cord-003926-ycdaw2vh	150	22	the	the	DT
cord-003926-ycdaw2vh	150	23	central	central	JJ
cord-003926-ycdaw2vh	150	24	nervous	nervous	JJ
cord-003926-ycdaw2vh	150	25	system	system	NN
cord-003926-ycdaw2vh	150	26	and	and	CC
cord-003926-ycdaw2vh	150	27	lymph	lymph	NN
cord-003926-ycdaw2vh	150	28	nodes	node	NNS
cord-003926-ycdaw2vh	150	29	of	of	IN
cord-003926-ycdaw2vh	150	30	rhesus	rhesu	NNS
cord-003926-ycdaw2vh	150	31	monkeys	monkey	NNS
cord-003926-ycdaw2vh	150	32	Vaccine	Vaccine	NNP
cord-003926-ycdaw2vh	150	33	development	development	NN
cord-003926-ycdaw2vh	150	34	for	for	IN
cord-003926-ycdaw2vh	150	35	emerging	emerge	VBG
cord-003926-ycdaw2vh	150	36	virulent	virulent	JJ
cord-003926-ycdaw2vh	150	37	infectious	infectious	JJ
cord-003926-ycdaw2vh	150	38	diseases	disease	NNS
cord-003926-ycdaw2vh	150	39	Pan	Pan	NNP
cord-003926-ycdaw2vh	150	40	American	American	NNP
cord-003926-ycdaw2vh	150	41	Health	Health	NNP
cord-003926-ycdaw2vh	150	42	Organization	Organization	NNP
cord-003926-ycdaw2vh	150	43	/	/	SYM
cord-003926-ycdaw2vh	150	44	World	World	NNP
cord-003926-ycdaw2vh	150	45	Health	Health	NNP
cord-003926-ycdaw2vh	150	46	Organization	Organization	NNP
cord-003926-ycdaw2vh	150	47	.	.	.
cord-003926-ycdaw2vh	151	1	Zika	Zika	NNP
cord-003926-ycdaw2vh	151	2	-	-	HYPH
cord-003926-ycdaw2vh	151	3	Epidemiologic	Epidemiologic	NNP
cord-003926-ycdaw2vh	151	4	Report	Report	NNP
cord-003926-ycdaw2vh	152	1	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	152	2	Comparison	Comparison	NNP
cord-003926-ycdaw2vh	152	3	by	by	IN
cord-003926-ycdaw2vh	152	4	electron	electron	NN
cord-003926-ycdaw2vh	152	5	microscopy	microscopy	NNS
cord-003926-ycdaw2vh	152	6	of	of	IN
cord-003926-ycdaw2vh	152	7	the	the	DT
cord-003926-ycdaw2vh	152	8	Ntaya	Ntaya	NNP
cord-003926-ycdaw2vh	152	9	and	and	CC
cord-003926-ycdaw2vh	152	10	Zika	Zika	NNP
cord-003926-ycdaw2vh	152	11	viruses	virus	NNS
cord-003926-ycdaw2vh	152	12	Development	Development	NNP
cord-003926-ycdaw2vh	152	13	of	of	IN
cord-003926-ycdaw2vh	152	14	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	152	15	against	against	IN
cord-003926-ycdaw2vh	152	16	Zika	Zika	NNP
cord-003926-ycdaw2vh	152	17	virus	virus	NN
cord-003926-ycdaw2vh	152	18	Zika	Zika	NNP
cord-003926-ycdaw2vh	152	19	virus	virus	NN
cord-003926-ycdaw2vh	152	20	vaccine	vaccine	NN
cord-003926-ycdaw2vh	152	21	development	development	NN
cord-003926-ycdaw2vh	152	22	:	:	:
cord-003926-ycdaw2vh	153	1	Progress	progress	VB
cord-003926-ycdaw2vh	153	2	in	in	IN
cord-003926-ycdaw2vh	153	3	the	the	DT
cord-003926-ycdaw2vh	153	4	face	face	NN
cord-003926-ycdaw2vh	153	5	of	of	IN
cord-003926-ycdaw2vh	153	6	new	new	JJ
cord-003926-ycdaw2vh	153	7	challenges	challenge	NNS
cord-003926-ycdaw2vh	154	1	Vaccines	vaccine	NNS
cord-003926-ycdaw2vh	154	2	for	for	IN
cord-003926-ycdaw2vh	154	3	emerging	emerge	VBG
cord-003926-ycdaw2vh	154	4	infectious	infectious	JJ
cord-003926-ycdaw2vh	154	5	diseases	disease	NNS
cord-003926-ycdaw2vh	154	6	:	:	:
cord-003926-ycdaw2vh	154	7	Lessonso	Lessonso	NNS
cord-003926-ycdaw2vh	154	8	from	from	IN
cord-003926-ycdaw2vh	154	9	MERS	MERS	NNP
cord-003926-ycdaw2vh	154	10	coronavirus	coronavirus	NN
cord-003926-ycdaw2vh	154	11	and	and	CC
cord-003926-ycdaw2vh	154	12	Zika	Zika	NNP
cord-003926-ycdaw2vh	154	13	virus	virus	NN
cord-003926-ycdaw2vh	155	1	An	an	DT
cord-003926-ycdaw2vh	155	2	update	update	NN
cord-003926-ycdaw2vh	155	3	on	on	IN
cord-003926-ycdaw2vh	155	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	155	5	vaccine	vaccine	NN
cord-003926-ycdaw2vh	155	6	developments	development	NNS
cord-003926-ycdaw2vh	155	7	.	.	.
cord-003926-ycdaw2vh	156	1	Expert	Expert	NNP
cord-003926-ycdaw2vh	156	2	Rev	Rev	NNP
cord-003926-ycdaw2vh	156	3	Safety	Safety	NNP
cord-003926-ycdaw2vh	156	4	,	,	,
cord-003926-ycdaw2vh	156	5	tolerability	tolerability	NN
cord-003926-ycdaw2vh	156	6	,	,	,
cord-003926-ycdaw2vh	156	7	and	and	CC
cord-003926-ycdaw2vh	156	8	immunogenicity	immunogenicity	NN
cord-003926-ycdaw2vh	156	9	of	of	IN
cord-003926-ycdaw2vh	156	10	two	two	CD
cord-003926-ycdaw2vh	156	11	Zika	Zika	NNP
cord-003926-ycdaw2vh	156	12	virus	virus	NN
cord-003926-ycdaw2vh	156	13	DNA	dna	NN
cord-003926-ycdaw2vh	156	14	vaccine	vaccine	NN
cord-003926-ycdaw2vh	156	15	candidates	candidate	NNS
cord-003926-ycdaw2vh	156	16	in	in	IN
cord-003926-ycdaw2vh	156	17	healthy	healthy	JJ
cord-003926-ycdaw2vh	156	18	adults	adult	NNS
cord-003926-ycdaw2vh	156	19	:	:	:
cord-003926-ycdaw2vh	156	20	Randomised	randomised	JJ
cord-003926-ycdaw2vh	156	21	,	,	,
cord-003926-ycdaw2vh	156	22	open	open	JJ
cord-003926-ycdaw2vh	156	23	-	-	HYPH
cord-003926-ycdaw2vh	156	24	label	label	NN
cord-003926-ycdaw2vh	156	25	,	,	,
cord-003926-ycdaw2vh	156	26	phase	phase	NN
cord-003926-ycdaw2vh	156	27	1	1	CD
cord-003926-ycdaw2vh	156	28	clinical	clinical	JJ
cord-003926-ycdaw2vh	156	29	trials	trial	NNS
cord-003926-ycdaw2vh	156	30	Safety	safety	NN
cord-003926-ycdaw2vh	156	31	and	and	CC
cord-003926-ycdaw2vh	156	32	immunogenicity	immunogenicity	NN
cord-003926-ycdaw2vh	156	33	of	of	IN
cord-003926-ycdaw2vh	156	34	an	an	DT
cord-003926-ycdaw2vh	156	35	anti	anti	JJ
cord-003926-ycdaw2vh	156	36	-	-	JJ
cord-003926-ycdaw2vh	156	37	Zika	zika	JJ
cord-003926-ycdaw2vh	156	38	virus	virus	NN
cord-003926-ycdaw2vh	156	39	DNA	dna	NN
cord-003926-ycdaw2vh	156	40	vaccine	vaccine	NN
cord-003926-ycdaw2vh	156	41	-	-	:
cord-003926-ycdaw2vh	156	42	Preliminary	Preliminary	NNP
cord-003926-ycdaw2vh	156	43	Report	Report	NNP
cord-003926-ycdaw2vh	157	1	In	in	IN
cord-003926-ycdaw2vh	157	2	vivo	vivo	NN
cord-003926-ycdaw2vh	157	3	protection	protection	NN
cord-003926-ycdaw2vh	157	4	against	against	IN
cord-003926-ycdaw2vh	157	5	ZIKV	ZIKV	NNP
cord-003926-ycdaw2vh	157	6	infection	infection	NN
cord-003926-ycdaw2vh	157	7	and	and	CC
cord-003926-ycdaw2vh	157	8	pathogenesis	pathogenesis	NN
cord-003926-ycdaw2vh	157	9	through	through	IN
cord-003926-ycdaw2vh	157	10	passive	passive	JJ
cord-003926-ycdaw2vh	157	11	antibody	antibody	NN
cord-003926-ycdaw2vh	157	12	transfer	transfer	NN
cord-003926-ycdaw2vh	157	13	and	and	CC
cord-003926-ycdaw2vh	157	14	active	active	JJ
cord-003926-ycdaw2vh	157	15	immunization	immunization	NN
cord-003926-ycdaw2vh	157	16	with	with	IN
cord-003926-ycdaw2vh	157	17	a	a	DT
cord-003926-ycdaw2vh	157	18	prMEnv	prmenv	JJ
cord-003926-ycdaw2vh	157	19	DNA	dna	NN
cord-003926-ycdaw2vh	157	20	vaccine	vaccine	NN
cord-003926-ycdaw2vh	157	21	Rapid	Rapid	NNP
cord-003926-ycdaw2vh	157	22	development	development	NN
cord-003926-ycdaw2vh	157	23	of	of	IN
cord-003926-ycdaw2vh	157	24	a	a	DT
cord-003926-ycdaw2vh	157	25	DNA	dna	NN
cord-003926-ycdaw2vh	157	26	vaccine	vaccine	NN
cord-003926-ycdaw2vh	157	27	for	for	IN
cord-003926-ycdaw2vh	157	28	Zika	Zika	NNP
cord-003926-ycdaw2vh	157	29	virus	virus	NN
cord-003926-ycdaw2vh	157	30	Preliminary	preliminary	JJ
cord-003926-ycdaw2vh	157	31	aggregate	aggregate	JJ
cord-003926-ycdaw2vh	157	32	safety	safety	NN
cord-003926-ycdaw2vh	157	33	and	and	CC
cord-003926-ycdaw2vh	157	34	immunogenicity	immunogenicity	NN
cord-003926-ycdaw2vh	157	35	results	result	NNS
cord-003926-ycdaw2vh	157	36	from	from	IN
cord-003926-ycdaw2vh	157	37	three	three	CD
cord-003926-ycdaw2vh	157	38	trials	trial	NNS
cord-003926-ycdaw2vh	157	39	of	of	IN
cord-003926-ycdaw2vh	157	40	a	a	DT
cord-003926-ycdaw2vh	157	41	purified	purify	VBN
cord-003926-ycdaw2vh	157	42	inactivated	inactivate	VBN
cord-003926-ycdaw2vh	157	43	Zika	Zika	NNP
cord-003926-ycdaw2vh	157	44	virus	virus	NN
cord-003926-ycdaw2vh	157	45	vaccine	vaccine	NN
cord-003926-ycdaw2vh	157	46	candidate	candidate	NN
cord-003926-ycdaw2vh	157	47	:	:	:
cord-003926-ycdaw2vh	157	48	Phase	phase	NN
cord-003926-ycdaw2vh	157	49	1	1	CD
cord-003926-ycdaw2vh	157	50	,	,	,
cord-003926-ycdaw2vh	157	51	randomised	randomised	JJ
cord-003926-ycdaw2vh	157	52	,	,	,
cord-003926-ycdaw2vh	157	53	double	double	JJ
cord-003926-ycdaw2vh	157	54	-	-	HYPH
cord-003926-ycdaw2vh	157	55	blind	blind	JJ
cord-003926-ycdaw2vh	157	56	,	,	,
cord-003926-ycdaw2vh	157	57	placebo	placebo	NN
cord-003926-ycdaw2vh	157	58	-	-	HYPH
cord-003926-ycdaw2vh	157	59	controlled	control	VBN
cord-003926-ycdaw2vh	157	60	clinical	clinical	JJ
cord-003926-ycdaw2vh	157	61	trials	trial	NNS
cord-003926-ycdaw2vh	157	62	Vaccine	Vaccine	NNP
cord-003926-ycdaw2vh	157	63	protection	protection	NN
cord-003926-ycdaw2vh	157	64	against	against	IN
cord-003926-ycdaw2vh	157	65	Zika	Zika	NNP
cord-003926-ycdaw2vh	157	66	virus	virus	NN
cord-003926-ycdaw2vh	157	67	from	from	IN
cord-003926-ycdaw2vh	157	68	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	157	69	Protective	protective	JJ
cord-003926-ycdaw2vh	157	70	efficacy	efficacy	NN
cord-003926-ycdaw2vh	157	71	of	of	IN
cord-003926-ycdaw2vh	157	72	multiple	multiple	JJ
cord-003926-ycdaw2vh	157	73	vaccine	vaccine	NN
cord-003926-ycdaw2vh	157	74	platforms	platform	NNS
cord-003926-ycdaw2vh	157	75	against	against	IN
cord-003926-ycdaw2vh	157	76	Zika	Zika	NNP
cord-003926-ycdaw2vh	157	77	virus	virus	NN
cord-003926-ycdaw2vh	157	78	challenge	challenge	NN
cord-003926-ycdaw2vh	157	79	in	in	IN
cord-003926-ycdaw2vh	157	80	rhesus	rhesu	NNS
cord-003926-ycdaw2vh	157	81	monkeys	monkey	NNS
cord-003926-ycdaw2vh	158	1	Modified	modify	VBN
cord-003926-ycdaw2vh	158	2	mRNA	mrna	NN
cord-003926-ycdaw2vh	159	1	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	159	2	protect	protect	VBP
cord-003926-ycdaw2vh	159	3	against	against	IN
cord-003926-ycdaw2vh	159	4	Zika	Zika	NNP
cord-003926-ycdaw2vh	159	5	virus	virus	NN
cord-003926-ycdaw2vh	159	6	infection	infection	NN
cord-003926-ycdaw2vh	159	7	Purified	purify	VBN
cord-003926-ycdaw2vh	160	1	inactivated	inactivate	VBN
cord-003926-ycdaw2vh	160	2	Zika	Zika	NNP
cord-003926-ycdaw2vh	160	3	vaccine	vaccine	NN
cord-003926-ycdaw2vh	160	4	candidates	candidate	NNS
cord-003926-ycdaw2vh	160	5	afford	afford	VBP
cord-003926-ycdaw2vh	160	6	protection	protection	NN
cord-003926-ycdaw2vh	160	7	against	against	IN
cord-003926-ycdaw2vh	160	8	lethal	lethal	JJ
cord-003926-ycdaw2vh	160	9	challenge	challenge	NN
cord-003926-ycdaw2vh	160	10	in	in	IN
cord-003926-ycdaw2vh	160	11	mice	mouse	NNS
cord-003926-ycdaw2vh	161	1	A	a	DT
cord-003926-ycdaw2vh	161	2	measles	measles	NN
cord-003926-ycdaw2vh	161	3	virus	virus	NN
cord-003926-ycdaw2vh	161	4	-	-	HYPH
cord-003926-ycdaw2vh	161	5	based	base	VBN
cord-003926-ycdaw2vh	161	6	vaccine	vaccine	NN
cord-003926-ycdaw2vh	161	7	candidate	candidate	NN
cord-003926-ycdaw2vh	161	8	mediates	mediate	VBZ
cord-003926-ycdaw2vh	161	9	protection	protection	NN
cord-003926-ycdaw2vh	161	10	against	against	IN
cord-003926-ycdaw2vh	161	11	Zika	Zika	NNP
cord-003926-ycdaw2vh	161	12	virus	virus	NN
cord-003926-ycdaw2vh	161	13	in	in	IN
cord-003926-ycdaw2vh	161	14	an	an	DT
cord-003926-ycdaw2vh	161	15	allogeneic	allogeneic	NN
cord-003926-ycdaw2vh	161	16	mouse	mouse	NN
cord-003926-ycdaw2vh	161	17	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	161	18	model	model	NN
cord-003926-ycdaw2vh	161	19	Animal	Animal	NNP
cord-003926-ycdaw2vh	161	20	models	model	NNS
cord-003926-ycdaw2vh	161	21	of	of	IN
cord-003926-ycdaw2vh	161	22	Zika	Zika	NNP
cord-003926-ycdaw2vh	161	23	virus	virus	NN
cord-003926-ycdaw2vh	161	24	infection	infection	NN
cord-003926-ycdaw2vh	161	25	,	,	,
cord-003926-ycdaw2vh	162	1	pathogenesis	pathogenesis	NN
cord-003926-ycdaw2vh	162	2	,	,	,
cord-003926-ycdaw2vh	162	3	and	and	CC
cord-003926-ycdaw2vh	162	4	immunity	immunity	NN
cord-003926-ycdaw2vh	162	5	Zika	Zika	NNP
cord-003926-ycdaw2vh	162	6	virus	virus	NN
cord-003926-ycdaw2vh	162	7	infection	infection	NN
cord-003926-ycdaw2vh	162	8	during	during	IN
cord-003926-ycdaw2vh	162	9	pregnancy	pregnancy	NN
cord-003926-ycdaw2vh	162	10	in	in	IN
cord-003926-ycdaw2vh	162	11	mice	mouse	NNS
cord-003926-ycdaw2vh	162	12	causes	cause	VBZ
cord-003926-ycdaw2vh	162	13	placental	placental	JJ
cord-003926-ycdaw2vh	162	14	damage	damage	NN
cord-003926-ycdaw2vh	162	15	and	and	CC
cord-003926-ycdaw2vh	162	16	fetal	fetal	JJ
cord-003926-ycdaw2vh	162	17	demise	demise	NN
cord-003926-ycdaw2vh	163	1	Increased	increase	VBN
cord-003926-ycdaw2vh	163	2	hospitalizations	hospitalization	NNS
cord-003926-ycdaw2vh	163	3	for	for	IN
cord-003926-ycdaw2vh	163	4	neuropathies	neuropathy	NNS
cord-003926-ycdaw2vh	163	5	as	as	IN
cord-003926-ycdaw2vh	163	6	indicators	indicator	NNS
cord-003926-ycdaw2vh	163	7	of	of	IN
cord-003926-ycdaw2vh	163	8	Zika	Zika	NNP
cord-003926-ycdaw2vh	163	9	virus	virus	NN
cord-003926-ycdaw2vh	163	10	infection	infection	NN
cord-003926-ycdaw2vh	163	11	,	,	,
cord-003926-ycdaw2vh	163	12	according	accord	VBG
cord-003926-ycdaw2vh	163	13	to	to	IN
cord-003926-ycdaw2vh	163	14	Health	Health	NNP
cord-003926-ycdaw2vh	163	15	Information	Information	NNP
cord-003926-ycdaw2vh	163	16	System	System	NNP
cord-003926-ycdaw2vh	163	17	data	data	VBZ
cord-003926-ycdaw2vh	163	18	Guillain	Guillain	NNP
cord-003926-ycdaw2vh	163	19	-	-	HYPH
cord-003926-ycdaw2vh	163	20	Barré	Barré	NNP
cord-003926-ycdaw2vh	163	21	syndrome	syndrome	NN
cord-003926-ycdaw2vh	163	22	,	,	,
cord-003926-ycdaw2vh	163	23	acute	acute	JJ
cord-003926-ycdaw2vh	163	24	disseminated	disseminate	VBN
cord-003926-ycdaw2vh	163	25	encephalomyelitis	encephalomyelitis	NN
cord-003926-ycdaw2vh	163	26	and	and	CC
cord-003926-ycdaw2vh	163	27	encephalitis	encephalitis	NN
cord-003926-ycdaw2vh	163	28	associated	associate	VBN
cord-003926-ycdaw2vh	163	29	with	with	IN
cord-003926-ycdaw2vh	163	30	Zika	Zika	NNP
cord-003926-ycdaw2vh	163	31	virus	virus	NN
cord-003926-ycdaw2vh	163	32	infection	infection	NN
cord-003926-ycdaw2vh	163	33	in	in	IN
cord-003926-ycdaw2vh	163	34	Brazil	Brazil	NNP
cord-003926-ycdaw2vh	163	35	:	:	:
cord-003926-ycdaw2vh	163	36	Detection	detection	NN
cord-003926-ycdaw2vh	163	37	of	of	IN
cord-003926-ycdaw2vh	163	38	viral	viral	JJ
cord-003926-ycdaw2vh	163	39	RNA	RNA	NNP
cord-003926-ycdaw2vh	163	40	and	and	CC
cord-003926-ycdaw2vh	163	41	Isolation	Isolation	NNP
cord-003926-ycdaw2vh	163	42	of	of	IN
cord-003926-ycdaw2vh	163	43	virus	virus	NN
cord-003926-ycdaw2vh	163	44	during	during	IN
cord-003926-ycdaw2vh	163	45	late	late	JJ
cord-003926-ycdaw2vh	163	46	infection	infection	NN
cord-003926-ycdaw2vh	163	47	Ethical	ethical	JJ
cord-003926-ycdaw2vh	163	48	Considerations	consideration	NNS
cord-003926-ycdaw2vh	163	49	for	for	IN
cord-003926-ycdaw2vh	163	50	Zika	Zika	NNP
cord-003926-ycdaw2vh	163	51	Virus	Virus	NNP
cord-003926-ycdaw2vh	163	52	Human	Human	NNP
cord-003926-ycdaw2vh	163	53	Challenge	Challenge	NNP
cord-003926-ycdaw2vh	163	54	Trials	Trials	NNPS
cord-003926-ycdaw2vh	163	55	;	;	:
cord-003926-ycdaw2vh	163	56	National	National	NNP
cord-003926-ycdaw2vh	163	57	Institutes	Institutes	NNPS
cord-003926-ycdaw2vh	163	58	of	of	IN
cord-003926-ycdaw2vh	163	59	Health	Health	NNP
cord-003926-ycdaw2vh	163	60	Bystander	Bystander	NNP
cord-003926-ycdaw2vh	163	61	risk	risk	NN
cord-003926-ycdaw2vh	163	62	,	,	,
cord-003926-ycdaw2vh	163	63	social	social	JJ
cord-003926-ycdaw2vh	163	64	value	value	NN
cord-003926-ycdaw2vh	163	65	,	,	,
cord-003926-ycdaw2vh	163	66	and	and	CC
cord-003926-ycdaw2vh	163	67	ethics	ethic	NNS
cord-003926-ycdaw2vh	163	68	of	of	IN
cord-003926-ycdaw2vh	163	69	human	human	JJ
cord-003926-ycdaw2vh	163	70	research	research	NN
cord-003926-ycdaw2vh	163	71	Zika	Zika	NNP
cord-003926-ycdaw2vh	163	72	vaccines	vaccine	NNS
cord-003926-ycdaw2vh	163	73	:	:	:
cord-003926-ycdaw2vh	163	74	Role	role	NN
cord-003926-ycdaw2vh	163	75	for	for	IN
cord-003926-ycdaw2vh	163	76	controlled	control	VBN
cord-003926-ycdaw2vh	163	77	human	human	JJ
cord-003926-ycdaw2vh	163	78	infection	infection	NN